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Cell migration is an exquisitely intricate process common to many higher organisms.  
Variations in the signals driving cell movement, the distance cells travel, and whether cells 
migrate as individuals, clusters, or as intact epithelia are all possible. Cell migration can be 
beneficial, as in development or wound healing, or detrimental, as in cancer metastasis. To 
begin to unravel the complexities inherent to cell migration, the Andrew lab uses the Drosophila 
salivary gland as a relatively simple model system for learning the molecular/cellular events 
underlying cell movement. The salivary gland begins as a placode of polarized columnar 
epithelial cells on the surface of the embryo that invaginates and move dorsally until a turning 
point is reached. There, it reorients and begins posterior migration, which continues until the 
gland reaches its final position along the anterior-posterior axis of the embryo. The broad goal 
of my work is to identify and characterize other key players in salivary gland migration.  I 
characterized two G-protein coupled receptors (GPCRs) – Tre1 and mthl5 – which are expressed 
dynamically in the embryo. By creating a null allele of Tre1, I found that Tre1 plays a key role in 
germ cell migration and affects microtubule organization in the migrating salivary gland. I 
created a mthl5 mutant allele using the CRISPR/Cas9 system. mthl5 plays a role in the cell shape 
changes that drive salivary gland invagination.  I have identified a potential ligand of Mthl5, fog, 
which plays a known role in mediating cell shape changes. Mutant alleles of fog phenocopy 
mutant alleles of mthl5. In a separate project, I characterized the role of the Fox transcription 
factor FoxL1 in the Drosophila embryo. Mis-expression of FoxL1 causes severe defects in salivary 
gland migration and muscle organization. I found that FoxL1 is upstream of the signaling 
molecule sema2a and plan to identify more targets through microarray analysis. Together, these 
data provide important information for how tissues integrate signaling information to arrive at 
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All organisms begin life as a single cell. How does this single cell provide the basis for an 
entire plant, worm or human?  Within an organism, how does a group of cells become an arm? 
How does this arm know where and when to form, and how does it “know” that it’s not a brain 
or an eye or a foot?  These types of questions fuel the field of developmental biology, and are 
partially answered by the genetic and transcriptional pathways that govern development.   
In the Andrew Lab, we use the Drosophila embryonic salivary gland to study the process of 
development. This simple model simple is specified by the activity of three transcription factors 
(Sex Combs Reduced, extradenticle,  and homothorax) that impart salivary gland identity to the 
cells that form the gland placode (Henderson and Andrew, 2000). The salivary gland starts as a 
flat placode of cells on the surface of the embryo that then invaginate to form the nascent 
salivary gland tube (Myat et al 2000b). As development progresses, the gland continues to 
internalize and move dorsally in the embryo. Shortly thereafter, the salivary gland begins to 
actively migrate posteriorly in the embryo. Throughout this process, the cells of the salivary 
gland are also undergoing active rearrangement. These rearrangements enable the gland to 
form a single layer epithelial tube; without them, flat placode would invaginate into something 
more resembling a cone. Much work has been done by our lab and others to understand the 
mechanism that govern gland invagination and migration (Myat and Andrew, 2000; Bradley et al 
2003; Vining et al 2004; Harris and Beckendorf,2005 Kolesnikov and Beckendorf, 2007), but 
several key questions remain. For example, what triggers the first cell to invaginate at the start 
of salivary gland internalization?  Moreover, the migration pathways that affect salivary gland 
migration do not cause fully penetrant defects, suggesting the presence of additional pathways 
that influence migration. 
G-protein coupled receptors (GPCRs) are interesting candidate molecules for answering 
some of these questions. GPCRs span the plasma membrane seven times, and are able sense 
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signaling molecules or ligands with the extracellular domains, and trigger signaling cascades 
through their intracellular domains. GPCRs are involved in migration of neural crest stem cells 
(Kruger et al 2003), single celled amoeba (Insall et al 1994), and clusters of lymphatic endothelial 
cells (Valtcheva et al 2013). A former graduate student, Melissa Vining, surveyed the Berkeley 
Drosophila Genome Project Expression Profile database and found that three GPCRs are 
expressed in the Drosophila embryonic salivary gland. One GPCR, CrzR, is a peptide hormone 
receptor that is not expressed until the end of embryogenesis when the glands have stopped 
migrating. Therefore, we suspected that this receptor had little to do with sensing signals that 
drive migration. The two other genes – Tre1 and mthl5 —became the basis for my thesis work.  
Tre1 is a member of the Orphan family of GPCRs in the fly and is most closely related to 
Rhodopsin family melatonin receptors in mammals. As its name suggests, the ligand for Tre1 is 
unknown. Work from other labs showed that Tre1 directs the migration of single-celled germ 
cells to the gonad (Kunwar et al 2003). Since Tre1 is expressed in the salivary gland during its 
migration, we investigated if Tre1 can also influence salivary gland migration. Using a previously 
characterized mutant allele (Tre1ΔEP5), we examined gland migration and morphology and saw 
no major defects. Closer examination of this allele, which was a small deletion in the 5’ UTR of 
Tre1, revealed that it was not a null allele and still expressed normal levels of Tre1 transcript. 
Therefore, this allele did not allow us to answer our initial question. To address this, we created 
a Tre1 null allele by homologous recombination (heretofore referred to as Tre1KO, where the 
entire open reading frame of Tre1was replaced by the white+ marker gene.  
Characterization of the Tre1KO allele showed major defects in germ cell migration. These 
defects were much more severe than the previously reported phenotypes. Moreover, Tre1 was 
initially characterized because the germ cells were trapped in the endoderm (Kunwar et al 
2003), but our analysis showed that germs cells in a Tre1KO disperse throughout the entire 
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embryo. This phenotype similar to that of the reported scattershot (sctt) allele of Tre1, a mutant 
that lacks an arginine residue crucial for Rhodopsin GPCR signaling (Kamps et al 2010). 
Moreover, Tre1ΔEP5 had been shown to affect the polarized localization of proteins such as E-
Cadherin and Rho1, a phenotype that we did not observe. Instead, our data, along with the sctt 
work, suggests that loss of Tre1 does not affect the mechanics of migration, but instead affects 
directed migration. 
We then used the new allele to examine salivary gland migration. Unlike the germ cells, 
salivary gland migration was unaffected by the loss of Tre1. The salivary gland migrates as an 
intact, polarized epithelium, and it receives multiple migratory cues from nearby tissues, such as 
the mesoderm, central nervous system, and fat body (Harris and Beckendorf, 2005; Vining et al 
2005; Kolesnikov and Beckendorf 2007). Loss of a single signaling pathway may not grossly 
affect salivary gland migration due to redundant cues from multiple tissues. Closer examination 
of the salivary gland did reveal altered microtubule dynamics in a Tre1KO. Tre1 is known to play a 
role in microtubule dynamics as it relates to polarized cell division of neuroblasts, and this role 
appears to be conserved in the salivary gland. We plan to further investigate these changes as 
they may cause subtle defects in salivary gland migration that have not been previously 
observed. 
The second GPCR I examined is methuselah like 5 (mthl5). The Methuselah family has 
sixteen members, and only one (mist/mthl1) has been fully characterized in the Drosophila 
embryo.  For decades, it was known that a GPCR was involved in gastrulation (Costa et al, 1994; 
Parks and Wieschaus, 1991). Both a ligand (fog) and the downstream signaling pathway (the Gα 
concertina) were known, but the receptor linking the two remained elusive. Recently, Mist was 
identified as the GPCR that binds Fog and mediates gastrulation. Because (1) Mist and Mthl5 are 
closely related, and (2) the cell shape changes that occur during gastrulation are similar to those 
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that happen during salivary gland invagination, we asked if Mthl5 mediates cell shape changes 
during the initial steps of salivary gland invagination, and if Fog is also a Mthl5 ligand. We found 
that Mthl5 is strongly localized to the apical membrane at the early steps of salivary gland 
invagination. Using the CRISPR/Cas9 system, we created a null allele of mthl5. We also made 
constructs for mthl5 over-expression and obtained fog mutant and over-expression lines. All of 
these constructs showed similar irregularities following invagination in the salivary gland apical 
membrane, suggesting an interaction between fog and mthl5. Given the nature of the 
irregularities and the early expression of both mthl5 and fog in the salivary gland, we wanted to 
look more closely at the cellular dynamics early in invagination. Interestingly, cells in the salivary 
gland placode do not decrease their apical area in a mthl5 mutant as they do in wild-type glands. 
This strongly suggests that Mthl5 is binding Fog and triggering the initial cell shape changes that 
drive invagination. Together, my work investigating Tre1 and mthl5 add insight into the role of 
GPCR signaling in tissue migration.  
The final project that I worked on was a departure from the GPCR studies. This work 
involved the characterization of the Fox (Forkhead box) transcription factor foxL1. Fox proteins 
play a variety of roles in Drosophila development (Lee and Frasch).  forkhead (fkh) itself plays a 
key role in salivary gland migration – in fkh mutants, the salivary gland cells do not undergo 
apical constriction and thus do not invaginate (Myat and Andrew, 2000a). The expression 
pattern of foxL1 (previously known as fd64a) was first observed by Rika Maruyama, a former 
post-doctorate fellow in the Andrew lab. Interestingly, the salivary gland migrates directly on 
top of a small subset of cells expressing foxL1. We indentified these cells as Ventral 
Intersegmental 5 (VIS5), a muscle that is located only in the thoracic region of the embryo. 
Moreover, I found that VIS5 is not one large muscle as previously described (Bate 1990), but is 
three independent fibers in each of the three thoracic segments. foxL1 is expressed in only the 
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second and third segments, which is where the salivary gland is positioned. Because of the 
intimate association of the salivary gland and the foxL1 expressing cells, I wondered if foxL1 and 
its targets were influencing salivary gland guidance. I created several lines to study the function 
of foxL1, including a knock-out via homologous recombination, a null allele via CRISPR/Cas9, and 
an mCherry knock-in that enables us to better characterize the foxL1 expressing cells. While loss 
of foxL1 does not overtly affect salivary gland migration, mis-expression of foxL1 causes the 
salivary gland to mis-migrate. Moreover, the same mis-expression causes severe defects in 
muscle formation. These data suggest that targets of foxL1 may include signaling molecules that 
affect how cells signal to one another. I identified to known signaling molecule sema2a as a 
target of foxl1 in VIS5 of thoracic segment three. Our future plans include performing a 
microarray with the alleles I have made to gain a better understand of the targets of foxL1 that 
are causing salivary gland mis-migration and muscle malformation.  
Overall, my thesis work has contributed to a better understanding of how the salivary gland 
is formed. The characterization of Tre1 and mthl5 have broader implications for how GPCRs 
function during development. Now that I have created null alleles of Tre1, mthl5, and foxL1, our 
lab can begin to evaluate the role of compensatory signaling in directing salivary gland 
migration. By using double and triple mutants, we can examine the more nuanced roles that 
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The past two decades have witnessed incredible progress toward understanding the genetic and 
cellular mechanisms of organogenesis.  Among the organs that have provided key insight into 
how patterning information is integrated to specify and build functional body parts is the 
Drosophila salivary gland, a relatively simple epithelial organ specialized for the synthesis and 
secretion of high levels of protein.  Here, we discuss what the past couple of decades of research 
have revealed about organ specification, development, specialization and death, and what 





Drosophila has proven to be an ideal model system for revealing the molecular and cellular 
underpinnings of organ development.  In particular, the salivary gland (SG) has been crucial for 
studying how polarized epithelial organs form and specialize. The SG starts out as two plates of 
approximately one hundred fifty cells each on the ventral surface of the embryo (Figure 1).  
Following internalization and initial tube formation, the fully polarized SG elongates and actively 
migrates to its final position in the embryo. Each of the secretory glands connects to an 
individual duct. Individual ducts connect to one another in a central common duct, which 
attaches to the mouthparts. The SG that forms during embryonic development persists through 
larval life to the beginning of pupation, when it produces a final burst of secretion before being 
destroyed during metamorphosis. Subsequently, the imaginal ring cells, which are found 
between the SG duct and secretory cells and that proliferate during larval and pupal stages, 
form the adult gland.   
 
As a model system, the SG has been a valuable platform for addressing questions of cell fate 
specification and maintenance, and for learning how cells coordinate their activities to build an 
organ of the right size, shape and position in the animal. The SG has been excellent in revealing 
how the sequential deployment of gene expression programs controls all aspects of epithelial 
tube form and function. Morphogenetic processes, including invagination, tube elongation and 
migration, continue to be studied in the SG, and new molecules driving these events are being 
uncovered. The SG has also been used extensively to study programmed cell death in the 
context of a living organism. In the following review, we discuss our current understanding of SG 
formation, maintenance and death, and how findings from these studies have provided insight 
into more general aspects of organ development and gene function.  
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Figure 1.  Confocal images of the embryonic SG. (A) Ventral views of the SG stained with 
nuclear markers. The secretory portion of the SG forms from two placodes of cells on the 
surface of the embryo, with the duct precursors located between the two secretory placodes (st 
10).  At this stage, the expression of duct (red) versus secretory (green) markers is not so clear.  
During st 11, the gland invaginates into the embryo.  At this stage, the distinction between duct 
(red) and secretory markers (green) is more evident.  As development progresses (st 12-15), the 
secretory tubes elongate, and the individual duct (id) and common ducts (cd) form.  (B) Lateral 
views of SG during elongation and migration.  All membranes are marked in green, with the 
apical membrane specifically marked in red. Following invagination, the SG moves dorsally (st 
11) and then turns (st 12) and migrates posteriorly. Posterior migration continues (st 14-16) until 
the SG reaches its final resting place. Throughout this dynamic process, the SG migrates as an 








SPECIFICATION OF SALIVARY GLANDS 
SG specification and the distinction between secretory, duct and imaginal ring (pre-adult) cell 
populations occur through the integration of anterior-posterior patterning information, largely 
mediated by HOX genes, and the dorsal-ventral patterning system, specifically Dpp-signaling in 
dorsal cells and EGF-signaling along the ventral midline. Since SG precursors stop dividing once 
specified, the process of specification determines both where the primordia will arise and the 
final number of cells in the fully formed tissue.   
 
Anterior-posterior patterning genes and SG specification 
Scr, Exd and Hth: positive determinants of SG fates 
SG specification requires positive input from three transcription factors: Sex combs reduced 
(Scr), Extradenticle (Exd) and Homothorax (Hth) (Figure 2)1-3.  SGs form from the ventral 
ectodermal cells of parasegment 2 (PS2), which express Scr, the only spatially limited 
component required to activate SG formation. Exd, a TALE (three amino acid loop extension) 
homeodomain protein that is expressed throughout the embryo3, is also required for SG 
formation.  Scr and Exd bind each other and bind DNA.  The physical association of Exd with Scr 
distorts the N-terminus of the Scr homeodomain, allowing it to fit into the relatively narrow 
minor groove of its target DNA sites4. Exd activity is limited by regulated nuclear entry, mediated 
through binding to its essential cofactor Hth5.  Hth, another broadly-expressed TALE protein 
with highly conserved mammalian orthologues (MEIS1,2,3 and PREP1,2 proteins) is also 
absolutely required for SG formation2. Whether Hth is directly involved in the binding of the Scr-
Exd complex to target sequences is not clear, but the homeodomain of Hth, which is present in 
only one of two alternative splice forms, is not required for Scr-Exd dependent activation of the 
single SG target reporter that has been directly tested6.  Early expression of Scr in SG precursors  
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Figure 2.  SGs are specified by the integration of patterning information along both major 
body axes. Scr (purple in cartoon), a Hox protein expressed in PS2 and dorsal cells of PS3, is 
the only spatially-regulated activator of SG cell fates. The more globally expressed Exd and Hth 
Tale-homeodomain proteins are also required for SG formation and these proteins function at 
multiple levels. Tsh (brown in cartoon), expressed in PS3-13, and AbdB (red in cartoon), 
expressed in PS14, block SG activation in the trunk and abdomen. SG formation is limited to the 
ventral cells of PS2 by Dpp signaling (blue in cartoon) in the dorsal cells.  EGF-signaling (green in 
cartoon) along the ventral midline specifies the duct cell fate by blocking expression of Fkh.  In 
turn, Fkh plays a major role in maintaining the secretory cell fate by regulating itself as well as 
multiple other secretory-specific genes and by blocking expression of duct-specific genes. Ser, 
which is expressed in duct cells, signals adjacent Notch expressing cells in the common 
secretory/imaginal ring cell primordia to become imaginal ring cells (dark blue in diagram) – the 







requires both Exd and Hth, revealing that TALE proteins function at multiple levels in SG 
specification2.  Most other Hox proteins also require Exd and Hth for target gene regulation3,7.  
One exception is Abdominal-B (Abd-B), which instead represses Exd and Hth expression to 
mediate specification of another embryonic organ in Drosophila, the posterior spiracle8,9. 
 
Ectopic expression of Scr driven by heat shock or by ubiquitous Gal4 causes ectopic expression 
of many SG markers in all segments at early stages1,4,10,11; expression of SG markers persists, 
however, only in PS2 and the two parasegments more anterior, PS0 and PS1. Expression of SG 
markers in posterior segments is transient, disappearing completely by mid-embryogenesis11. 
Moreover, SG marker-expressing cells in posterior regions do not invaginate to form SGs – which 
does occur in the more anterior regions. Persistent expression of SG markers induced by global 
expression of Scr is only observed in PS3-13 in the complete absence of teashirt (tsh) function 
(see below)10.   
 
Posterior Hox genes and Tsh:  Negative regulators of SG fates 
SG formation is further defined by negative regulation from two transcription factors. The major 
block to SG activation in PS3-13 is Teashirt, a zinc finger containing transcription factor (Figure 
2)10,12.  In the absence of Tsh, Scr early expression expands to PS3 and SGs form in PS3.  A role 
for Tsh in blocking Scr-induced SG formation fits well with the previously described role for Tsh 
in distinguishing trunk from head13,14.  Tsh directly regulates at least one SG target gene 12 and 
Tsh has been shown to physically contact Scr 15; the exact mechanisms whereby Tsh prevents 
Scr’s SG-inducing activity, however, remain unclear. Nonetheless, Tsh appears to function at two 
levels: repression of early Scr expression in the ventral cells of PS3 and repression of Scr’s SG-




In PS14, Scr-induced SG gene activation is blocked by another Hox gene, Abdominal B (Abd-B) 
(Figure 2)10.  The block by Abd-B is not absolute and may be due to “posterior prevalence”, a 
phenomenon wherein more posteriorly expressed Hox proteins block the activities of more 
anteriorly expressed Hox proteins16-21.  Recent work suggests that posterior prevalence occurs 
because posteriorly expressed Hox proteins compete more successfully for the shared essential 
cofactor Exd6.  Alternatively, given recent findings that Abd-B shuts off expression of Exd and 
Hth, the block by Abd-B could be due to the absence of these essential SG-inducing cofactors in 
PS148. 
 
Dorsal-ventral patterning genes further refine SG coordinates 
Although Scr, Exd and Hth drive SG formation, not all cells that express these transcription 
factors become SGs; SGs form only from ventral ectodermal cells.  Thus, dorsal-ventral 
patterning information also feeds into the system. Loss of dorsal (dl), a major early determinant 
of ventral cell fates, results in a complete loss of SG marker expression1.  Dl promotes SG 
development by blocking ventral expression of the gene encoding the BMP ligand 
Decapentaplegic (Dpp), which is normally expressed in only dorsal cells. In turn, Dpp signaling 
blocks SG formation (Figure 2); loss of any one component in the Dpp signaling pathway results 
in the dorsal expansion of all tested SG markers1,22,23.  
 
Maintaining the SG fate 
Although Scr, Exd and Hth are absolutely required for SG formation, their expression/nuclear 
localization disappears from the SG shortly after the onset of morphogenesis2. So, how is cell 
fate maintained in this tissue? Among the genes activated by Scr, Exd and Hth is the winged 
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helix transcription factor Fork head (Fkh), a key player in maintaining SG fates (Figure 3). Fkh, 
the single FoxA family protein in flies, maintains its own expression24 and the expression of two 
other transcription factor genes that are highly expressed in the secretory cells – CrebA, which 
encodes a bZip transcription factor related to the Creb3/Creb3L family of mammalian proteins, 
and Sage, which encodes a less well conserved bHLH transcription factor distantly related to 
several mammalian proteins25-27.  fkh affects the expression, either directly or indirectly, of 
about 60% of all SG genes, including those it represses in the SG duct (see below), as well as 
downstream targets of CrebA and Sage11,28.  As will be discussed later, sustained expression of 
Fkh, Sage and CrebA is critical for SG function26-29. Fkh, Sage and another downstream 
transcription factor Senseless (Sens) are also required for secretory cell survival; embryos 
mutant for any one of these three genes undergo extensive apoptotic SG cell death following 
elevated expression of the apoptotic activator genes, reaper (rpr) and head involution defective 
(hid)25,28,30. Moreover, Fkh is essential for SG morphogenesis25. 
 
Duct versus secretory fate specification 
Ducts form from approximately 25-30 cells on each side of PS2 between the ventral midline and 
the more laterally positioned SG placodes. Once the SG has internalized, duct and secretory cells 
can be distinguished at the molecular level since expression of several genes is restricted to only 
one of these domains (Figure 1). For example, fkh and its many transcriptional targets, are 
expressed to high levels in the gland cells and levels are either reduced or absent in duct cells. In 
contrast, expression of several other genes, including Serrate (Ser)31 32, breathless (btl)33 and 
dead ringer (dri)34, is duct-specific. The secretory versus duct cell distinction is not so clear prior 
to invagination.  Although levels of secretory gene expression in the cells flanking the midline 
are generally lower, there is considerable cell-to-cell variation, variation that disappears as  
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Figure 3. The secretory specific genes directly activated by Scr, Exd and Hth include several 
transcription factors – CrebA, Fork head (Fkh), Sage and Huckebein – as well as a splicing 
factor – Pasilla.  The early expressed genes both maintain and implement the secretory cell fate 
decision.  Pasilla and CrebA function to increase secretory capacity in the professional secretory 
cells of the SG.  Fkh maintains its own expression as well as expression of CrebA and Sage.  Fkh 
also controls morphogenesis and in collaboration with Sage and their downstream target 
Senseless, activates expression of SG-specific genes and represses the apoptotic genes reaper 







morphogenesis proceeds (Figure 1).  The changes in secretory versus duct cell marker 
expression may reflect the graded distribution of the signal(s) that induce(s) specific cell fates 
(e.g. EGF – see below) followed by boundary sharpening through repression and/or activation of 
gene expression by the transcription factors expressed to higher levels in one versus the other 
cell type.  
 
Dorsal specifies duct cell fates through activation of EGF signaling 
Dl plays an instrumental role in distinguishing SG duct versus secretory cell fates (Figure 4).  Dl 
(through both direct and indirect mechanisms) activates expression of the bHLH transcription 
factor Single minded (Sim) along the ventral midline35. In turn, Sim activates expression of 
rhomboid (rho)36, which encodes the spatially limited component required for Epidermal Growth 
Factor (EGF) signaling37. Sim, Rho and the EGF ligand Spitz are all required for duct specification; 
loss-of-function mutations in any one of these genes results in a ventral expansion of secretory 
cell markers at the expense of duct cell markers1,38.  
 
EGF signaling specifies duct cell fates by repression of fkh 
The boundary between gland and duct cells is determined by the combination of two negatively 
regulated steps; the EGF signaling pathway represses fkh expression in the duct cells and Fkh 
represses expression of duct-specific genes in the gland cells38,39. Trachealess (Trh), a basic helix 
loop helix (bHLH)-PAS transcription factor, is initially expressed throughout the entire SG 
primordia22. As with other duct genes, trh expression is repressed by Fkh, remaining on in only 
duct cells22,38. Early experiments suggested that loss of trh resulted in a loss of expression of all 
other tested duct markers38; Trh appears, however, to affect expression of only a subset of duct 
genes, in many cases simply boosting their expression levels39.  Thus, EGF-dependent duct cell  
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Figure 4. The duct is specified by Scr, Exd and Hth in combination with EGF signaling.  EGF 
signaling blocks expression of Fkh in the most ventral cells of PS2, allowing the expression of 
duct-specific genes such as Trh and its downstream targets, btl, eyg and, presumably, other 
genes.  The absence of Fkh expression in the ventral cells also allows expression of two other 








specification appears to be mediated largely by repression of fkh expression in future duct cells 
(Figure 4).   
 
Notch signaling specifies the adult SG primordia 
Notch signaling through Ser, one of two Drosophila Notch ligands, specifies the imaginal ring 
cells (Figure 2)39.  Ser expression is duct specific31,32, whereas Notch is transiently upregulated in 
secretory cells40.  Ser loss results in the absence of imaginal ring cells39.  Correspondingly, a 
mutant allele of Notch that specifically affects its response to Ser, but not to Delta, the other 
Notch ligand in flies, also results in a loss of the imaginal ring cells41.  Although it is clear that 
imaginal ring cells are specified during embryogenesis39, whether this happens prior to or during 
tube morphogenesis is unknown.  Roles for Notch signaling in specifying distinct cell types 
within developing organs has also been documented in the vertebrate vasculature42, pituitary 





CONSTRUCTION OF THE SECRETORY TUBES 
Once specified, the SG primordial cells undergo morphological changes and internalize to form 
epithelial tubes. Since no further cell division or cell death occurs during SG differentiation, all 
subsequent changes take place within and between pre-existing cells. Polarity is maintained 
throughout the entire process of tube morphogenesis and, in the fully internalized SG tubes, the 
apical domain forms the luminal surface and the basal domain contacts surrounding tissues 
(Figure 1).  
 
Regulated sequential secretory cell internalization 
The first SG cells to internalize are located in the dorsal-posterior regions of the SG placodes, 
plate-like structures of columnar epithelial cells that form shortly after Scr expression is first 
observed in the primordia.  The dorsal-posterior cells undergo apical constriction, a process 
whereby nuclei move to the basal domain and the apical domain constricts to create the 
pyramidal shaped cells thought to drive tube internalization46.   Subsequently, neighboring cells 
invaginate to create nascent epithelial tubes, with their newly formed lumens contiguous with 
the apical surface of the SG cells still on the surface. Through a series of less well-characterized 
shape changes and cell rearrangement, the remaining placode cells internalize to form 
elongated fully internalized epithelial tubes.  
 
Fkh is required for secretory cell internalization 
Fkh plays a major role in SG morphogenesis; the SG primordia in fkh mutant embryos rescued 
from cell death do not undergo apical constriction and completely fail to internalize. Basal 
movement of nuclei, however, is unaffected by fkh loss, indicating that the two processes – 
apical constriction and basal nuclear movement – are separable25.  Fkh, as a transcription factor, 
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likely controls SG invagination (and other processes) indirectly, through its downstream targets; 
the Fkh targets that mediate internalization, however, remain to be identified and/or 
characterized. 
 
Rho-GTPases and the actinomyosin cytoskeleton mediate secretory gland internalization 
Several molecules that directly affect SG internalization have been discovered, many of which 
are known to be more generally involved in cell shape changes (Table 1).  Mutations in folded 
gastrulation (fog), a secreted ligand for the G protein-coupled receptor Mist47, and RhoGEF2, a 
Rho GTPase exchange factor required for invagination of the ventral furrow48,49, result in partial 
failure of SG internalization49,50. RhoGEF2 affects apical constriction by regulating apical 
accumulation of Spaghetti squash (Sqh), the Myosin regulatory light chain49. Embryos mutant for 
18 wheeler (18W), a Toll-like receptor protein, and two Rho-GAPs, RhoGAP5A and 
RhoGAP88C/Crossveinless-c (CV-C), also show delays and/or partial failure of SG internalization, 
further supporting the idea that Rho signaling is critical50. Indeed, both Rho1 mutants and 
embryos with SG-specific expression of a dominant-negative Rho1 construct showed partial 
defects in SG invagination51. Rho1 regulates SG internalization by two mechanisms: 1) 
upregulation and apical localization of transcripts for crumbs (crb), which encodes an apical 
membrane protein necessary for the establishment and maintenance of apical-basal polarity 
and for apical membrane expansion52-55, and 2) induced apical constriction and cell shape 
changes mediated by Rho-kinase (Rok)51.  
 
As with other morphogenetic processes, cytoskeletal events associated with cell shape changes 
are key for SG tube formation. Indeed, a prominent multi-cellular Myosin II cable forms around 
the SG placode prior to invagination. This cable is maintained throughout the process of SG  
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Table 1: Genes implicated in salivary gland (SG) morphogenesis with their currently 
understood roles and interactions 
 
  
Ligand for GPCR Mist in mesoderm Transmembrane protein
Genetically interacts with 
Cad99C 
Coordinates invagination





Influences apical membrane 
release from  ECM and 
consequent cell 
rearrangements 
Increases Crb levels Upstream of Crb 
Maintains Crb, aPKC, and Stardust 
apical localization
Regulates moesin activity 
(indirect) 
Apical membrane protein Lolal 
Mediates nuclear localization 
of Rib in the SG (and other 
ectoderm) 
Establishes and maintains 
apical/basal polarity 
ERM family member; actin 
linker
Along with aPKC, prevents Rok 
accumulation and MyoII cable 
formation in SG
Increases apical stiffness 
when phosphorylated 
aPKC 
Along with Crb, negatively regulates 
Rok and MyoII
Cdc42 Rho GTPase; activates Pak1 
Rho kinase Serine-threonine kinase 
Induces cell-shape changes and 
apical constriction
Regulates lateral E-Cad 
endocytosis through Merlin, 
Dynamin, and Rab5 
Positive regulator of MyoII Cell-cell adhesion
Rho guanine nucleotide exchange 
factor
Mediates cell shape changes 
in the SG [e.g. expansion 
along the apical P/D axis] 
Regulates apical constriction via Sqh 
localization
Myosin regulatory light chain
Creates intracellular myosin network




Component of Rho pathway
Coordinates invagination
Non-receptor tyrosine kinase





























Process: Secretory cell invagination 






internalization and cinches up as more cells are internalized, suggesting that tension created by 
this cable provides a motive force driving internalization56.  The myosin cable forms at the 
interface between peripheral SG cells and their immediate non-SG neighbors through 
downregulation of Rok.  The high levels of Crb and atypical protein kinase C (aPKC) found within 
SG cells (and not in neighboring non-SG cells) negatively regulate Rok accumulation, preventing 
the formation of the Myosin II cable within the placodes56. Actin reorganization is also essential  
for timely invagination of the SG. Null mutations in Tec29/Btk29A, a member of the Tec family of 
non-receptor tyrosine kinases, cause a delay in SG invagination due, in part, to a shift in the 
equilibrium between F- and G-actin57. Although most mutants with invagination defects appear 
to affect the apical surface, a recent study has revealed that Guanylyl cyclase at 76C (Gyc76C) 
and its downstream cGMP-dependent kinase 1 (DG1) affect invagination, collective migration 
and SG lumen shape partly by regulating localization of Talin and the laminin matrix surrounding 





ELONGATION OF THE SECRETORY TUBES 
As the SG primordia internalize and the resulting tube moves to its final correct position in the 
embryo, the tube elongates through both cell shape change and cell rearrangement.  
 
Tube elongation by cell elongation 
Hkb regulates polarized growth and delivery of apical membrane 
Polarized growth and delivery of apical membranes is critical for tube elongation59. In embryos 
mutant for huckebein (hkb), which encodes a zinc finger transcription factor60, the SG cells 
internalize but almost completely fail to elongate, resulting in small ‘puck-shaped’ SGs with very 
little apical surface area46,59. Hkb controls SG apical expansion through increased translation 
and/or stabilization of Crb52-55, and increased transcription of klarsicht (klar), which encodes a 
putative regulator of the dynein ATPase that mediates microtubule-dependent vesicle transport 
to the apical surface61,62.  Thus, Hkb facilities tube elongation through both Crb-mediated apical 
membrane expansion and Klar-driven apical targeting of membrane vesicles (Table 1).  
 
Ribbon reduces apical stiffness to facilitate membrane expansion 
Ribbon (Rib), a BTB-containing transcription factor, modulates apical membrane expansion to 
elongate the SG, and two other tubes, the trachea and Malpighian tubules63-65. rib mutant SGs 
achieve only 60% of the WT lumen length and live imaging studies indicate that rib mutant SGs 
elongate more slowly than WT66. Rib interacts with Lola like, another BTB-domain containing 
protein required for robust nuclear localization of Rib, to upregulate crb transcription and to 
downregulate the activity of Moesin (Moe), a protein that cross-links the apical membrane to 
the apical cytoskeleton65,67,68. Genetic and mechanical analyses suggest that the increased apical 
stiffness caused by increased Moe activity (increased phosphorylated Moe) is a major 
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contributor to the rib mutant phenotype65,66. Thus, tube elongation requires not only the 
generation of sufficient apical membrane for expansion but also modulation of the mechanical 
properties of the apical domain (Table 1). 
 
Tube elongation by cell rearrangement 
Rho1 controls tube length by cell elongation and rearrangement 
To achieve fully elongated tubes, the SG also undergoes cell rearrangement.  This process 
simultaneously reduces the number of cells in circumference and increases the number of cells 
along the length of the tube. Some molecules, such as the Rho1 GTPase, control SG lumen size 
by regulating both cell rearrangement and cell shape. Proximal SG cells of Rho1 mutant embryos 
fail to rearrange and the apical domains do not elongate fully69. SG-specific knockdown of Rok 
by RNAi causes similar defects as observed in Rho1 mutants, suggesting that Rho1 affects tube 
architecture, at least in part, through Rok regulation of myosin mechanics69.  Rho1 also appears 
to work with Rib to limit apical phosphorylated Moe, suggesting more direct effects on the 
apical actin cytoskeleton, an idea supported by the observed changes in F-actin distribution69. 
Interestingly, cell rearrangements mediated by Rho, Rock and Myosin II also drive tube 
elongation in the vertebrate gut70, suggesting a conserved role for Rho1 in cell rearrangement. 
 
Reduced cell-cell adhesion facilitates cell rearrangement 
Allowing cells to rearrange while maintaining polarity requires tight regulation of the junctional 
complexes that hold epithelial cells together. Since septate junctions (structures equivalent to 
vertebrate tight junctions) do not fully mature until late embryogenesis71, the major junction 
requiring modulation during SG cell rearrangement is the adherens junction (AJ). Regulation of 
cell rearrangement in the SG appears to be through Rac1 modulation of the AJ protein E-
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Cadherin (E-Cad)72. Too little Rac1 – through either mutations in multiple Rac1 genes [Rac1, Rac2 
and Mig 2-like] or through SG expression of a dominant-negative Rac1 construct – results in 
increased E-Cad (and another AJ protein – -
localized E-Cad blocks cell rearrangement. Consequently, the distal gland, which likely forms 
without significant cell rearrangement, forms relatively normally, but many of the proximal SG 
cells, which must rearrange during internalization, remain on the embryo surface. As the distal 
cells continue to migrate posteriorly in the rac1 mutants, the gland often breaks, resulting in 
multiple small glands surrounding separate lumens. Correspondingly, excessive Rac activity 
results in reduced E-Cad at the AJs and a corresponding loss of adhesion – SG cells disperse and 
eventually die. The dispersion phenotype driven by SG expression of constitutively-active Rac 
can be rescued simply by overexpressing E-Cad, supporting the idea that Rac affects cell 
rearrangement largely through the localization of E-Cad.  Rac1 appears to modulate E-Cad pools 
in the different membrane domains by regulated endocytosis, since altering the endocytic 
pathway also alters the Rac1 phenotypic outcomes72.   
 
Not surprisingly, E-Cad turnover is also key to the proximal-distal elongation of individual SG 
cells.  In this case, endocytic turnover of E-Cad is differentially regulated along the axis of 
polarity by p21-activated kinase 1 (Pak1).  Pak1 belongs to a serine-threonine kinase family that 
in other systems binds and is activated by Cdc42 and/or Rac to regulate diverse biological 
processes73,74. SG expression of dominant-negative Cdc42 and/or loss of Pak1 results in a 
complete loss of lateral membrane pools of E-Cad and a widening of cells along the dorsal-
ventral axis.  Correspondingly, high-level expression of activated Pak1 depletes the apical pools 
of E-Cad, resulting in the loss of the single shared apical lumen and the appearance of multiple 
intercellular lumena. The intercellular lumena arise between cells in the lateral domains from 
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endocytosed E-Cad containing vesicles75. Pak1 activity in the SG depends on Rab5, Dynamin and 
the ERM protein Merlin, a substrate of Pak175,76.  
 
Just as cells have to release their attachment to their neighbors to rearrange, they also have to 
release their attachment to the matrix77. SGs mutant for AdamTS-A, which encodes an apically-
targeted and secreted zinc metalloproteinase, have highly irregular luminal surfaces due to a 
failure of the cells to easily rearrange during tube elongation and posterior migration.  AdamTS-
A null mutants also have over-stretched apical domains in the distal-most SG cells and show 
increased accumulation of apical actin, suggesting that these cells are under increased tension.  
Further support for a role of AdamTS-A in releasing the apical cell surface from the apical matrix 
emerges from the finding that null mutations in Cadherin99C (Cad99C) rescue the apical 
irregularities associated with AdamTS-A loss77.  Cad99C, an atypical cadherin with a large 
extracellular domain, localizes to the apical surface of SG cells and other epithelia78,79 80. 
Through its attachment to (currently unidentified) apically secreted proteins, Cad99C is 
proposed to resist and balance the forces driving tube elongation80. Thus, associations between 





POSITIONING THE SALIVARY GLANDS 
To attain its final correct position in the embryo, the SG actively migrates in direct contact with 
several other tissues.  Whereas some of the contacting tissues may serve only as tracks or 
barriers to migration, others also provide guidance cues to either attract or repel the gland.  
 
Surrounding tissues promote SG movement 
The visceral mesoderm provides a track for SG migration 
The internalization process positions the secretory tubes in an approximate dorsal-posterior 
orientation, with the distal most cells directly contacting the dorsally-positioned visceral 
mesoderm (VM) (Figure 5).  As the secretory cells sequentially contact this tissue, they turn and 
migrate along it to eventually arrive at their final position, with the long axis of the tube aligned 
with the long axis of the embryo. In mutants where the VM is discontinuous, the SG will often 
continue to move dorsally instead of turning posteriorly, although the gland still appears to 
maximize contact with whatever VM tissues remain in these mutants81. Posterior migration of 
integrins77,81. With loss of any of these molecules, the SG completely fails to migrate; SG tubes 
still elongate, however, resulting in buckled, U-shaped tubes. These findings suggest that the VM 
provides a suitable substrate for SG migration.  At later stages, contact between the SG and VM 
is abrogated by the ingression of caudal mesoderm cells between the gland and VM.  Failure of 
this population to migrate results in the continued attachment of the SG to the VM and, during 





Figure 5. The SG contacts or comes close to several tissues as it migrates to its correct final 
position in the embryo, including the circular (c) visceral mesoderm  (cVM), the longitudinal (l) 
visceral mesoderm (lVM), the fat body, the somatic musculature and the central nervous 
system.  The cVM provides a suitable substrate for posterior SG migration through the 
expresses αPS1βPS integrin, which also binds the secreted laminin.  Both the integrins and 
laminin are essential for posterior migration (starred). The lVM migrates between the SG and 
the cVM to detach these two cell types.  The SG also expresses several receptor genes, which 
allow it to properly navigate to its final correct position in response to local sources of the 
corresponding ligands. In turn, the SG is likely to also provide cues for the migration of other cell 








Other tissues also provide SG migration cues 
The SG either directly contacts or comes near several other tissues during migration, including 
the somatic muscle, the fat body, the central nervous system (CNS) and the gastric caeca, long 
tubular extensions of the midgut that emerge during later embryonic stages (Figure 5)82.  
Studies suggest that most, perhaps all, of these tissues provide cues that direct SG movement.  
Several guidance cues have been discovered that seem to function either to attract or repel the 
migrating SG.  
 
Molecular guidance 
Like most migrating tissues, the SG responds to a range of guidance cues during its posterior 
migration.  The Netrin/Frazzled (Fra), Slit/Robo, and Wnt/Derailed (Drl)/Frizzled (Fz) pathways 
have all been shown to influence SG migration83,84 (Figure 5). The Netrin ligands are expressed in 
both the VM and CNS, whereas their receptor Fra is expressed in the SG. Loss-of-function 
mutations in the netrin genes or in fra cause a mild migration defect of the glands curving away 
from the midline84. Overexpression of NetrinB (NetB) causes more pronounced mis-migration of 
the SG towards the source of expression, suggesting that NetB acts as an attractant for the fra-
expressing SGs. Conversely, Slit acts as a strong SG repellent. Loss of Robo1 and Robo2, 
receptors for Slit, which is expressed in midline cells, cause the SG to mis-migrate towards the 
midline84.  Wnt signaling also acts to repel the migrating SG83. Wnt4 and Wnt5 are expressed in 
the CNS; their respective receptors Fz/Fz2 and Drl are expressed in the SG. Loss of any of these 
factors causes the SG to curve towards the CNS. The PDGF/VEGF pathway has been implicated 
in SG migration: mutations in both the receptor and two of the ligands result in ventrally curved 
SGs83. It remains unclear, however, whether this pathway affects migration or some other 
aspect of SG morphology. Additional cues, provided by other cell types, will likely be discovered 
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to influence final SG placement; disrupting these pathways, however, may lead to relatively 
subtle defects in SG placement given the number of tissues providing guidance cues.  How an 
intact epithelial tissue, such as the SG, integrates signals from multiple different sources to 





FORMATION OF THE SALIVARY DUCT 
Duct cells internalize by wrapping and convergent extension 
Duct cells internalize immediately following the secretory cells, beginning with the cells that will 
form the individual ducts (Figure 1)85.  These cells form tubes by a wrapping type mechanism, 
whereby the cells become wedge-shaped – wider on the basal side, narrower on the apical side - 
as they sink below the embryo surface86.  The internalizing individual duct cells eventually meet 
and close, beginning distally and extending proximally until they meet up with the common duct 
primordia at the ventral midline. Once the individual ducts tubes have formed, the common 
duct tube forms from the more anterior ventral primordia using a similar mechanism.  The duct 
tubes also continue to elongate, eventually forming tubes that are about two cells in diameter 
for the individual ducts and 3-4 cells for the common duct.  Thus, duct elongation occurs by 
convergent extension85, a common developmental process that narrows and elongates tissue by 
cell intercalation87 and that has been implicated in tube elongation in several Drosophila 
tissues88-91 as well as in the vertebrate neural tube92. Posterior migration of the gland coupled 
with the attachment of the duct to the mouthparts may provide the tensile forces required for 
duct elongation by cell intercalation. 
 
Trh and Eyg are required for duct cell invagination 
Trh plays a critical role in internalizing both individual and common ducts since the entire duct 
fails to invaginate and remains on the ventral surface in trh mutant embryos22,38. eye gone (eyg), 
which encodes a Pax transcription factor positively regulated by Trh, is required to distinguish 
individual from common duct domains85. Eyg is also necessary for morphogenesis of the 
individual duct tubes85; in eyg mutants, the individual ducts often fail to elongate to connect the 
secretory cells to the common duct, resulting in closed internalized secretory tubes that are 
39 
 
disconnected from the rest of the digestive tract.  We expect that many more genes that 





SALIVARY GLAND FUNCTION:  SECRETION AND PRODUCTION OF TISSUE-SPECIFIC GENE 
PRODUCTS 
As the SG undergoes the process of morphogenesis, it simultaneously begins to specialize into a 
secretory organ. Several transcription factor genes that are induced in the earliest stages of SG 
formation – fkh, sage and CrebA - continue to be expressed throughout the life of this organ.  
These same genes are also expressed in the adult gland, suggesting that they may play similar 
roles in both the larval and adult tissues.  As will be discussed, Fkh, Sage and CrebA play key 
roles in the main function of the SG – the synthesis and secretion of high levels of protein 
(Figure 3). 
 
Fkh, Sage (and Sens) regulate SG-specific gene products 
fkh is required for expression of most SG genes 
As mentioned previously, Fkh controls many aspects of SG development, from specification to 
internalization to gland maintenance. How can Fkh have so many distinct functions in the SG 
when it is also expressed and required in multiple other tissues93? Whereas there may be some 
commonality in Fkh’s role in some tissues, Fkh also has distinct tissue-specific functions. In the 
SG, tissue-specific Fkh function is largely mediated by Sage28, a SG-specific bHLH transcription 
factor. 
 
Sage – a SG-specific bHLH transcription factor – provides specificity to Fkh function 
In embryos, Sage (salivary gland E-box binding protein) is expressed only in the SG94, making it a 
prime candidate for controlling SG identity and specialization.  sage null mutant SG cells 
internalize and form elongated secretory tubes, but undergo massive apoptotic cell death once 
fully internalized. This finding suggests that even after gland formation and internalization, the 
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SG must be actively kept alive throughout development. sage mutant glands can be rescued 
from death by co-expression of the anti-apoptotic P35 protein.  Although overall gland 
morphology and polarity is normal, the rescued glands have thin, irregular lumens28. 
 
Microarray studies reveal that Sage regulates SG-specific secreted or transmembrane proteins 
and their modifiers. Interestingly, expression of Sage targets entirely depends on Fkh; loss of fkh 
resulted in a complete loss of SG expression of Sage targets.  Moreover, experiments expressing 
either fkh or sage alone or co-expressing both genes reveal that the combined activity of Fkh 
and Sage is required for inducing Sage target gene expression in multiple distinct cell types27,28.  
Moreover, Sage, Fkh and another downstream SG transcription factor – Sens – localize to largely 
overlapping sites on SG polytene chromosomes28.  Thus, Fkh and Sage (+/- Sens) clearly work 
together to directly regulate expression of SG-specific genes; the exact mechanism by which 
these proteins collaborate, however, remains to be elucidated.  Similar collaborations between 
FoxA and Sage-related bHLH proteins are likely to underlie tissue specific gene expression in 
mammalian dopaminerginic neurons95,96, pancreas97-99, as well as the secretory cells of the C. 
elegans pharynx 100. 
 
CrebA upregulates secretory capacity 
CrebA and expression of secretory machinery 
Early experiments designed to learn how core components of the secretory machinery are 
regulated in professional secretory cells, such as the SG, revealed that regulation occurs at the 
transcriptional level.  Thirty-four genes encoding protein components of the machinery required 
at all early steps of the secretory pathway are expressed to significantly higher levels in the SG 
secretory cells than in surrounding tissues26.  A combination of in vitro and in vivo DNA binding 
42 
 
experiments, as well as in vivo expression studies, established that CrebA directly regulates 
secretory pathway component gene (SPCG) expression through a consensus sequence identified 
by computational analysis of the enhancers for all 34 SPCGs29.  Genome-wide microarray studies 
revealed that CrebA is largely dedicated to the regulation of secretory capacity – well over 200 
genes encoding core secretory machinery proteins, as well as secreted cargo, require CrebA for 
their full expression29.  Moreover, expression of every SPCG that has been tested can be 
activated in additional cells simply by overexpressing CrebA – or the activated form of any of its 
five human orthologues, the Creb3/Creb3L family of bZip transcription factors - in those 
cells29,101.  Thus, CrebA is both necessary and sufficient for elevated secretory capacity and 
Creb3/Creb3L have similar activities. CrebA and its human orthologues also appear to boost 
expression of secreted cargo genes.  Whereas direct regulation of cargo genes by the 
mammalian proteins has been observed102, studies in flies suggest CrebA may work indirectly by 
up-regulating expression of Sage (see above); sage transcript levels decrease about twofold in 
CrebA mutants29. 
 
Pasilla encodes a splicing factor also required for high-level SG secretion 
Among the early expressed SG genes that come on and stay on in the SG, is pasilla (ps), which 
encodes a KH domain-containing nuclear splicing factor related to two mammalian proteins, 
Nova1 and Nova2103.  Loss of ps in the SG results in late-stage apical lumen irregularities that are 
linked to a significant reduction in material secreted into the lumen and a corresponding 
reduction in the size and number of secretory vesicles.  Although more than 400 genes have 





Diaphanous targets apical secretion 
Apical targeting of secretory vesicles in multiple epithelial tubular organs in Drosophila, 
including the SG, is mediated by Diaphanous (Dia), an actin-nucleation factor that localizes 
tightly to the apical surface, and by Myosin V (MyoV)105. Loss of Dia, which is expressed to high 
levels in the SG and other secretory organs, or of MyoV has no effect on overall apical-basal 
polarity but significantly compromises apical secretion.  Apical localization of Dia is mediated by 
its interactions with PIP2 and Rho1, both of which are enriched in the apical membrane106.  Dia 
is proposed to nucleate apically directed actin filaments, towards which secretory vesicles are 
targeted via MyoV-based transport. Mammalian Dia plays a similar role in other secretory 





THE LARVAL-PUPAL SALIVARY GLAND 
The larval SG of Drosophila has been used to study several basic cellular functions, including 
secretion, hormone responsiveness and the cell death pathways. Morphologically, the larval SG 
looks quite similar to the late embryonic SG, with the salivary duct, imaginal ring cells and 
secretory gland arranged from proximal to distal (Figure 6). In the larva, the proximal region of 
the secretory gland is termed the transition zone and the cells in the most distal portion of the 
secretory tube are called the corpus cells.  The SG is among the last larval tissues to be 
destroyed prior to pupation, and its contents are vital to pupae formation as the fly transitions 
to adulthood.  
 
Ecdysone signaling in the SG 
One of the most notable characteristics of the larval SG is its responsiveness to the hormone 20-
hydroxy-ecdysone (20E or ecdysone).  During the third instar stage, the final stage of larval 
development, there are three relatively small pulses of ecdysone, followed by a large pulse that 
signifies the transition from larva to prepupa108 (Figure 7). This final pulse of ecdysone is 
approximately five times larger than the earlier pulses109. An early observation of insect SGs was 
that the presence of ecdysone led to the formation of puffs along the polytenized 
chromosomes110. Successful in vitro culture of the Drosophila larval SGs allowed for a more 
complete study of this phenomenon as well as the mapping of the ecdysone-induced puffs to 
specific chromosomal regions111,112. The small pulses of ecdysone induce the intermolt puffs in 
late larvae that regress during the large ecdysone pulse at the end of the third instar stage113. 
The next set of ecdysone-sensitive puffs has been separated into three distinct groups based on 
how rapidly they are induced by the large ecdysone pulse: early genes, early-late genes, and late 
genes. Many early genes encode transcription factors, such as the Broad complex (Br-C), E74, 
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and E75114-119. The early genes, in turn, activate expression of the late genes and repress their 
own expression120.  There are many more late genes than early genes, indicating a 
transcriptional hierarchy in the larval SG not unlike that seen the embryonic gland. 
 
SG glue secretion  
The first genes to be induced by the small pulses of ecdysone are those in the intermolt puffs, 
many of which contain Salivary glue secretion (Sgs) genes. Expression of at least three Sgs genes 
(Sgs 1, 3, and 4) is controlled by Fkh128,129 and several Sgs genes were identified as potential 
targets of Sage 130, suggesting that the same transcription factors that cooperate to regulate SG 
specific expression in embryos also work together to activate larval SG-specific genes. Sgs genes 
encode glue proteins, several of which are highly glycosylated. Once secreted, glue proteins 
adhere the pupa to a solid surface during metamorphosis129,131,132.  The Sgs proteins are 
synthesized in both the transition and corpus cells of the SG124, where they accumulate in 
approximately eleven thousand secretory granules per cell, which coalesce into fewer larger 
granules prior to their secretion133. The final large pulse of ecdysone has two effects on the Sgs 
genes: transcriptional repression and glue protein secretion134. Secretion of the glue granules is 
dependent on Clathrin, the AP adaptor proteins AP-1, AP47, and EpsinR135. Overexpression of 
E63-1, an early gene that encodes a calcium binding protein, induces premature secretion of 
glue granules124. Moreover, loss of E63-1 and calmodulin impairs secretion136. Together, these 
data suggest a coordinated sequence of events that starts with accumulation of Sgs transcripts 
and glue proteins, followed by a halt in Sgs transcription due to increased ecdysone, which also 
signals the cells to secrete their contents. Without glue protein secretion, the pupa cannot 
adhere to solid substrates and further development is arrested.  In signaling pupa formation, the 
large ecdysone pulse also signals the larva to destruct (discussed below). 
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Figure 6.  Confocal image of the larval salivary gland with the different cell types artificially 
colorized.  The larval salivary gland includes the large polytenized secretory cells (light blue), the 
medium sized duct cells (light purple) and the small imaginal ring cells (blue).  The fat body 








Figure 7.  Fkh (likely in collaboration with Sage and Sens) keeps the SG alive until the prepupal 
stage by preventing expression of the apoptosis inducers reaper (rpr) and head involution 
defective (hid).   Fkh (and Sage +/- Sens) in combination with low level ecdysone signaling 
activate transcription of the Salivary glue secretion (Sgs) genes in late larvae.  High-level 
ecdysone signaling just prior to pupation activates expression of the early ecdysone-responsive 
genes, which encode transcription factors.  A subset of these transcription factors repress fkh 
and Sgs transcription and activate expression of genes required for glue secretion.  Thus, the 
glue is secreted when Fkh begins to disappear.  In turn, the disappearance of Fkh results in rpr 
and hid expression, which overcome DIAP and activate the cell death pathway.  Thus, the SG 









In addition to spurring secretion of SG contents, the final large pulse of ecdysone also signals 
gland death. By this time, many other larval tissues are already partially destroyed. How does 
the SG remain intact for longer than the surrounding tissues?  Two molecules keep the glands 
alive until after all of their glue is expelled: Fkh, which has kept SG cells alive since the gland was 
first specified25, and Drosophila inhibitor of apoptosis 1 (Diap1)137.  The late pulse of ecdysone 
induces Br-C transcription, which, in turn, represses fkh transcription and induces the apoptotic 
cell death cascades. Sustained expression of fkh in the SGs delays death, whereas RNAi 
knockdown of fkh at earlier stages induces premature cell death137. Although expression of both 
rpr and hid RNA are repressed by Fkh, hid seems to have the most impact on SG death; 
overexpression of hid alone can induce death and hid loss results in gland persistence138. 
Overexpression of other known pro-apoptotic genes - rpr, dronc, sickle or grim - does not lead to 
cell death, at least not on their own, and loss of rpr alone does not affect gland persistence76. 
The upregulation of hid (and rpr) that occurs when Fkh is shut off overcomes the action of 
Diap1, allowing apoptosis to proceed.  Overexpression of p53 alone induces some SG death 
through apoptotic mechanisms, but is insufficient by itself to cause full gland death139. Indeed, 
SGs also show many signs of autophagic cell death140. Overexpression of the autophagy gene 
atg1 results in premature cell death139, which can be rescued by the simultaneous knock down 
of atg12. Moreover, atg8a and atg18 mutant SGS show cleavage of a caspase substrate as well 
as positive TUNEL staining, suggesting that the apoptotic death pathways remain active when 
autophagy is blocked. These data reinforce the idea that both autophagy and apoptosis 




Genes separate from the canonical death pathways also play important roles in SG death. The 
matrix metalloprotease Mmp1 is upregulated in the dying glands, whereas its inhibitor Timp 
(Tissue inhibitor of metalloprotease) is downregulated141. Small GTPases are also induced, 
indicative of cell rearrangements and migration142. Mdh2, a mitochondrial malate 
dehydrogenase, also plays a unique role in cell death143. mdh2 mutant SGs survive longer than 
wild-type, and although autophagy is initiated in mdh2 mutant glands, it is not completed. 
Caspase-3 activation is blocked in mdh2 mutants, but expression of rpr, hid and grim occurs 
normally. mdh2 mutants also have reduced ATP levels relative to wild-type larva. These studies 
suggest that Mdh2 functions downstream of the previously described death pathways. The 
findings that Mdh2 and other factors impact SG death suggest that many additional genes 




Studies of the Drosophila SG have broader implications regarding how epithelial organs are 
specified, formed, specialized, maintained and eventually destroyed.  Importantly, cell fate is 
determined by integrating patterning information along both major body axes – anterior-
posterior and dorsal-ventral.  This is true not only of the SG, but of all other Drosophila tissues 
that have been studied to the same level of detail, such as the trachea and mesodermal 
derivatives144,145. Although this finding suggests that there may be no true “organ-specifying” 
genes, clearly there are genes that play major roles in organ development and homeostasis. For 
the SG, Fkh has this role, affecting all aspects of gland biology. Nonetheless, approximately 40% 
of SG expressed genes are unaffected by fkh loss and Fkh (even with its SG-specific partner Sage) 
is incapable of stably converting other cell types to a SG fate11.  Importantly, the only additional 
cells that persistently express SG markers upon ubiquitous expression of Fkh and Sage, are cells 
that also express Scr, the Hox gene required for SG formation28.  To date, Scr itself is the only 
gene capable of driving ectopic gland formation1,10.   
 
Excellent progress has been made regarding contributions of the small GTPases and cytoskeletal 
components to SG morphogenesis, particularly with respect to converting a plate of polarized 
epithelial cells on the embryo surface into an elongated, fully internalized secretory tube (Table 
1)49-51,56,69.  Understanding the initiation and coordination of these events within the gland 
primordia is the next challenge. We expect that the identification and characterization of early-
expressed Fkh targets will be key to fully understanding this process, since fkh mutant SGs 




The SG also provides an excellent model for collective cell migration.  The SG is the ultimate 
collective, since the gland migrates (and elongates) as a fully polarized epithelium.  Several 
pathways and tissues that guide migration have been discovered, but very few of these 
pathways completely impede migration, leading to the hypothesis that additional guidance 
molecules exist.  Much remains to be learned about how the SG responds to each of the signals 
and integrates this information to reproducibly arrive at its appropriate final destination, where 
carrying out its functions is presumably optimized and where the SG in turn can provide cues for 
positioning other body parts. Understanding the forces fueling tube elongation will also be key.  
 
The past decade has been exciting with regards to learning how SGs specialize – specifically, 
how SG cells prepare for their major function – high-level secretion – and how SG cells become 
programmed to produce the right products.  High-level secretion is controlled by a single 
transcription factor – CrebA, which appears to directly activate expression of the entire battery 
of proteins that make up the early secretory machinery26,29.  Having a single protein (as in flies) 
or very few proteins (as in humans) with the capacity to coordinately up-regulate the entire 
secretory pathway provides a simple mechanism for generating sufficient machinery to meet 
the very different levels of secretory load experienced by various cell types. The beauty of 
addressing this issue in flies is that with only a single gene with this activity (instead of up to five 
potentially redundant genes), the consequences of gene loss are much more apparent.  
 
Fkh – like the vertebrate FoxA proteins – is expressed and required in a broad array of 
embryonic tissues, from cells of the nervous and immune systems to multiple different organ 
types.  Studies of Sage have revealed that Drosophila Fkh achieves SG specificity by partnering 
up with this tissue-specific bHLH protein28.  We predict that Fkh will partner with other tissue-
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specific proteins (perhaps also other bHLH transcription factors) to regulate completely different 
sets of targets in the other cells in which it is expressed and required.  The next task is to 
uncover the mechanisms by which Fkh and Sage cooperate to control SG specific gene 
expression. 
 
Finally, the SG performs vital functions for the animal up to the minutes and hours before its 
demise.  To ensure that these functions can be achieved, Fkh continues to hold death at bay 
until the final task is completed137.  Fkh (and likely Sage) work together with the ecdysone-
signaling pathway to ensure that not only are the right proteins made at the right time, but that 
the SG is quickly and cleanly disposed of once its function is accomplished.  A relatively complex 
and seemingly redundant set of events – including what appears to be death by multiple 




Special thanks to members of the Andrew lab for helpful comments and suggestions. 
Our own work in this area has been funded by the RUTH L. KIRSCHSTEIN NATIONAL INDIVIDUAL 





1. Panzer S, Weigel D, Beckendorf SK. Organogenesis in Drosophila melanogaster: 
embryonic salivary gland determination is controlled by homeotic and dorsoventral 
patterning genes. Development 1992, 114:49-57 
2. Henderson KD, Andrew DJ. Regulation and function of Scr, exd, and hth in the 
Drosophila salivary gland. Developmental biology 2000, 217:362-374 
3. Ryoo HD, Mann RS. The control of trunk Hox specificity and activity by Extradenticle. 
Genes Dev 1999, 13:1704-1716 
4. Joshi R, Passner JM, Rohs R, Jain R, Sosinsky A, Crickmore MA, Jacob V, Aggarwal AK, 
Honig B, Mann RS. Functional specificity of a Hox protein mediated by the recognition of 
minor groove structure. Cell 2007, 131:530-543 
5. Mann RS, Abu-Shaar M. Nuclear import of the homeodomain protein extradenticle in 
response to Wg and Dpp signalling. Nature 1996, 383:630-633 
6. Noro B, Lelli K, Sun L, Mann RS. Competition for cofactor-dependent DNA binding 
underlies Hox phenotypic suppression. Genes & development 2011, 25:2327-2332 
7. Ryoo HD, Marty T, Casares F, Affolter M, Mann RS. Regulation of Hox target genes by a 
DNA bound Homothorax/Hox/Extradenticle complex. Development 1999, 126:5137-
5148 
8. Rivas ML, Espinosa-Vazquez JM, Sambrani N, Greig S, Merabet S, Graba Y, Hombria JC. 
Antagonism versus cooperativity with TALE cofactors at the base of the functional 
diversification of Hox protein function. PLoS genetics 2013, 9:e1003252 
9. Castelli Gair Hombria J, Rivas ML, Sotillos S. Genetic control of morphogenesis - Hox 
induced organogenesis of the posterior spiracles. The International journal of 
developmental biology 2009, 53:1349-1358 
10. Andrew DJ, Horner MA, Petitt MG, Smolik SM, Scott MP. Setting limits on homeotic 
gene function: restraint of Sex combs reduced activity by teashirt and other homeotic 
genes. Embo J 1994, 13:1132-1144 
11. Maruyama R, Grevengoed E, Stempniewicz P, Andrew DJ. Genome-wide analysis reveals 
a major role in cell fate maintenance and an unexpected role in endoreduplication for 
the Drosophila FoxA gene Fork head. PloS one 2011, 6:e20901 
12. Alexandre E, Graba Y, Fasano L, Gallet A, Perrin L, De Zulueta P, Pradel J, Kerridge S, Jacq 
B. The Drosophila teashirt homeotic protein is a DNA-binding protein and modulo, a 
HOM-C regulated modifier of variegation, is a likely candidate for being a direct target 
gene. Mechanisms of development 1996, 59:191-204 
13. Fasano L, Roder L, Core N, Alexandre E, Vola C, Jacq B, Kerridge S. The gene teashirt is 
required for the development of Drosophila embryonic trunk segments and encodes a 
protein with widely spaced zinc finger motifs. Cell 1991, 64:63-79 
14. Roder L, Vola C, Kerridge S. The role of the teashirt gene in trunk segmental identity in 
Drosophila. Development 1992, 115:1017-1033 
15. Taghli-Lamallem O, Gallet A, Leroy F, Malapert P, Vola C, Kerridge S, Fasano L. Direct 
interaction between Teashirt and Sex combs reduced proteins, via Tsh's acidic domain, 
is essential for specifying the identity of the prothorax in Drosophila. Developmental 
biology 2007, 307:142-151 
16. Struhl G. Role of the esc+ gene product in ensuring the selective expression of segment-
specific homeotic genes in Drosophila. Journal of embryology and experimental 
morphology 1983, 76:297-331 
57 
 
17. Schneuwly S, Klemenz R, Gehring WJ. Redesigning the body plan of Drosophila by 
ectopic expression of the homoeotic gene Antennapedia. Nature 1987, 325:816-818 
18. Gibson G, Schier A, LeMotte P, Gehring WJ. The specificities of Sex combs reduced and 
Antennapedia are defined by a distinct portion of each protein that includes the 
homeodomain. Cell 1990, 62:1087-1103 
19. Gonzalez-Reyes A, Morata G. Organization of the Drosophila head as revealed by the 
ectopic expression of the Ultrabithorax product. Development 1991, 113:1459-1471 
20. Gonzalez-Reyes A, Urquia N, Gehring WJ, Struhl G, Morata G. Are cross-regulatory 
interactions between homoeotic genes functionally significant? Nature 1990, 344:78-80 
21. Mann RS, Hogness DS. Functional dissection of Ultrabithorax proteins in D. 
melanogaster. Cell 1990, 60:597-610 
22. Isaac DD, Andrew DJ. Tubulogenesis in Drosophila: a requirement for the trachealess 
gene product. Genes & development 1996, 10:103-117 
23. Henderson KD, Isaac DD, Andrew DJ. Cell fate specification in the Drosophila salivary 
gland: the integration of homeotic gene function with the DPP signaling cascade. 
Developmental biology 1999, 205:10-21 
24. Zhou B, Bagri A, Beckendorf SK. Salivary gland determination in Drosophila: a salivary-
specific, fork head enhancer integrates spatial pattern and allows fork head 
autoregulation. Developmental biology 2001, 237:54-67 
25. Myat MM, Andrew DJ. Fork head prevents apoptosis and promotes cell shape change 
during formation of the Drosophila salivary glands. Development 2000, 127:4217-4226 
26. Abrams EW, Andrew DJ. CrebA regulates secretory activity in the Drosophila salivary 
gland and epidermis. Development 2005, 132:2743-2758 
27. Abrams EW, Mihoulides WK, Andrew DJ. Fork head and Sage maintain a uniform and 
patent salivary gland lumen through regulation of two downstream target genes, 
PH4alphaSG1 and PH4alphaSG2. Development 2006, 133:3517-3527 
28. Fox RM, Vaishnavi A, Maruyama R, Andrew DJ. Organ-specific gene expression: the 
bHLH protein Sage provides tissue specificity to Drosophila FoxA. Development 2013, 
140:2160-2171 
29. Fox RM, Hanlon CD, Andrew DJ. The CrebA/Creb3-like transcription factors are major 
and direct regulators of secretory capacity. J Cell Biol 2010, 191:479-492 
30. Chandrasekaran V, Beckendorf SK. senseless is necessary for the survival of embryonic 
salivary glands in Drosophila. Development 2003, 130:4719-4728 
31. Fleming RJ, Scottgale TN, Diederich RJ, Artavanis-Tsakonas S. The gene Serrate encodes 
a putative EGF-like transmembrane protein essential for proper ectodermal 
development in Drosophila melanogaster. Genes & development 1990, 4:2188-2201 
32. Thomas U, Speicher SA, Knust E. The Drosophila gene Serrate encodes an EGF-like 
transmembrane protein with a complex expression pattern in embryos and wing discs. 
Development 1991, 111:749-761 
33. Klambt C, Glazer L, Shilo BZ. breathless, a Drosophila FGF receptor homolog, is essential 
for migration of tracheal and specific midline glial cells. Genes & development 1992, 
6:1668-1678 
34. Gregory SL, Kortschak RD, Kalionis B, Saint R. Characterization of the dead ringer gene 
identifies a novel, highly conserved family of sequence-specific DNA-binding proteins. 
Molecular and cellular biology 1996, 16:792-799 
35. Kasai Y, Stahl S, Crews S. Specification of the Drosophila CNS midline cell lineage: direct 
control of single-minded transcription by dorsal/ventral patterning genes. Gene 
expression 1998, 7:171-189 
58 
 
36. Nambu JR, Franks RG, Hu S, Crews ST. The single-minded gene of Drosophila is required 
for the expression of genes important for the development of CNS midline cells. Cell 
1990, 63:63-75 
37. Klambt C. EGF receptor signalling: roles of star and rhomboid revealed. Current biology : 
CB 2002, 12:R21-23 
38. Kuo YM, Jones N, Zhou B, Panzer S, Larson V, Beckendorf SK. Salivary duct determination 
in Drosophila: roles of the EGF receptor signalling pathway and the transcription factors 
fork head and trachealess. Development 1996, 122:1909-1917 
39. Haberman AS, Isaac DD, Andrew DJ. Specification of cell fates within the salivary gland 
primordium. Dev Biol 2003, 258:443-453 
40. Kidd S, Baylies MK, Gasic GP, Young MW. Structure and distribution of the Notch protein 
in developing Drosophila. Genes & development 1989, 3:1113-1129 
41. Yamamoto S, Charng WL, Rana NA, Kakuda S, Jaiswal M, Bayat V, Xiong B, Zhang K, 
Sandoval H, David G, Wang H, Haltiwanger RS, Bellen HJ. A mutation in EGF repeat-8 of 
Notch discriminates between Serrate/Jagged and Delta family ligands. Science 2012, 
338:1229-1232 
42. Gridley T. Notch signaling in the vasculature. Current topics in developmental biology 
2010, 92:277-309 
43. Nantie LB, Himes AD, Getz DR, Raetzman LT. Notch signaling in postnatal pituitary 
expansion: proliferation, progenitors and cell specification. Molecular endocrinology 
2014, me20131425 
44. Murtaugh LC, Stanger BZ, Kwan KM, Melton DA. Notch signaling controls multiple steps 
of pancreatic differentiation. Proceedings of the National Academy of Sciences of the 
United States of America 2003, 100:14920-14925 
45. Patten BA, Peyrin JM, Weinmaster G, Corfas G. Sequential signaling through Notch1 and 
erbB receptors mediates radial glia differentiation. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 2003, 23:6132-6140 
46. Myat MM, Andrew DJ. Organ shape in the Drosophila salivary gland is controlled by 
regulated, sequential internalization of the primordia. Development 2000, 127:679-691 
47. Manning AJ, Peters KA, Peifer M, Rogers SL. Regulation of epithelial morphogenesis by 
the G protein-coupled receptor mist and its ligand fog. Science signaling 2013, 6:ra98 
48. Rogers SL, Wiedemann U, Hacker U, Turck C, Vale RD. Drosophila RhoGEF2 associates 
with microtubule plus ends in an EB1-dependent manner. Current biology : CB 2004, 
14:1827-1833 
49. Nikolaidou KK, Barrett K. A Rho GTPase signaling pathway is used reiteratively in 
epithelial folding and potentially selects the outcome of Rho activation. Current biology : 
CB 2004, 14:1822-1826 
50. Kolesnikov T, Beckendorf SK. 18 wheeler regulates apical constriction of salivary gland 
cells via the Rho-GTPase-signaling pathway. Dev Biol 2007, 307:53-61 
51. Xu N, Keung B, Myat MM. Rho GTPase controls invagination and cohesive migration of 
the Drosophila salivary gland through Crumbs and Rho-kinase. Developmental biology 
2008, 321:88-100 
52. Tepass U, Theres C, Knust E. crumbs encodes an EGF-like protein expressed on apical 
membranes of Drosophila epithelial cells and required for organization of epithelia. Cell 
1990, 61:787-799 
53. Tepass U, Knust E. Crumbs and stardust act in a genetic pathway that controls the 




54. Wodarz A, Hinz U, Engelbert M, Knust E. Expression of crumbs confers apical character 
on plasma membrane domains of ectodermal epithelia of Drosophila. Cell 1995, 82:67-
76 
55. Tepass U. Crumbs, a component of the apical membrane, is required for zonula 
adherens formation in primary epithelia of Drosophila. Dev Biol 1996, 177:217-225 
56. Roper K. Anisotropy of Crumbs and aPKC drives myosin cable assembly during tube 
formation. Developmental cell 2012, 23:939-953 
57. Chandrasekaran V, Beckendorf SK. Tec29 controls actin remodeling and endoreplication 
during invagination of the Drosophila embryonic salivary glands. Development 2005, 
132:3515-3524 
58. Patel U, Myat MM. Receptor guanylyl cyclase Gyc76C is required for invagination, 
collective migration and lumen shape in the Drosophila embryonic salivary gland. 
Biology open 2013, 2:711-717 
59. Myat MM, Andrew DJ. Epithelial tube morphology is determined by the polarized 
growth and delivery of apical membrane. Cell 2002, 111:879-891 
60. Bronner G, Jackle H. Regulation and function of the terminal gap gene huckebein in the 
Drosophila blastoderm. The International journal of developmental biology 1996, 
40:157-165 
61. Mosley-Bishop KL, Li Q, Patterson L, Fischer JA. Molecular analysis of the klarsicht gene 
and its role in nuclear migration within differentiating cells of the Drosophila eye. 
Current biology : CB 1999, 9:1211-1220 
62. Welte MA, Gross SP, Postner M, Block SM, Wieschaus EF. Developmental regulation of 
vesicle transport in Drosophila embryos: forces and kinetics. Cell 1998, 92:547-557 
63. Bradley PL, Andrew DJ. ribbon encodes a novel BTB/POZ protein required for directed 
cell migration in Drosophila melanogaster. Development 2001, 128:3001-3015 
64. Shim K, Blake KJ, Jack J, Krasnow MA. The Drosophila ribbon gene encodes a nuclear BTB 
domain protein that promotes epithelial migration and morphogenesis. Development 
2001, 128:4923-4933 
65. Kerman BE, Cheshire AM, Myat MM, Andrew DJ. Ribbon modulates apical membrane 
during tube elongation through Crumbs and Moesin. Developmental biology 2008, 
320:278-288 
66. Cheshire AM, Kerman BE, Zipfel WR, Spector AA, Andrew DJ. Kinetic and mechanical 
analysis of live tube morphogenesis. Developmental dynamics : an official publication of 
the American Association of Anatomists 2008, 237:2874-2888 
67. Medina E, Williams J, Klipfell E, Zarnescu D, Thomas G, Le Bivic A. Crumbs interacts with 
moesin and beta(Heavy)-spectrin in the apical membrane skeleton of Drosophila. J Cell 
Biol 2002, 158:941-951 
68. Polesello C, Delon I, Valenti P, Ferrer P, Payre F. Dmoesin controls actin-based cell shape 
and polarity during Drosophila melanogaster oogenesis. Nature cell biology 2002, 4:782-
789 
69. Xu N, Bagumian G, Galiano M, Myat MM. Rho GTPase controls Drosophila salivary gland 
lumen size through regulation of the actin cytoskeleton and Moesin. Development 2011, 
138:5415-5427 
70. Reed RA, Womble MA, Dush MK, Tull RR, Bloom SK, Morckel AR, Devlin EW, Nascone-
Yoder NM. Morphogenesis of the primitive gut tube is generated by Rho/ROCK/myosin 
II-mediated endoderm rearrangements. Developmental dynamics : an official 
publication of the American Association of Anatomists 2009, 238:3111-3125 
60 
 
71. Tepass U, Hartenstein V. The development of cellular junctions in the Drosophila 
embryo. Developmental biology 1994, 161:563-596 
72. Pirraglia C, Jattani R, Myat MM. Rac function in epithelial tube morphogenesis. 
Developmental biology 2006, 290:435-446 
73. Bokoch GM. Biology of the p21-activated kinases. Annual review of biochemistry 2003, 
72:743-781 
74. Arias-Romero LE, Chernoff J. A tale of two Paks. Biology of the cell / under the auspices 
of the European Cell Biology Organization 2008, 100:97-108 
75. Pirraglia C, Walters J, Myat MM. Pak1 control of E-cadherin endocytosis regulates 
salivary gland lumen size and shape. Development 2010, 137:4177-4189 
76. Yin VP, Thummel CS. Mechanisms of steroid-triggered programmed cell death in 
Drosophila. Seminars in cell & developmental biology 2005, 16:237-243 
77. Ismat A, Cheshire AM, Andrew DJ. The secreted AdamTS-A metalloprotease is required 
for collective cell migration. Development 2013, 140:1981-1993 
78. Schlichting K, Wilsch-Brauninger M, Demontis F, Dahmann C. Cadherin Cad99C is 
required for normal microvilli morphology in Drosophila follicle cells. Journal of cell 
science 2006, 119:1184-1195 
79. D'Alterio C, Tran DD, Yeung MW, Hwang MS, Li MA, Arana CJ, Mulligan VK, Kubesh M, 
Sharma P, Chase M, Tepass U, Godt D. Drosophila melanogaster Cad99C, the orthologue 
of human Usher cadherin PCDH15, regulates the length of microvilli. J Cell Biol 2005, 
171:549-558 
80. Chung SY, Andrew DJ. Cadherin 99C regulates apical expansion and cell rearrangement 
during epithelial tube elongation. Development 2014,  
81. Bradley PL, Myat MM, Comeaux CA, Andrew DJ. Posterior migration of the salivary gland 
requires an intact visceral mesoderm and integrin function. Dev Biol 2003, 257:249-262 
82. Vining MS, Bradley PL, Comeaux CA, Andrew DJ. Organ positioning in Drosophila 
requires complex tissue-tissue interactions. Dev Biol 2005, 287:19-34 
83. Harris KE, Schnittke N, Beckendorf SK. Two ligands signal through the Drosophila 
PDGF/VEGF receptor to ensure proper salivary gland positioning. Mechanisms of 
development 2007, 124:441-448 
84. Kolesnikov T, Beckendorf SK. NETRIN and SLIT guide salivary gland migration. Dev Biol 
2005, 284:102-111 
85. Jones NA, Kuo YM, Sun YH, Beckendorf SK. The Drosophila Pax gene eye gone is required 
for embryonic salivary duct development. Development 1998, 125:4163-4174 
86. Kerman BE, Andrew DJ. Staying alive: dalmation mediated blocking of apoptosis is 
essential for tissue maintenance. Developmental dynamics : an official publication of the 
American Association of Anatomists 2010, 239:1609-1621 
87. Irvine KD, Wieschaus E. Cell intercalation during Drosophila germband extension and its 
regulation by pair-rule segmentation genes. Development 1994, 120:827-841 
88. Iwaki DD, Johansen KA, Singer JB, Lengyel JA. drumstick, bowl, and lines are required for 
patterning and cell rearrangement in the Drosophila embryonic hindgut. Developmental 
biology 2001, 240:611-626 
89. Lengyel JA, Iwaki DD. It takes guts: the Drosophila hindgut as a model system for 
organogenesis. Developmental biology 2002, 243:1-19 
90. Jung AC, Denholm B, Skaer H, Affolter M. Renal tubule development in Drosophila: a 




91. Caussinus E, Colombelli J, Affolter M. Tip-cell migration controls stalk-cell intercalation 
during Drosophila tracheal tube elongation. Current biology : CB 2008, 18:1727-1734 
92. Keller R, Davidson L, Edlund A, Elul T, Ezin M, Shook D, Skoglund P. Mechanisms of 
convergence and extension by cell intercalation. Philosophical transactions of the Royal 
Society of London. Series B, Biological sciences 2000, 355:897-922 
93. Weigel D, Jurgens G, Kuttner F, Seifert E, Jackle H. The homeotic gene fork head encodes 
a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 
1989, 57:645-658 
94. Moore AW, Barbel S, Jan LY, Jan YN. A genomewide survey of basic helix-loop-helix 
factors in Drosophila. Proceedings of the National Academy of Sciences of the United 
States of America 2000, 97:10436-10441 
95. Kele J, Simplicio N, Ferri AL, Mira H, Guillemot F, Arenas E, Ang SL. Neurogenin 2 is 
required for the development of ventral midbrain dopaminergic neurons. Development 
2006, 133:495-505 
96. Lin W, Metzakopian E, Mavromatakis YE, Gao N, Balaskas N, Sasaki H, Briscoe J, Whitsett 
JA, Goulding M, Kaestner KH, Ang SL. Foxa1 and Foxa2 function both upstream of and 
cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting 
mesodiencephalic dopaminergic neuron development. Developmental biology 2009, 
333:386-396 
97. Krapp A, Knofler M, Frutiger S, Hughes GJ, Hagenbuchle O, Wellauer PK. The p48 DNA-
binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic 
helix-loop-helix protein. The EMBO journal 1996, 15:4317-4329 
98. Krapp A, Knofler M, Ledermann B, Burki K, Berney C, Zoerkler N, Hagenbuchle O, 
Wellauer PK. The bHLH protein PTF1-p48 is essential for the formation of the exocrine 
and the correct spatial organization of the endocrine pancreas. Genes & development 
1998, 12:3752-3763 
99. Gao N, Le Lay J, Qin W, Doliba N, Schug J, Fox AJ, Smirnova O, Matschinsky FM, Kaestner 
KH. Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-
cell. Molecular endocrinology 2010, 24:1594-1604 
100. Smit RB, Schnabel R, Gaudet J. The HLH-6 transcription factor regulates C. elegans 
pharyngeal gland development and function. PLoS genetics 2008, 4:e1000222 
101. Barbosa S, Fasanella G, Carreira S, Llarena M, Fox R, Barreca C, Andrew D, O'Hare P. An 
orchestrated program regulating secretory pathway genes and cargos by the 
transmembrane transcription factor CREB-H. Traffic 2013, 14:382-398 
102. Murakami T, Saito A, Hino S, Kondo S, Kanemoto S, Chihara K, Sekiya H, Tsumagari K, 
Ochiai K, Yoshinaga K, Saitoh M, Nishimura R, Yoneda T, Kou I, Furuichi T, Ikegawa S, 
Ikawa M, Okabe M, Wanaka A, Imaizumi K. Signalling mediated by the endoplasmic 
reticulum stress transducer OASIS is involved in bone formation. Nature cell biology 
2009, 11:1205-1211 
103. Seshaiah P, Miller B, Myat MM, Andrew DJ. pasilla, the Drosophila homologue of the 
human Nova-1 and Nova-2 proteins, is required for normal secretion in the salivary 
gland. Developmental biology 2001, 239:309-322 
104. Brooks AN, Yang L, Duff MO, Hansen KD, Park JW, Dudoit S, Brenner SE, Graveley BR. 
Conservation of an RNA regulatory map between Drosophila and mammals. Genome 
research 2011, 21:193-202 
105. Massarwa R, Schejter ED, Shilo BZ. Apical secretion in epithelial tubes of the Drosophila 




106. Rousso T, Shewan AM, Mostov KE, Schejter ED, Shilo BZ. Apical targeting of the formin 
Diaphanous in Drosophila tubular epithelia. eLife 2013, 2:e00666 
107. Geron E, Schejter ED, Shilo BZ. Directing exocrine secretory vesicles to the apical 
membrane by actin cables generated by the formin mDia1. Proceedings of the National 
Academy of Sciences of the United States of America 2013, 110:10652-10657 
108. Redfern CPF. Ecdysteroid synthesis by the ring gland of Drosophila melanogaster during 
late-larval, prepupal and pupal development. Journal of insect physiology 1983, 29:65-
71 
109. Warren JT, Yerushalmi Y, Shimell MJ, O'Connor MB, Restifo LL, Gilbert LI. Discrete pulses 
of molting hormone, 20-hydroxyecdysone, during late larval development of Drosophila 
melanogaster: correlations with changes in gene activity. Developmental dynamics : an 
official publication of the American Association of Anatomists 2006, 235:315-326 
110. Clever U, Karlson P. [Induction of puff changes in the salivary gland chromosomes of 
Chironomus tentans by ecdysone]. Experimental cell research 1960, 20:623-626 
111. Ashburner M, Lemeunier F. Patterns of puffing activity in the salivary gland 
chromosomes of Drosophila. VII. Homology of puffing patterns on chromosome arm 3L 
in D. melanogaster and D. yakuba, with notes on puffing in D. teissieri. Chromosoma 
1972, 38:283-295 
112. Ashburner M. Patterns of puffing activity in the salivary gland chromosomes of 
Drosophila. VI. Induction by ecdysone in salivary glands of D. melanogaster cultured in 
vitro. Chromosoma 1972, 38:255-281 
113. Lehmann M, Korge G. Ecdysone regulation of the Drosophila Sgs-4 gene is mediated by 
the synergistic action of ecdysone receptor and SEBP 3. Embo J 1995, 14:716-726 
114. Crossgrove K, Bayer CA, Fristrom JW, Guild GM. The Drosophila Broad-Complex early 
gene directly regulates late gene transcription during the ecdysone-induced puffing 
cascade. Developmental biology 1996, 180:745-758 
115. Fletcher JC, D'Avino PP, Thummel CS. A steroid-triggered switch in E74 transcription 
factor isoforms regulates the timing of secondary-response gene expression. 
Proceedings of the National Academy of Sciences of the United States of America 1997, 
94:4582-4586 
116. Sun G, Zhu J, Li C, Tu Z, Raikhel AS. Two isoforms of the early E74 gene, an Ets 
transcription factor homologue, are implicated in the ecdysteroid hierarchy governing 
vitellogenesis of the mosquito, Aedes aegypti. Molecular and cellular endocrinology 
2002, 190:147-157 
117. Zhou B, Hiruma K, Jindra M, Shinoda T, Segraves WA, Malone F, Riddiford LM. 
Regulation of the transcription factor E75 by 20-hydroxyecdysone and juvenile hormone 
in the epidermis of the tobacco hornworm, Manduca sexta, during larval molting and 
metamorphosis. Developmental biology 1998, 193:127-138 
118. Segraves WA, Hogness DS. The E75 ecdysone-inducible gene responsible for the 75B 
early puff in Drosophila encodes two new members of the steroid receptor superfamily. 
Genes & development 1990, 4:204-219 
119. Burtis KC, Thummel CS, Jones CW, Karim FD, Hogness DS. The Drosophila 74EF early puff 
contains E74, a complex ecdysone-inducible gene that encodes two ets-related proteins. 
Cell 1990, 61:85-99 
120. Ashburner M. Sequential gene activation by ecdysone in polytene chromosomes of 
Drosophila melanogaster. II. The effects of inhibitors of protein synthesis. 
Developmental biology 1974, 39:141-157 
63 
 
121. Koelle MR, Talbot WS, Segraves WA, Bender MT, Cherbas P, Hogness DS. The Drosophila 
EcR gene encodes an ecdysone receptor, a new member of the steroid receptor 
superfamily. Cell 1991, 67:59-77 
122. King-Jones K, Charles JP, Lam G, Thummel CS. The ecdysone-induced DHR4 orphan 
nuclear receptor coordinates growth and maturation in Drosophila. Cell 2005, 121:773-
784 
123. Talbot WS, Swyryd EA, Hogness DS. Drosophila tissues with different metamorphic 
responses to ecdysone express different ecdysone receptor isoforms. Cell 1993, 
73:1323-1337 
124. Biyasheva A, Do TV, Lu Y, Vaskova M, Andres AJ. Glue secretion in the Drosophila 
salivary gland: a model for steroid-regulated exocytosis. Developmental biology 2001, 
231:234-251 
125. Yao TP, Forman BM, Jiang Z, Cherbas L, Chen JD, McKeown M, Cherbas P, Evans RM. 
Functional ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature 
1993, 366:476-479 
126. Costantino BF, Bricker DK, Alexandre K, Shen K, Merriam JR, Antoniewski C, Callender JL, 
Henrich VC, Presente A, Andres AJ. A novel ecdysone receptor mediates steroid-
regulated developmental events during the mid-third instar of Drosophila. PLoS genetics 
2008, 4:e1000102 
127. Costantino BF. The Larval salivary gland of Drosophila melanogaster: A model system for 
temporal and spatial steroid hormone regulation. UNLV 
Theses/Dissertations/Professional Papers/Capstones 2008,  
128. Mach V, Ohno K, Kokubo H, Suzuki Y. The Drosophila fork head factor directly controls 
larval salivary gland-specific expression of the glue protein gene Sgs3. Nucleic acids 
research 1996, 24:2387-2394 
129. Roth GE, Wattler S, Bornschein H, Lehmann M, Korge G. Structure and regulation of the 
salivary gland secretion protein gene Sgs-1 of Drosophila melanogaster. Genetics 1999, 
153:753-762 
130. Li TR, White KP. Tissue-specific gene expression and ecdysone-regulated genomic 
networks in Drosophila. Developmental cell 2003, 5:59-72 
131. Muskavitch MA, Hogness DS. An expandable gene that encodes a Drosophila glue 
protein is not expressed in variants lacking remote upstream sequences. Cell 1982, 
29:1041-1051 
132. Garfinkel MD, Pruitt RE, Meyerowitz EM. DNA sequences, gene regulation and modular 
protein evolution in the Drosophila 68C glue gene cluster. Journal of molecular biology 
1983, 168:765-789 
133. Farkas R, Suakova G. Developmental regulation of granule size and numbers in larval 
salivary glands of drosophila by steroid hormone ecdysone. Cell biology international 
1999, 23:671-676 
134. Andres AJ, Fletcher JC, Karim FD, Thummel CS. Molecular analysis of the initiation of 
insect metamorphosis: a comparative study of Drosophila ecdysteroid-regulated 
transcription. Developmental biology 1993, 160:388-404 
135. Burgess J, Jauregui M, Tan J, Rollins J, Lallet S, Leventis PA, Boulianne GL, Chang HC, Le 
Borgne R, Kramer H, Brill JA. AP-1 and clathrin are essential for secretory granule 
biogenesis in Drosophila. Molecular biology of the cell 2011, 22:2094-2105 
136. Thummel CS. Ecdysone-regulated puff genes 2000. Insect biochemistry and molecular 
biology 2002, 32:113-120 
64 
 
137. Cao C, Liu Y, Lehmann M. Fork head controls the timing and tissue selectivity of steroid-
induced developmental cell death. J Cell Biol 2007, 176:843-852 
138. Juhasz G, Sass M. Hid can induce, but is not required for autophagy in polyploid larval 
Drosophila tissues. European journal of cell biology 2005, 84:491-502 
139. Berry DL, Baehrecke EH. Growth arrest and autophagy are required for salivary gland 
cell degradation in Drosophila. Cell 2007, 131:1137-1148 
140. Lee CY, Simon CR, Woodard CT, Baehrecke EH. Genetic mechanism for the stage- and 
tissue-specific regulation of steroid triggered programmed cell death in Drosophila. 
Developmental biology 2002, 252:138-148 
141. Gorski SM, Chittaranjan S, Pleasance ED, Freeman JD, Anderson CL, Varhol RJ, Coughlin 
SM, Zuyderduyn SD, Jones SJ, Marra MA. A SAGE approach to discovery of genes 
involved in autophagic cell death. Current biology : CB 2003, 13:358-363 
142. Lee CY, Clough EA, Yellon P, Teslovich TM, Stephan DA, Baehrecke EH. Genome-wide 
analyses of steroid- and radiation-triggered programmed cell death in Drosophila. 
Current biology : CB 2003, 13:350-357 
143. Wang L, Lam G, Thummel CS. Med24 and Mdh2 are required for Drosophila larval 
salivary gland cell death. Developmental dynamics : an official publication of the 
American Association of Anatomists 2010, 239:954-964 
144. Lee HH, Frasch M. Nuclear integration of positive Dpp signals, antagonistic Wg inputs 
and mesodermal competence factors during Drosophila visceral mesoderm induction. 
Development 2005, 132:1429-1442 
145. Maruyama R, Andrew DJ. Drosophila as a model for epithelial tube formation. 
Developmental dynamics : an official publication of the American Association of 













G-protein coupled receptors (GPCRs) are the largest family of receptors in many organisms, 
including worms, mice, and humans. GPCRs are seven-transmembrane spanning proteins that 
are activated by binding a stimulus (or ligand) in the extracellular space.  They transduce 
information to the inside of the cell through conformational changes. In turn, the 
conformational changes activate heterotrimeric G-proteins, which execute the downstream 
signaling pathways. The ligand-GPCR interaction is highly specific, and an efficient cellular 
response is vital for the health of the cell and organism. In this Commentary, we focus on the 
Drosophila GPCRs, which are not as well-characterized as their worm and mammalian 
counterparts. We also present here a phylogenetic analysis which has led us to uncover several 
interesting relationships among Drosophila GPCRs, such as the clustering of several taste 
receptors with neurotransmitter receptors. Because many GPCRs remain uncharacterized 
orphan receptors, this analysis suggests potential roles for several family members. Finally, we 
discuss recently emerged roles of GPCRs in Drosophila embryogenesis, a field we expect will 




Introduction to G-protein coupled receptors – finely tuned environmental sensors 
How cells sense and respond to outside stimuli has been a key question in biology for well 
over a century. The hypothesized existence of receptors that span the cell membrane and are 
able to both sense and transduce signals seems logical today, but when this idea was first 
proposed, it was summarily rejected (Lefkowitz, 2013). Decades of biochemical studies have 
since proven that such receptors exist, and that most are G-protein coupled receptors (GPCRs). 
The main feature of GPCRs is their seven transmembrane-spanning segments, which position 
the N-terminus of the protein on the outside of the cell and the C-terminus inside. GPCRs bind 
an astoundingly diverse set of ligands – proteins, peptides, hormones, drugs, photons – usually 
by capturing the ligand with their N-terminus and/or within a pocket formed by the extracellular 
and transmembrane domains (Fig. 1). The GPCR cycle, described in more detail below, is an 
elegant cellular solution for sensing a specific exogenous signal, transducing it to a signaling 
cascade, and then terminating the signal.   
GPCRs are widely represented in all forms of life, from bacteria to plants and animals, 
including all of the major model organisms.  Over 800 GPCRs are encoded in the human genome 
and well over 700 in the zebrafish (Fredrikkson and Schioth, 2005). Caernorhabditis elegans is 
predicted to encode over 1000 GPCRs, a particularly impressive number, as this figure accounts 
for over five percent of the entire worm genome.   Mice also encode a large number of GPCRs 
(over 1300).  Drosophila encodes over 200 GPCRs, and just over 50 are found in Dictyostelium 
(Prabhu and Eichinger, 2006). In contrast, yeast encode a surprisingly small number of GPCRs – 
three in Saccharomyces cerevisciae and nine in S. pombe. One kingdom where GPCRs were 
thought to be conspicuously absent was the plants, due to lack of encoded G-protein exchange 
factors (GEFs) (Urano et al 2012); more recent work has, however, identified at least twelve 
plant GPCRs (Taddese et al 2014), restoring GPCRs’ status as ubiquitous signaling systems.   
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Figure1: The G-protein coupled receptor (GPCR) cycle. The GPCR cycle starts on the top left of 
the figure. In its basal state, a GPCR is free of ligand. Gα binds to GDP and associates with Gβγ. 
The heterotrimeric protein complex may associate with the receptor at this point, or remain 
free in the membrane as pictured. Upon ligand binding the GPCR becomes activated and 
undergoes a conformational change. The activated GPCR acts as a GEF for Gα. The resulting 
GTP-bound Gα separates from βγ, and the heterotrimeric proteins are active (*). Activated Gα 
can then interact with an effector (E), such as phospholipase C) (PLC) or adenylate cyclase, 
which results in  effector activation (*) and initiation of  a second- messenger cascade. The GTP 
in Gα is then hydrolyzed to GDP through the activity of Gα and RGS proteins (not shown), 
leading to Gα  inactivation and reassociation of heterotrimeric protein complex. Independently, 
GRKs bind to and phosphorylate the GPCR. This stimulates its binding by β-arrestin, which 
promotes internalization of the receptor. The GPCR can then be recycled back to the cell surface 







GPCRs are involved in nearly every aspect of life, from early development to heart function 
to neuronal activity (Wettschurek et al 2005). Mutations in GPCRs are linked to a number of 
human diseases, such as Usher syndrome, which results in variable onset deaf-blindness 
(Schoneberg et al 2004). Cell migration is another process that requires GPCRs, in both 
beneficial and detrimental ways. The single-celled amoeba Dictyostelium uses four GPCRs, cAR1-
4, to detect cAMP, triggering migration and coalescence into a multicellular organism (Prabhu 
and Eichinger, 2006). In both zebrafish and mice, germ cell migration is regulated by the 
chemokine receptor CXCR4 and its ligand stromal derived factor 1 (SDF1) (Doitsidou et al., 2002; 
Molyneaux et al 2003). Neutrophils also migrate via activation of a GPCR (Becker et al 1987). 
GPCR-regulated cell migration can also be detrimental for the organism, primarily during cancer 
(Lappano et al 2011). Overly activated GPCRs are able to trans-activate EGFR and other 
receptors, which can cause unregulated growth and cell migration.  
In this Commentary, we first cover the basics of GPCR signaling, from how the receptor is 
arranged in the membrane to heterotrimeric protein activation and receptor recycling. We focus 
then on the Drosophila GPCR family, including the gustatory and odorant receptors. 
Phylogenetic trees representing the entire repertoire of GPCRs in Drosophila are presented, 
revealing interesting relationships among GPCRs previously considered to be distantly related.  
Moreover, this analysis suggests potential roles for some of the many uncharacterized GPCRs. 
Finally, we discuss the known roles of GPCRs in Drosophila development, an open and exciting 





Because the GPCR superfamily is so diverse, there is little sequence conservation among 
families. Nonetheless, the superfamily does share several architectural features. The N-terminus 
and extracellular loops (ECL) are responsible for ligand binding. This can involve direct binding of 
the ECL to the ligand (as is the case for metabotropic Glutamate (mGlu) receptors) or funneling 
of a hydrophobic ligand into a binding pocket formed by the transmembrane domains 
(Venkatakrishnan et al 2013). ECLs often contain disulphide bridges to stabilize the loops and 
prevent promiscuous GPCR signaling. Indeed, ligand-binding does not induce a simple on-off 
state for GPCRs. GPCRs are dynamic proteins that fluctuate between many states (Fig. 1). Ligand 
binding stabilizes the GPCR into an “on” position, which is further stabilized by binding of a G-
protein (Kobilka, 2012).   
Bioinformatic analyses show that residues, such as Asparagine, Tryptophan, and Proline, 
cause clustering of transmembrane (TM) domains and stabilization of the transmembrane 
domains of the GPCR, termed the GPCR barrel due to their shape in the membrane 
(Venkatakrishnan et al, 2013). Ligand contact triggers movement of TM3 and causes 
conformational changes of the intracellular loops (ICL). In the Rhodopsin family, ICL2 contains an 
E/DRY motif near the boundary between ICL2 and TM3 (Rovati et al 2006). Mutations within this 
motif can result in constitutive GPCR signaling or impaired G-protein binding. Interestingly, 
other than the E/DRY motif, very little is known about how GPCRs associate with specific G-
proteins. Chimeras resulting from swapping of ICL3 domains between GPCRs result in a switch in 
their G-protein selectivity (Kobilka et al 1988), suggesting that this domain imparts specificity for 
the downstream signaling pathway of the receptor.  
The localization of a GPCR within a cell membrane can affect its ability to signal. Lateral 
movement of GPCRs within the plasma membrane is often restricted by the preferential 
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localization of GPCRs in specific lipid microenvironments (Allen et al 2007). Although GPCRs are 
usually shown as monomers, they can form oligomers (i.e. homo and heterodimers) within lipid 
rafts and are stabilized by interactions that are mediated through their TM domains (Ferre et al, 
2014). Planar lipid rafts and caveolae both influence GPCR signaling by either excluding or 
recruiting G-proteins and their effectors. Because native GPCRs are not highly expressed in cells 
(McCusker 2007), lipid rafts concentrate GPCRs and their associated proteins to promote 
receptor dimerization and signaling.  Caveolar-localized GPCRs are also subject to more rapid 






Signal propagation and the GPCR cycle 
The presence of a ligand-receptor binding event must then be propagated and responded to 
by the cell itself. The effectors of GPCR activation are the heterotrimeric G-proteins Gα, Gβ, and 
Gγ.  All organisms encode several types of each G-protein, and different combinations of these 
proteins into heterotrimers preferentially activates different signaling pathways.  Gα is a 
GTPase, which catalyzes the hydrolysis of GTP to GDP. Gα is typically anchored in the membrane 
via N-terminal palmitolyation and Gα can also be myristolyated (Vogler et al 2008). Gγ is 
isoprenylated at its C-terminal CAAX motif (Higgins et al 1994). Gβ does not have any 
membrane-anchoring post-translational modifications. Instead, Gβ is tightly linked to Gγ 
through hydrophobic interactions (Sondek et al 1996). The heterotrimeric complex can dock to 
an inactivated receptor or drift in the membrane, but once it encounters a ligand-bound GPCR, 
downstream signaling is initiated (Fig. 1). Activated GPCRs act as guanine nucleotide exchange 
factors (GEFs), and exchange GDP for GTP in the Gα subunit, which activates the protein. Upon 
GTP binding, Gα changes its conformation, allowing it to separate from the Gβγ dimer. The 
subunits are then free to interact with downstream targets. When Gα hydrolyzes GTP into GDP, 
it becomes inactivated, allowing Gα to reassociate with Gβγ. This process represents a full GPCR 
G-protein cycle.    
Gα proteins are divided into four subclasses with each targeting a specific type of signaling 
cascade (Wettschurek et al 2005). Gαs and Gαi/o both regulate adenylate cyclase (AC). Gαs 
stimulates AC activity, whereas Gαi/o is inhibitory. The third subclass, Gαq/11 targets 
phospholipase C, which cleaves phosphatidylinositol 4,5-bisphosphate (PtdInsP2) into inositol 
triphosphate (IP3) and membrane-bound diacyl-glycerol (DAG). Finally, Gα12/13 activates Rho-
GEFs, which in turn activate Rho. Previous models suggested that an individual GPCR interacts 
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with only one specific type of Gα, but it is now established that GPCRs are able to activate 
several Gα types, albeit with a marked preference for one (Cerione et al 1985).   
 Gαs is a weak GTPase, which slows the signaling cascade since new signaling information 
cannot be integrated (Kleuss et al 1994). To accelerate GTP hydrolysis, Gαs are targeted by the 
regulator of G-protein signaling (RGS) molecules (De Vries et al 2000).  RGS proteins are 
somewhat promiscuous for Gαs, and several RGS proteins have been shown to bind to specific 
Gγs and prevent re-formation of the heterotrimeric complex (Witherow et al 2003). Conversely, 
activators of G-protein signaling (AGS) can act as GEFs for Gα to prolong signaling (Vogler et al 
2008). Recent work has shown that Gα can be activated by non-receptor GEFs, which 
themselves are activated through associations with non-GPCR signaling pathways such as like 
the receptor tyrosine kinase (RTK) pathway (Garcia-Merces et al 2014). Some AGS proteins act 
as guanine-nucleotide-dissociation inhibitors (GDIs) (e.g. proteins containing a GoLoCo motif 
and GPR proteins) and cause Gα to remain in a GDP-bound state. These GDI-AGS proteins are 
termed G protein signaling modulators (GPSMs) and affect the amount of free Gβγ that can 
signal because they prevent re-association of the heterotrimeric protein complexes. 
Compared to Gα, there are a fewer number of Gβ and Gγ genes in mammals (23 alpha, 5 
beta, and 12 gamma genes).  Therefore, there is a vast array of possible βγ complexes, which 
each have different preferences for specific Gα subunits (Dingus et al 2005). Consequently, Gβγ 
can affect a wide range of ion channels and other signaling effectors, including pathways that 
are targeted by Gα, such as phospholipase C (Lau et al 2013).  Because the Gβγ dimer was long 
considered to be a less important pathway component, the exact roles the different 
combinations of Gβγ dimers have on GPCR signaling remain to be elucidated.   
Several mechanisms exist to attenuate GPCR signaling. The same conformational change in 
the GPCR that results in the release of the heterotrimeric complex results in residues becoming 
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accessible for phosphorylation by G-protein coupled receptor kinases (GRKs) (Palczewsk et al 
1991). Gβγ is able to recruit a GRK to the GPCR, thus establishing a negative feedback loop 
(Luttrell et al 1999). GRKs usually phosphorylate GPCRs at serine or threonine residues in the 
ICL3 or the C-terminal tail of the activated receptor (Pitcher et al, 1998). This phosphorylation of 
the GPCR results in the binding of β-arrestin (Drake et al 2006), which then recruits clathrin and 
its adaptor AP-2, to internalize the GPCR. Several different fates await the GPCR following 
internalization and GPCRs are divided into two classes depending upon how strongly they 
maintain β-arrestin binding. Class A GPCRs lose β-arrestin following internalization (Oakley et al 
2000) and can be dephosphorylated and recycled back to the cell-surface. An emerging concept 
in the field is the ability of GPCRs to maintain signaling once they are endocytosed 
(Mullershausen et al 2009). It is thought that by continuing to signal at endosomes instead of 
the plasma membrane, the physical distance between the GPCR and the nucleus is reduced, 
which results in more efficient signaling to transcriptional pathways (Tsvetnova et al 2014). 
Returning a GPCR back to the plasma membrane completes the GPCR cycle (Fig. 1). Class B 
GPCRs maintain β-arrestin binding. Here, GRK-mediated phosphorylation and binding to β-
arrestin can stimulate the ubiquitination of GPCRs. Ubiquitinated receptors are then targeted to 
the lysozome for degradation.  More recently, the so-called GPCR-associated sorting protein 
(GASP) family has been identified, which assists in the decision whether GPCRs are degraded or 
recycled (Bornert et al 2013; Simonin et al 2004). The amino acid sequence at the C-terminus of 
the GPCR is thought to direct the type of adaptor protein that binds the receptor, thus 






The Rhodopsin-like family is the largest family of GPCRs in most organisms. Members of this 
family are well-known for the diversity of their ligands, which range from hormones to peptides 
to photons of light. Rhodopsin was first described as a light-sensitive compound in animals 
(Kuhne, 1877), and was cloned over a century later (Nathans and Hogness, 1983).  This finding 
incited the explosion of subsequent GPCR research. Because the Rhodopsin-like family 
represents over 80% of human GPCRs (Fredrikkson and Schioth, 2005), it has been intensely 
studied for potential therapeutic benefits.   
Another important GPCR familiar is the Secretin-like family; its main feature is its large N-
terminal extra-cellular domain (ECD) (Watkins et al 2012), which is crucial for the recognition 
and binding of ligands, typically peptides or hormones. Historically, this family was named for 
the intestinal hormone secretin, which, in the early twentieth century, was the first hormone 
discovered (Bayliss and Starling, 1902). Its receptor was described nearly eighty years later 
(Jensen and Gardner, 1981; Chey and Chang, 2003). 
Metabotropic glutamate-like (mGlu) receptors bind a diverse set of ligands, such as 
pheromones, amino acids, and calcium (Chun, 2012). Members of this family contain a large 
extracellular domain that forms a so-called venus flytrap (VFT) module (Bessis et al 2002). Upon 
ligand binding to one lobe of the VFT, the other lobe closes, introducing a conformational 
change that is transduced to the rest of the protein through a cysteine-rich region. mGlu 
receptors function as dimers, which are either covalently linked by disulfide bonds or by shared 
ion-binding. Compared to the other GPCR families, the mGlu family was discovered relatively 
late. Although glutamate was a known neurotransmitter, it was assumed to function solely 
through channels or ionotropic receptors, which themselves function as channels (Curtis and 
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Watkins, 1965).  However, metabotropic receptors function as conventional GPCRs by binding a 
ligand and modulating that signal through the membrane.  
The final family of GPCRs are the atypical GPCRs, which includes receptors such as Frizzled 
or adhesion GPCRs. Members of these families were initially thought to not signal primarily 
through heterotrimeric G-proteins (Tang et al, 2012).  Members of the Frizzled family contain a 
cysteine-rich domain in their N-terminus that binds lipoglycoproteins of the Wingless (Wnt) 
family (Yang-Snyder, 1996). Upon ligand-binding, Frizzled family members primarily signal 
through the phosphoprotein Disheveled (Schulte and Bryja, 2007). GPCRs of the adhesion group 
often contain cadherin or integrin domains, and these receptors often contain auto-proteolytic 
activity (Krasnoperov et al, 1997). Their ligands include components of the extracellular matrix, 






The most common way to characterize Drosophila GPCRs is through heterologous 
expression systems, such as Xenopus oocytes, HEK293 cells, or CHO cells. In this way, specific 
GPCRs can then be exposed to individual ligands to test for functionality. Heterologous 
expression systems are preferentially used to identify ligands for GPCRs (a process called “de-
orphanizing”) because it reduces the possibility of endogenous proteins triggering the receptor, 
as most GPCRs are quite specific for ligand recognition (Caers et al 2014). Many downstream 
effectors have not been singularly identified as coupling to a specific receptor, and instead 
output is typically measured through changes in calcium levels. Activation of Gαq releases 
calcium through the downstream effector PLC, and various calcium reporters can be used to 
track this change. However, changes in cAMP and RhoGEF activity are not as easily tracked. To 
circumvent this problem, GPCRs are usually expressed along with the promiscuous human Gα16, 
which readily couples with many GPCRs to cause changes in intracellular calcium. Whereas this 
system can identify ligand-receptor interactions, it does not identify the endogenous Gα that 
interacts with a GPCR. Moreover, as stated above, GPCRs are known to interact with more than 
one Gα, causing multiple output changes. Studies that have identified specific Gα coupling to a 






Drosophila encodes approximately two hundred GPCRs, which are categorized into the four 
types of families described above (Brody and Cravchik, 2000). Unsurprisingly, modulators of 
GPCR signaling, such as GRKs and arrestins, are also encoded in the Drosophila genome. One 
aspect of Drosophila GPCR signaling that makes it particularly appealing for study is the reduced 
number of G proteins – six alpha subunits, three beta, and two gamma (Table 1) (Katanayeva, 
2010). Because flies have only eleven G-protein subunits, Drosophila offers a unique and 
advantageous system for studying GPCR signaling.  However, compared to worms and 
mammals, the GPCR field in the fly is not as well-characterized. Nearly half of the Drosophila  
GPCRs are orphans, suggesting that the field is relatively wide open for new discoveries. Here, 
we present new insights into this field that may aid in future characterization of Drosophila 
GPCRs and we discuss the receptors’ roles in embryonic development, which is also a rather 
unstudied side of GPCR signaling. 
 
Phylogenetic analysis of Drosophila GPCRs 
 Using Clustal Omega with five combined iterations, we have created a phylogenetic tree 
using full-length sequences of all seven-transmembrane proteins that are encoded by the 
Drosophila genome (Fig. 2, Supplemental Table 1).For this analysis, we did not include odorant 
or gustatory receptors, which will be dicussed more below. We termed this GPCR set “NOG” 
GPCRS, since they are not odorant or gustatory. The NOG data set comprises 123 proteins, 
whose sequences were obtained from Flybase (www.flybase.org); for proteins with more than 
one isoform, only the first isoform listed was used. Historically, Drosophila GCPRs have been 
classified into four separate families: Rhodopsin-like, Secretin-like, metabotropic Glutamate-like, 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2: Rooted phylogenetic tree of Drosophila Not Odorant or Gustatory (NOG) GPCRs. 
Full length sequences of GPCRs obtained from Flybase (www.flybase.org) were used to 
construct the tree. The names on correspond with the colored clades. Colors also correspond to 









Cysteine-rich, Frizzled/Smoothened, Atypical, Cell Adhesion, Secretin, Methuselah, Rhomboid, 
Orphan, Neuropeptide, Glycoprotein, Peptide, Opsin, Biogenic Amine, Peptide Hormone, and 
Adenosine. Four proteins (CG12290, Boss, CG32547, and CG30340) do not fit cleanly into any of 
these clades, but three of them are closely related to single clades: CG12290 and CG30340, 
which are uncharacterized genes, are closely related to the Glutamate receptors and Peptide 
receptors, respectively. Boss, an Atypical GPCR that acts as a ligand for a receptor tyrosine 
kinase, is closely related to the Methuselah receptors in our analysis. Both Boss and Methuselah  
receptors are known to have long extracellular domains, which may drive their close 
relationship in this phylogenetic tree. 
Several interesting patterns emerge from the phylogenetic tree. Notably, the sixteen clades 
do not fit cleanly into the four previously described super families. Members of the 
metabotropic Glutamate-like family do not fall into one particular clade. In contrast, the 
Secretin-like and Atypical families are individual clades, which belong to a larger clade that, in 
addition, also contains methuselahs, cell adhesion GPCRs, Frizzled/Smoothened GPCRs, and 
cysteine-rich GPCRs. The classical Rhodpsin family is split into eight clades that cannot be rooted 
from a common point.  As the Rhodpsin family is the largest GPCR family in all organisms, our 
tree represents a refinement of this large family into distinct sub-families.  
This NOG-GPCR family tree might also point to potential roles for uncharacterized GPCRs or 
to their ligands. For instance, two GPCRs that initially were identified as orphan receptors (Brody 
and Cravchik, 2000) can now been sorted into families: CG33539 appears to be a member of the 
Neuropeptide family, whereas CG13579 belongs to the Biogenic Amine receptors clade and is 
closely related to DopEcR. Furthermore, CG12796 sorts into a small clade together with the 
Adenosine Receptor, suggesting these receptors might have similar roles. Finally, CG44153 is 
found to be a member of the Glutamate clade, whereas CG13575 sorts into the Glycoprotein 
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clade.  Very little is known about these candidate genes (CGs), so this bioinformatic analysis 
suggests potential roles, ligands, and/or signaling pathways for each of these receptors. 
We also constructed a phylogenetic tree that in addition to the NOG-GPCRs also includes  
the odorant and gustatory receptors (Supplemental Figure 1). This genome-wide comparison 
indicates that some of the GPCRs might not belong to clades they have been previously 
associated with. For example, Methuselah-like5 and Methuselah-like14 are not members of the 
Methuselah clade, but instead sort into a more distant clade, which includes the Secretin clade, 
Cell Adhesion clade, Atypical clade, and Rhomboid-7 (Fig. 3A). 
The odorant receptors sort into one super-clade, with two notable exceptions. Or88a, one 
of only two known receptors that detect both male and female pheromones, belongs to the 
Frizzled clade (Fig. 3B). This unique localization within the phylogenetic tree is unexpected, and 
might reflect the special role this protein plays in the organism. Odorant co-receptor (Orco), the 
protein co-expressed with every odorant receptor protein, is also not a member of the odorant 
super-clade and instead is more closely related to Gr63a and Gr21a, the gustatory receptors for 
carbon dioxide (Fi. 3C). Interestingly, Orco is necessary for flies to sense carbon dioxide during 
flight, whereas Gr63a and Gr21a are not (Wasserman et at 2013).   When odorant receptors are 
considered in a tree by themselves, Orco and Or88a are off-shoots of the same clade, but do not 
share a branch with any other protein (Supplemental Figure 2, Supplemental Table 2).  Odorant 
receptors in insects have an inverse topology from typical GPCRs: the N-terminus is intracellular, 
whereas the C-terminus is extracellular (Benton et al 2006). Upon ligand binding, they activate 
Orco, which acts as an ion channel (Wicher 2008); this has led to the speculation that the 
Drosophila odorant receptors are not true GPCRs.   
The Drosophila gustatory receptors separate into six clades when they are analyzed 
together with the other GPCRs (Supplemental Figure 1).  Gustatory receptors are located on the 
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antenna, labellum, wing hairs and leg hairs, and sense a diverse array of compounds including 
sugars, bitter compounds, amino acids, and sex pheromones. The sweet-taste receptors (Gr64d, 
-64c, -64b, -61a, -64a, -5a, -64f, and -64e) all cluster together, as do the carbon dioxide 
receptors (Gr63a and Gr21a; see above).  Forty of the sixty gustatory receptors cluster into a 
large super-clade. Of these, the two receptors for a female mating pheromone (Gr68a and 
Gr32a) cluster together, but the majority of the other receptors in this super-clade are largely  
uncharacterized. The remaining gustatory receptors belong to clades that are independent of 
the major gustatory clade. Of these, six gustatory receptors separate into a clade that is more 
closely related to that containing the odorant receptors and the NOG-GPCR superfamily. Among 
these is Gr59f, which clusters with the odorant receptors, suggesting that this protein may have 
a unique role. Three gustatory receptors cluster with the NOG GPCR superfamily, and 
interestingly, two of these, Gr85a and Gr47a, cluster with GABA receptors (Fig. 3D). Gustatory 
neurons that respond to sweet taste are also known to express GABA receptors, and loss of 
these receptors influences the perception of sugar (Chu et al 2014). Thus, these receptors might 
be involved in facilitating this interaction. In a phylogenetic tree that is only composed of the 
gustatory receptors, the receptors separate into the sweet clade, the carbon dioxide clade, and 
the female-mating pheromones clade as described above (Supplemental Figure 3, 
Supplemental Table 3).  
 
GPCRS in Drosophila Development 
Many of the characterized Drosophila GPCRs regulate adult behavior, but considerably less 
is known about their role in development. Before cellularization occurs, embryonic development 
in Drosophila is largely dictated by the action of diffusible gradients. Because the early embryo is 
essentially one cell with many nuclei, cell-to-cell communication is not necessary. However, as  
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Figure 3: GPCRs that localize in non-native clades in NOG, Odorant, and Gustatory 
phylogenetic tree. A. Mthl5 and Mthl14 do not cluster with the other members of the 
Methuselah family. B. Or88a clusters with the Frizzled family. C. Orco clusters with the carbon 






development progresses, the activities of newly formed tissues and organs must be coordinated 
to from a viable organism.  Although many GPCRs are expressed during embryonic stages, little 
is known with regard to their roles in specific developmental processes. Interestingly, only one 
Gβ (Gβ13f) and one Gγ (Gγ1) are expressed predominantly in embryos (Table 1). 
One of the first major events of embryonic development is gastrulation. Concertina (a Gα) 
and Fog (a secreted protein) were known to be necessary for this process, but the GPCR that 
linked these two molecules was unknown for over twenty years (Parks and Wieschaus, 1991; 
Costa et al 1994). In addition, the GEF Ric-8 was also identified as a crucial component for 
gastrulation (Peters and Rogers, 2013), further supporting the idea that a GPCR was involved in 
this process. Recently, Mist has been identified as a GPCR that coordinates these events and 
triggers the initial cell-shape changes (Fig. 4A; Manning et al 2013).  The GPCR kinase Gprk2 acts 
downstream of Fog signaling and limits the cell-shape changes to ventral mesodermal cells (Fuse 
et al 2013), potentially by limiting Mist activity.  
The atypical GPCRs of the Frizzled family are well-characterized for their role in segment 
polarity through the Wnt signaling pathway. Frizzled family members can also act as canonical 
GPCRs by signaling through Go (Katanev et al 2005), which in turn recruit Rab5, an important 
regulator of endocytosis, to the plasma membrane (Purvanov et al 2010). Endocytosis and 
morphogenesis are tightly linked, so this link between Go and Rab5 has potentially important 
implications for embryonic development. Frizzled and other proteins involved in planar polarity 
have also proven roles in tracheal development (Chung et al., 2009; Warrington et al 2013), but 
a specific role of Frizzled in GPCR signaling within the context of this developmental process has 
not been examined. 
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Figure 4: GPCRs in Drosophila development. A. The GPCR Mist binds to its ligand Fog in the 
early embryo; this activates the Gα Concertina (Cta) and its downstream effector Rho1 to 
mediate apical constriction of mesodermal cells during gastrulation. B. Tre1 has two roles in the 
developing embryo. In the germ cells, Tre1 activates Gβ13f and Gγ1 to relocalize Rho1 and E-
cadherin (ECad) to the rear of the migrating cells. In neuroblast stem cells, Tre1 interacts with 
Gαo, which binds to Pins. Pins interacts with proteins that orient the mitotic spindle in such a 
way so that correct cell fates are established. C. Moody activates Gαi, Gαo, Gβ13f, and Gγ1 to 
alter the accumulation of actin in the surface glia, and affecting the organization of septate 
junction (SJ) proteins. D. An unknown GPCR is activated in cardial cells (CC), which activates 
Gαo, Gβ13f, and Gγ1. These proteins influence the localization of SJ proteins in CCs, which 
interact in trans with SJ proteins on pericardial cells (PC), thereby facilitating adhesion between 







As in other organisms, embryonic germ cell migration is also directed by GPCR signaling in 
the fly. Loss of Tre1 severely affects germ cell migration in the embryo (Fig. 4B; Kunwar et al 
2003).  Tre1 was named for its phenotype: instead of migrating to the gonad, the germ cells 
remain trapped in the endoderm. The arginine in the DRY motif is necessary for Tre1 function 
(Kamps et al 2010). Tre1 was shown to influence distribution of Rho1 and E-cadherin in the germ 
cells, although the mechanism for this interaction remains unknown (Kunwar et al 2008). Tre1 
also influences embryonic neuroblast stem cell divisions (Yoshiura et al 2012). Through 
interactions with its partners Gao and Pins (a GDI protein), Tre1 was shown to play a key role in  
the oriented cell divisions that establish neuroblast cell polarity and cell fate. Despite these 
known roles for Tre1 in controlling individual cell behavior, Tre1 remains an orphan receptor as 
its ligand is unknown. 
There are also some insights into the role of Drosophila GPCRs in cell adhesion and 
boundary integrity. The Gαo-Gβ13F-Gγ1 complex mediates cardiomyocyte adhesion, and loss of 
Gγ1 causes mislocalization of septate junction proteins in the embryonic heart (Fig. 4D; Yi et al 
2008).  Septate junctions are also compromised in moody mutants, which functions in the late 
embryonic surface glia to form the blood brain barrier that insulates the nerve cord (Fig. 4C; 
Schwabe et al 2005). Gi, Go, and Loco likely function in the same pathway, which is thought to 
directly affect the actin organization required for septate junction assembly. Like Tre1, Moody is 
also an orphan receptor, and these proteins belong to the same clade in our phylogenetic 
analysis.  As many Drosophila GPCRs remain uncharacterized, exciting work remains to fully 






In conclusion, GPCR signaling is vital to organismal life. GPCRs are able to translate an 
outside stimulus into a cellular response on a millisecond timescale, thus connecting a cell’s 
behavior to its outer environment. GPCRs are involved in many key developmental events, but 
they are also involved in more refined events, such as discerning the difference between two 
closely-related scents. Ligands for GPCRs are immensely diverse, and many GPCRs remain 
orphans.  Through phylogenetic analysis of the GPCRs encoded by the Drosophila genome, we 
hope to add new insights into the activities of this important family.  Heterologous expression 
systems have historically been used to identify GPCR ligands. However, this method has 
limitations. Most notably, this method ignores spatiotemporal information, an aspect which is 
vital in living organisms. Most ligand-receptor pairs have been identified in adult organisms 
responding to behavior inputs such as odorants or mating pheromones. More nuanced analysis 
is needed to understand the role of GPCRs in developmental processes, where both components 
are genetically encoded and must be expressed at the right time and place to interact with one 
another. Bioinformatic analysis can point to potential shared or related ligands in clades where 
well-characterized and uncharacterized receptors cluster together.  Our analysis suggests roles 
for several uncharacterized Drosophila GPCRs, which will hopefully spur further research about 
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Tre1 is a G-protein coupled receptor that is expressed in multiple tissues throughout 
embryogenesis, including the germ cells and the salivary gland. Previous work by several labs 
demonstrated a role for Tre1 in germ cell migration (Kunwar et al 2003; Kamps et al 2010). 
These alleles, however, did not show defects in salivary gland migration. In situ analysis showed 
that the available mutant alleles were not complete nulls. Therefore, we made a clean Tre1 null 
allele using homologous recombination. Germ cell migration was severely affected in the null 
allele, whereas the salivary gland still migrated correctly. This suggests that germ cells, as single 
cells, are sensitive to the loss of one signaling receptor, while the salivary gland, which migrates 
as an intact epithelium, uses compensatory factors to direct its migration. Closer examination of 
the salivary gland revealed that microtubule organization is disrupted in the Tre1 knockout, a 
phenotype that is also observed during neuroblast division (Yoshiura et al, 2012). Over-
expression of Tre1 in the salivary gland causes defects in salivary gland migration, and mis-
expression of Tre1 in the trachea causes mis-migration of the tracheal dorsal branch. This 
indicates that migrating tissues are sensitive to levels of Tre1, which may enable them to react 
to Tre1’s unknown ligand. We plan to further investigate the effect of over-expression of Tre1 
on the microtubule structure. Moreover, we want to eliminate other signaling pathways in 







Cell migration is an exquisitely intricate process common to many higher organisms.  
Variations in the signals driving cell movement, the distance cells travel, and whether cells 
migrate as individuals, as cell clusters or as intact epithelia can are all possible.  Cell migration 
can be beneficial, as in development or wound healing, or detrimental, as in cancer metastasis.  
To begin to unravel the complexities inherent to collective cell migration, the Drosophila salivary 
gland provides a relatively simple model system for parsing the underlying molecular and 
cellular events.  
The salivary gland begins as a placode of ~140 polarized columnar epithelial cells on the 
embryo surface that internalizes and moves dorsally.  Dorsal movement persists until the gland 
reaches the gut mesoderm, where it reorients and begins posterior migration, which continues 
until the gland reaches its final correct position oriented along the anterior-posterior axis of the 
embryo.  Since the salivary gland does not undergo cell division or cell death during 
morphogenesis, it provides an ideal system for studying the cell biological events underlying 
migration.  Previous work has shown that the interaction of the salivary gland with several 
nearby tissues, including the visceral mesoderm, fat body, and somatic muscle, is vital for 
correct gland positioning (Vining et al, 2005).  Integrin subunits expressed in both the salivary 
gland and in the mesoderm upon which the gland migrates are also necessary for proper gland 
placement (Bradley et al, 2003).  Specific signaling pathways, such as Netrin (an attractant in the 
central nervous system and visceral mesoderm), Slit (a repellent from the midline glia), and Wnt 
signaling (repellents from the CNS and ventral nerve cord) are required for correct gland 
positioning (Harris and Beckendorf, 2007; Kolesnikov and Beckendorf, 2005).  The migration 
defects associated with mutations for components of these pathways are often quite subtle and 
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never fully penetrant, suggesting that multiple additional pathways contribute to final correct 
salivary gland placement.   
G protein coupled receptors (GPCRs) are the main conduit for cells to interact and respond 
to their outside environment. By spanning the membrane seven times, GPCRs are able to bind 
ligands extracellularly, triggering conformational changes intracellularly.  These conformational 
changes activate the heterotrimeric G-proteins (Gα, Gβ, and Gγ), which then activate second 
messenger pathways that dictate the cell’s response to the ligand.  GPCRs play key roles in 
directed cell migration in systems as varied as Dictyostelium aggregation and mouse heart 
development (Prabhu et al, 2006; Waller-Evans et al 2010). In zebrafish, the GPCR CXCR4 is 
expressed in migrating primordial germ cells, and its ligand SDF1 is expressed in the same zone 
of migration (Doitsidou et al, 2002). Knockdown of either component results in disrupted germ 
cell migration. The homologues of these proteins were also found to play the same role in the 
mouse (Molyneaux, 2003).  
In Drosophila, a GPCR was also found to direct germ cell migration. Using a small deletion 
combined with genomic rescue constructs containing a combination of WT and mutant versions 
of the two affected genes, Kunwar and others showed that Tre1 (Trapped in endoderm 1) is 
essential for germ cell migration (Kunwar et al, 2003). Germ cells lacking Tre1remain stuck in the 
endoderm and do not migrate through the primordial midgut.  The requirement for Tre1 is cell 
autonomous, as germ cells mutant for Tre1do not reach the gonad in an otherwise wild-type 
background.  This germ cell migration defect is linked to the failure to relocalize Gβ13f, Rho1, 
and E-Cadherin to the rear of the migrating germ cells (Kunwar 2008). This finding suggests that 
activation of Tre1 has the combined effect of re-localizing proteins to alter cell shape and 
polarities, and reducing adhesion, thus promoting migration. Notably, as with most GPCRs, Tre1 
is an orphan receptor with no known ligand. 
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Tre1 was independently discovered to affect polarity in embryonic neuroblasts (Yoshiura et 
al 2012). In this system, Tre1 was shown to bind Gao, which when activated, binds the GoLoCo 
protein Pins. Pins, through its binding partner Inscuteable, interacts with Bazooka and other 
members of the Par complex. In turn, these proteins interact with components of the mitotic 
spindle to correctly orient cell division. Neuroblasts lacking Tre1 deviate from the normal 90⁰ 
plane of division axis. Interestingly, the neuroblasts that show the Tre1 defects recover later in 
development and are positioned correctly.  Compensatory input from nearby glia provide 
additional unknown signals that ensure that neuroblasts are oriented correctly.  
The BDGP in situ database revealed that Tre1 is expressed in the salivary gland transiently, 
prior to and during the first stages of posterior gland migration. Our initial characterization of 
salivary gland phenotypes revealed only very subtle and low penetrant apical membrane 
irregularities but our studies also revealed that existing excision alleles of Tre1 are not null. 
Therefore, a Tre1 null allele, wherein nearly the entire open reading frame was replaced by the 
white+ eye color marker, was created via homologous recombination to determine if the low 
penetrance of salivary gland migration defects was due to residual Tre1 function.  Here, we 
characterize the defects associated with complete loss of Tre1 Tre1I in both germ cell and 
salivary gland migration, as well as in other tissues that express Tre1.   We also created both an 
untagged and C-terminal GFP tagged version of Tre1 that allows for overexpression of Tre1 and 




MATERIALS AND METHODS 
Fly Strains 
The Tre1 knockout line was made by Deborah Andrew using homologous recombination, as 
described by Gong and Golic (2003). ΔEP5 and ΔEP19 were obtained from Kunio Isono (Tohoku 
University, Sendai, Japan). UAS-tre1 and UAS-tre1-GFP were generated by Gateway cloning 
(Invitrogen, Carlsbad, CA) into the pTW and pTWG UAS vectors, respectively. These constructs 
were then injected into w1118 flies by Rainbow Transgenic Flies, Inc (Camarillo, CA). nos-Gal4 
was provided by Ruth Lehmann (New York University School of Medicine). MS1096-Gal4 was 
obtained through the Bloomington Stock Center (Bloomington, Indiana). jal5929 was made by 
Deborah Andrew (Andrew et al 1994). btl-Gal4 was created by Shiga et al (1996). fkh-Gal4 was 
created by our laboratory (Henderson and Andrew, 2000). Homozygous lethal lines were 
balanced over FM7-Ftz-LacZ, Cyo-Ftz-LacZ, or TM6-Ubx-LacZ embryos, and mutant 
chromosomes were identified by lacZ staining. 
Tre1 antibody generation 
DNA fragment of either the first 102 basepairs (corresponding to N-terminal extracellular 36 
amino acids) or the last 201 basepairs (corresponding C-terminal intracellular 67 amino acids). 
These fragments were cloned in-frame into the pGex-6p-1 vector using XhoI and EcoRI sites (GE 
Healthcare Bio-Sciences, Pittsburgh, PA) and expressed in E Coli.  Protein was induced during log 
growth phase with 0.1M IPTG and grown over-night at 16⁰C. Inclusion body preps were 
performed to isolate the induced protein and injected into either rats or rabbits (Covance).  
Immunohistochemistry and in situ hybridizations 
In situ hybridization and immunohistochemistry were performed as previously described 
(Lehmann and Tautz, 1994; Reuter et al., 1990). The Tre1 in situ probe was generated from the 
RE0771 cDNA (Drosophila Genomics Resource Center). The cg25c cDNA was obtained from 
104 
 
DGRC.  Antibody concentrations used in this study are as follows: RbαVasa (1:200; Santa Cruz 
Biotechnology), RbαGooseberry (undiluted; R. Holmgren), RbαForkhead (1:2000; a gift from S. 
Beckendorf, Berkeley, CA, USA),    RtαCrebA (1:1,000) (Andrew et al., 1997), RbαSAS (1:500; a 
gift from D. Cavener, Penn State University, PA, USA), mααSpectrin (1:2; Developmental Studies 
Hybridoma Bank, Iowa City, IA), mαCrumbs (1:100; DSHB), mαFasIII (1:100; DSHB), mαTubulin 
(1:10, DSHB), RbαGFP (1:500; Invitrogen)  and mαβgalactosidase (Promega, 1:10,000). All 
secondary antibodies (Vector Labs and Molecular Probes) were used at a 1:500 dilution. HRP 
images were developed using the Vectastain ABC kit (Vector Laboratories). Confocal images 
were obtained using a Zeiss LSM 510 or 700 Meta confocal microscope, using a Plan-Neofluor 
63x and 100x, 1.3 oil objective and the Zeiss LSM software. All other images were obtained using 
a Zeiss Axiophot microscope configured with a Nikon Coolpix 4500 digital camera or a Janoptik 
ProgResC14 Plus opitical imaging system.  Images were taken using a Plan-Neofluor 20x, 0.50 
objective.  Images were rotated and cropped using Inkscape, an open-source vector graphic 





Existing alleles of Tre1 are not completely nulls 
    Tre1 is an X-chromosome encoded G-protein coupled receptor (GPCR) expressed dynamically 
throughout the Drosophila embryo. Tre1 is expressed in the head mesoderm, trunk mesoderm, 
and endoderm early (Figure 1A), and is also expressed in the salivary gland and fat body starting 
at stage 11. From stage 14 onward, Tre1 is expressed in the proventriculus, in a small subset of 
midgut cells, in the central nervous system, the hindgut, and in pericardial cells. Expression of 
Tre1 in the salivary gland occurs at a particularly interesting time with regards to organ 
migration. Expression of Tre1 is first observed during internalization (st 11) and continues 
through the early stages of posterior migration; expression no longer detected by stage 14.  
Because GPCRs are known to play a vital role in directional sensing and migration, we set out to 
determine the role of Tre1 in salivary gland migration and to study its function in the other 
various tissues.  
The two existing P-element excision alleles of Tre1 were obtained, ΔEP19 and ΔEP5 (Ueno et 
al., 2011; Figure 1B).  ΔEP19 is a small deletion that removes the 5’UTR of Tre1 including part of 
the first exon.  ΔEP5 is a larger deletion that also removes the 5’UTR and the entire first exon.  
Notably, neither of these alleles remove the start codon of Tre1, and an alternative transcription 
start site closer to the Tre1 ORF has subsequently been discovered based on cDNA library 
screening (Flybase).  Unfortunately, there are no deficiencies that remove Tre1, potentially 
because the essential ribosomal protein gene rpl35 is located less than one kilobase from Tre1 
and heterozygosity for this gene may be problematic . 
Previous work has shown that Tre1 is required when the germ cells migrate through the 
endoderm toward the somatic gonad (Kunwar et al. 2003).  This phenotype was observed using 
the ΔEP5 allele mentioned above. When these lines were evaluated for their affects on salivary  
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Figure 1: A Tre1 null allele was created because existing alleles still expressed Tre1 transcript. 
A-B’’. Tre1 transcript pattern in wild-type embryos. An in situ probe was made from full-length 
RE0771 cDNA, which is from the Tre1-A isoform. A. At stage 9, Tre1 is expressed in the 
endoderm, mesoderm, and head. At stage 11 and 12, Tre1 expression continues in those tissues 
and is found in the salivary gland and fat body. At stage 13, expression in the salivary gland is 
lost and expression in the midgut and hindgut appears. At stage 15, staining in the 
proventriculus, midgut, hindgut and CNS is visible. At stage 16, staining in the cardiac mesoderm 
is visible. B’, B’’. Inset showing salivary gland (outlined) Tre1 expression is observed in stage 12 
and is gone by stage 13. C-D’. ΔEP19 and ΔEP5 express Tre1. B’ and C’ are insets of stage 12 
embryos showing Tre1 expression. E. The Tre1 genomic region on the X-chromosome. The 5’ 
end of tre1 is closer to the telomere and 3’ end is closer to the centromere, so the orientation of 
the gene in this diagram is the opposite of what is shown on Flybase. The untranslated 5’ and 3’ 
UTRs of Tre1 tanscript are shown in brown, whereas the open reading frame is shown in orange. 
There are three isoforms of Tre1: Isoforms A and C, which have the same transcription start site, 
and isoform B, which has a transcription start site closer to the coding exons. ΔEP19 and ΔEP5 
were created by excising the p-element EP496; Both disrupt the gene encoding the gustatory 
receptor for trehalose, Gr5A. ΔEP19 does not disrupt the first exon of Tre1, whereas ΔEP5 
deletes the first exon and half of the first intron of the A and C isoforms, but does not affect 
Tre1-B. F. Creation of a Tre1 null allele via homologous recombination. Each homology arm is 
approximately four kilobases (kb) long. The white+ replaces a region spanning from 
approximately 540nt upstream of the ATG up to the residues encoding the last twenty three 
residues of Tre1. Half-arrows indicate the primers used for PCR analysis in F. G. PCR analysis of 
the Tre1 null allele. Primers were designed to sit either just outside the region included in the 
clone designed for recombination or within the white+ gene. The resulting product is expected 
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to be just over four kb. H-I’. Tre1 in situ in the Tre1KO allele at stage 11 (H) and stage 14 (I). H’ 







gland migration, only modest irregularities were observed. The low penetrance of salivary gland 
irregularities was somewhat surprising given the severe effects loss of Tre1 had on germ cell 
migration. These differences could be attributed to several potential factors:  (1) single cells may 
be more sensitive to changes in signaling than groups of cells, (2) it may simply be more obvious 
when a single cell mismigrates than when a single cell in an entire epithelium mismigrates, (3) 
the salivary gland may have and use more compensatory cues to direct migration, or (4) the 
existing alleles may not impact salivary gland expression or function of Tre1. Indeed, neither 
excision allele appears to be null for Tre1 function in our hands (Figure 1C,D).  Both ΔEP19 and 
ΔEP5 express variable levels of Tre1 transcript, including in the salivary gland, thus complicating 
our analysis of its function in the salivary gland and other tissues.  
 
Creation of a Tre1 null allele 
To create a Tre1 null allele, we used homologous recombination to replace the Tre1 ORF 
with that of the white+ eye color gene (Figure 1E).  Over nine hundred potential Tre1 knockout 
lines were screened for replacement of the Tre1 ORF with white+. Although several lines were 
obtained in which recombination appeared to have occurred on one side or the other of the 
coding region, only a single line was a clean replacement; this allele will be referred to as Tre1KO. 
The complete knockout was verified by PCR and by in situ hybridization to assay for Tre1 
transcripts (Figure 1F-H’). 
 
Germ cell migration is severely impaired in the TreKO flies 
We first examined germ cell migration in the Tre1KO. In wild-type embryos, germ cells are 
clustered in the posterior midgut during embryonic stage 9. During stage 10, they migrate 
through the endoderm as single cells (Figure 2A,A’).  The germ cells then associate with 
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Figure 2: Germ cell migration is severely disrupted in the Tre1KO allele. A-D’. Germ cell 
migration in wild-type embryos. Germ cells are stained with Vasa. Dorsal views are shown in A-D 
and lateral views are shown in A’-D’. At stage 11, germ cells have started to move out of the 
midgut endoderm (A’) and begin to separate away from the midline into two bilateral groups of 
germ cells (A). At stage 12, the germ cells move anteriorly with germ band retraction. At stage 
13, the germ cells are clustered in a line along the anterior-posterior axis. By stage 15, the germ 
cells are clustered tightly into the gonad.  Arrowheads point out germ cells that have not 
coalesced with the other germ cells. E-G’. Germ cell migration at stage 15 in Tre1 mutant alleles. 
E-G are dorsal views, E’-G’ are lateral views. H-I’. Germ cell migration in nanos driven Tre1 over-
expression. J. Histogram of germ cell migration in Tre1 alleles. Numbers of mismigrating germ 








 mesodermal cells and migrate anteriorly through stage 13 (Figure 2C).  By stage 14, the germ 
cells have coalesced into the gonad, where they remain for the remainder of embryogenesis 
(Figure 2D). Both ΔEP19 and ΔEP5 have germ cell migration defects (Figure 2E-F’), where a 
number of germ cells fail to reach the gonad. The Tre1KO germ cell migration phenotype is, 
however, far more severe than the previously described excision alleles. The Tre1KO germ cells 
migrate out of the midgut, but seem unable to navigate to the gonad.  Germ cells in the Tre1 
null are found throughout the posterior end of the embryo (Figure 2G-G’). Mismigrating germ 
cells were counted in WT and Tre1 mutant animals and categorized into groups depending on 
the total number of mismigrating cells: zero to five, six to ten, or over eleven germ cells 
mismigrating (Figure 2J). Over ninety percent of wild-type embryos had fewer than five 
mismigrating germ cells, whereas the majority of Tre1KO embryos had over eleven mismigrating 
germ cells. ΔEP19 and ΔEP5 had an intermediate phenotype. From these data, we conclude that 
complete loss of Tre1 results in more severe and more penetrant germ cell migration defects 
that either of the previously characterized excision alleles. 
 
Salivary gland migration is not affected with loss of Tre1 
Salivary gland migration was only mildly affected with Tre1 loss (Figure 3A-D’). Crb staining 
was used to evaluate the apical surface membrane of the migrating salivary gland. In wild-type 
embryos, the apical membrane is even and smooth at the beginning of migration (stage 12) and 
at the end of gland placement (stage 15). Only minor irregularities in the apical membrane are 
seen in ΔEP5 and Tre1KO, and these irregularities occurred with relatively low penetrance (Figure 
3E).  Thus, the failure to observe defects in the salivary gland versus the germ cells is likely due 
to the relative insensitivity of the polarized collective of salivary glands to signal perturbation 
versus single migrating germ cells or to other compensatory pathways guiding migration. 
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Figure 3: Salivary gland migration is not affected in Tre1 mutant alleles. A-D’. Crb staining 
showing the apical membrane of the salivary gland at stage 12 (A-D) and stage 15 (A’-D’). 
Arrowheads point out slight apical membrane irregularities. E. Quantification of apical 
membrane irregularities in the Tre1 mutant alleles. F-F’’’. Gooseberry (arrow) and Crb staining 
showing the relationship between stage 12 salivary glands and the fat body. G-G’. jal5929 
reporter expression in wild-type (F) or Tre1KO. H-I’’’. SG2 (ER) and FasIII (cVM) staining at stage 
12 (H-H’’’) and stage 13 (I-I’’’). At stage 12, the SG and cVM are very close to one another. At 








Salivary glands migrate in close contact with a number of different tissues, including the fat 
body and the visceral mesoderm.  Thus, we examined the positional relationship between the 
fat body and the salivary gland during early stages of posterior migration. Co-staining with Crb 
and Gooseberry (Gsb) reveals the salivary gland lumen and the clusters of thoracic fat body cells 
(Figure 3F-F’’’). During stage 13, the salivary gland is completing its posterior turn, just dorsal to 
these fat body clusters. In both wild-type embryos and in the Tre1 mutant alleles, salivary gland 
position relative to the fat body appears entirely normal. The relationship between the fat body 
and the salivary gland was also examined using the jal5929 beta-gal insertion line, which marks 
nuclei in both the salivary gland and the fat body clusters (Figure 3G,G’). Using these markers, 
no difference was observed in the positioning of the salivary gland with respect to the fat body 
in wild-type versus Tre1KO mutants.  
The relationship between the salivary gland and the gut mesoderm was also examined. 
During posterior salivary gland migration, the dorsal portion of the gland is in direct contact with 
the circular visceral mesoderm (cVM; Vining et al 2005).  This contact is disrupted at the 
beginning of stage 14/end of stage 13when the longitudinal visceral mesoderm (lVM), which 
comes from a very posterior position in the embryo, migrates between the cVM and the gland. 
We examined the relative position of the salivary gland with respect to the cVM by staining with 
the salivary gland specific endoplasmic reticulum marker SG2 and with FasIII, which marks the 
cVM (Figure 3H-I’’’). In wild-type stage 12 embryos, the distal portion of the dorsal side of the 
gland is tightly adhered to the cVM. By stage 13, the distal tip of the salivary gland begins to 
separate from the cVM as the lVM cells migrate in between them. The same physical 
relationship between the salivary gland and cVM is seen in the Tre1 null mutant embryos. Thus, 
even when examined in combination with markers that highlight tissues the salivary gland 
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contacts during early stages of its migration, we see no overt changes in salivary gland migration 
with either partial or complete loss of Tre1.   
 
Other tissues are not affected in Tre1KO flies 
Tre1 is also expressed in the midgut and the proventriculus. We assayed for potential 
defects in the midgut by staining for Labial, which marks the cuprophilic cells that form near the 
second midgut constriction, which is the first constriction to form (Tremml and Bienz, 1992). At 
stage 15, Labial staining is present at the gut constriction and in a light band around the gut 
(Figure 4A). Similar staining is seen in ΔEP19, ΔEP5, and Tre1KO. Therefore, we conclude that the 
midgut forms normally in the absence of Tre1. The proventriculus was examined by staining for 
Fork head, a transcription factor that is expressed in the proventricular ectodermal cell nuclei, 
and CrebA, a transcription factor that is expressed in the proventricular endoderm cell nuclei. 
These two cell types are joined at stage 12, and then undergo morphogenic movements where 
the ectodermal cells invaginate in towards the endodermal cells (Fuss et al 2004).  By the end of 
development, the proventriculus is a U-shaped tube that links the foregut to the midgut.  The 
joining of the ectodermal and endodermal cells of the proventriculus is shown in Figure 4B, and 
this morphology is unchanged in the Tre1 mutants. 
 
Over- and mis-expression of Tre1 causes a range of defects in multiple tissues 
The very subtle apical membrane defects observed in the SG and other tissues in Tre1 
mutants may be due to functional redundancy with other GPCRs also in the salivary gland.  To 
explore this possibility, we developed tools to over-express Tre1 by placing the Tre1 ORF 
downstream of Upstream Activated Elements (UAS).  This method allows for tissue specific over- 
or mis-expression of Tre1 using various Gal4 drivers (Brand and Perrimon, 1993). In addition to  
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Figure 4: Loss of Tre1 does not affect the cuprophilic cells of the midgut or the formation of 
the proventriculus. A. Labial staining of the cuprophilic cells of the midgut in wild-type and Tre1 
mutants at stage 15. B. Fkh (red) and CrebA (green) staining of the endodermal and ectodermal 







the UAS-Tre1 construct, we also generated a UAS-Tre1-GFP construct, which placed GFP in 
frame at the C-terminal end of Tre1. This line was used to localize Tre1 in salivary gland cells, 
since our attempts at generating Tre1 antisera with both N- and C-terminal protein fragments 
was unsuccessful, as were the attempts of others (Figure 5A-B’’’; Yoshiura et al., 2012).  Over-
expression of Tre1 in the salivary gland by Fkh-Gal4 caused minor salivary gland defects (Figure 
5C’’), (Figure 5D). Over-expression of Tre1-GFP caused no major salivary gland defects (Figure 
5C’’’), suggesting that too much Tre1 in the salivary gland does not adversely affect migration 
(Figure 5D).  In the salivary gland, Tre1-GFP localized to the membranes, which is the expected 
localization of a GPCR (Figure 5E). Tre1-GFP colocalizes with the apical marker SAS (Figure 5E’’) 
and partially overlaps with αspectrin (Figure 5F’’), although it is more apically enriched. 
Therefore, Tre1-GFP is a clear marker for the lateral and apical membrane of the salivary gland, 
and it does not otherwise disrupt salivary gland migration.  
Both constructs were also used to over-express Tre1 in germ cells, a tissue where Tre1 is 
known to function. Over-expression of untagged Tre1 caused the germ cells to coalesce neatly 
into the gonad (Figure 2H, H’) and, in fact, had fewer germ cell mis-migrate than wild-type 
embryos. Tre1-GFP, however, had the opposite effect, and more closely resembled the Tre1KO 
phenotype (Figure 2I, I’). This suggests that the GFP tag may interfere with single-cell migration, 
while multicell migration (as in the salivary gland) is unaffected. Efforts to visualize Tre1-GFP in 
the germ cells were unsuccessful, but may need amplification methods to work, as has been 
shown with other germ cell proteins (Ismat et al 2013).  
Using btl-Gal4, UAS-Tre1 was mis-expressed in the trachea, a tissue that does not normally 
express the gene (Figure 6A-D’). Tracheal development in all branches of these animals was 
normal in early stages but defects were observed in the dorsal branches in late embryos. By 
embryonic stage 17, the fusion cells of almost all dorsal branches from either side of WT  
120 
 
Figure 5: Construction of Tre1 tools for protein detection and over-expression analysis. 
A. Topology cartoon of Tre1. The sequence in blue at the N-terminus were used for making the 
TreN antibody. The sequence in green at the C-terminus were used to make the TreC antibody. 
The red arginine indicates the conserved residue from Kamps et al (2010) which is the key 
residue for Tre1 function and germ cell migration. B-B’’’. Staining with the the TreN and TreC 
antibodies at 1:5000. B-B’. TreN shows salivary gland staining in wild-type embryos (B). This 
staining is seen in Tre1KO embryos and is therefore unlikely to be specific. B’’-B’’’. TreC antibody 
staining is not observed in wild-type embryos (B’’) and is not above background levels in Tre1 
over-expressing salivary glands (B’’’).  C-C’’’. Over-expression of Tre1 in the salivary gland. UAS-
Tre1 and UAS-Tre1-GFP constructs were made using the open reading frame of full-length Tre1-
A. The apical membrane was stained using Crb. D. Quantification of apical membrane 
irregularities with Tre1 over-expression in the salivary gland. E-F’’. UAS-Tre1-GFP localizes to the 
basolateral and apical membranes but is enriched at the apical surface. Fkh-Gal4 was used to 
drive UAS-Tre1-GFP in the salivary gland. GFP staining is shown in green and SAS (E,E’’) or 








Figure 6: Mis-expression of Tre1 in the trachea and adult wing. A-D’. Mis-expression of UAS-
Tre1in the trachea using btl-Gal4 at stage 17. The tracheal lumen is stained with 2A12. A’-D’ are 
zoomed in to metameres three through seven. Open arrowheads show lack of fusion of the 
dorsal branch. Closed arrowheads show additional terminal branches that normally begin to 
form at this stage. E. Quantification of unfused dorsal branches in wild-type, control, and btl-
Gal4 driven UAS-Tre1 trachea.  F-F’. Mis-expression of Tre1 in the adult wing. MS1096-Gal4 is 
expressed to high levels in the dorsal portion of the wing disc. Mis-expression of Tre1 results in 








embryos have fused with their contralateral partners and the terminal tip cells have turned back 
toward the side of the embryo from where they originally came. Whereas a few DBs were mis-
fused or unfused in both WT and control embryos (Figure 6B’,C’), approximately half of the DBs 
in embryos overexpressing Tre1 in the trachea have failed to fuse by embryonic stage 17 (Figure 
6E).  
Tre1 was also mis-expressed in the adult wing using the MS1096-Gal4 driver (Figure 6F-F’).  
MS1096-Gal4 is located on the X-chromosome, so progeny of the cross will either be 
heterozygous females or hemizygous males. Female wings mis-expressing Tre1are mis-folded 
and exhibit significant blistering. Male wings mis-expressing Tre1are severely mis-folded and do 
not unfurl enough to form a full wing. This suggests that Tre1 misexpression may disrupt the 
normal pathways required to properly position cells during tissue morphogenesis. 
 
Searching for a Tre1 ligand 
Tre1 is an orphan GPCR and has no known ligand. To identify candidate ligands, we  
screened the Drosophila Protein Interactions Map database  (https://interfly.med.harvard.edu/) 
for potential interacting molecules. This project expresses HA-tagged proteins in S2R+ cells, 
immunoprecipitates the proteins, then uses LC-MS to identify proteins binding to the bait 
molecule. The three highest hits for Tre1 binding are shown in Figure 7A. Vkg is one of the two 
Collagen IV molecules encoded in Drosophila (Figure 7D). Eb1 is a plus-end microtubule binding 
protein. We decided to investigate potential roles for these genes in salivary gland migration.  
Collagen IV is composed of a heterotrimer of both Vkg and Cg25c molecules (Figure 7H). 
Collagen IV is deposited by the hemocytes, cells that arise in the head and then migrate as 
individual cells throughout the embryo depositing basement membrane (Figure 7B, B’; Bunt et 
al 2010). A deficiency removing function of both Collagen IV genes does not affect salivary gland  
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Figure 7: Potential Tre1 interactors. A. Tre1 was used as a bait protein on the Drosophila 
Protein Interaction Map website (DPiM). The top three hits [Tre1 itself, Vkg and Eb1] are shown 
here, along with their Gene Ontology (GO) molecular and biological function. B-B’. In situ at 
stage 15 showing mRNA expression of the two collagen IV genes encoded in the fly. C-C’. Crb 
staining of wild-type and Df(2L)BSC172, which removes vkg, cg25c, and four other genes. D. 
Genomic region of cg25c and vkg. The 5’ end of the vkg gene is closer to the centromere and the 
3’ end is closer to the telomere, so the cartoon is in the opposite orientation than shown in 
flybase. E. Agarose gel of the PCR fragments used to construct a vkg cDNA econtaining the 
entire coding region. Lines in D correspond to the colors of the labels in E. The names of the 
exons refer to their position as coding exons within the ORF. F-F’.Mis-expression of UAS-vkg and 
UAS-cg25c in the salivary gland driven by Fkh-Gal4. Arrowheads point out the salivary gland 
staining that is not observed in WT embryos, as shown in B and B’. G-G’. Crb staining of the 
salivary gland apical membrane in embryos mis-expressing vkg or cg25c in the salivary gland. H. 
Cartoon of collagen heterotrimer, which is composed of two Cg25c strands and one Viking 
strand or one Cg25c strand and two Viking strands. I-J. Microtubule (green) staining in the 
salivary gland and germ cells in wild-type and Tre1KO embryos. I. SAS (red) marks the salivary 
gland apical membrane. J. Vasa (red) marks the germ cell cytoplasm. K-L’. Changes in ECad 







migration (Figure 7C,C’), which is not surprising as hemocytes are not closely associated with the 
salivary gland until very late embryonic stages.   
To over- or mis-express the Collagen IV molecules, UAS-vkg and UAS-cg25c constructs were 
made. A full-length cDNA existed for cg25c, but for vkg, a full-length cDNA had to be 
constructed. Using various genomic DNA fragments and available ESTs, a full-length vkg cDNA 
was made via two successive rounds of In-Fusion HD cloning. The constructs were successfully 
mis-expressed in the salivary gland (Figure 7F, F’), which did not cause apical membrane defects 
(Figure G, G’). The constructs may need to be over-expressed together so that functional 
heterotrimers can be formed.  
To investigate the relationship between the EB1 microtubule binding protein and Tre1, we 
examined the microtubule organization in wild-type and Tre1KO embryos. EB1 binds the plus-end 
of microtubules, which are located at the apical membrane of the salivary gland, whereas the 
minus ends are at the basal membrane (Myat and Andrew, 2002). In WT salivary glands, the 
microtubule staining is seen at both the lateral and apical membranes, although staining was 
more intense near the apical surface (Figure 7I, top). In Tre1KO salivary glands, the apical staining 
of the MTs was more diffuse (Figure 7I, bottom). Microtubule staining in germ cells is 
comparable between wild-type and Tre1KO embryos (Figure 7J), as is germ cell morphology and 





Tre1 encodes a GPCR that is expressed dynamically in tissues throughout the Drosophila 
embryo, including the germ cells, salivary gland, fat body, trunk mesoderm, proventriculus, 
midgut, hindgut, CNS, and pericardial cells. Mutant alleles created by p-element excision exist 
for Tre1; however, in our hands, these alleles are not null. Importantly, neither excision allele 
removes the start of transcription for the alternative Tre1-B isoform, and we observe robust 
Tre1 mRNA expression from very early stages with both alleles.  We therefore created a true null 
allele of Tre1, replacing entire the Tre1 coding region, by homologous recombination. This allele 
is RNA null and homozygous embryos from homozygous mothers have severe germ cell 
migration defects than observed with homozygous embryos from mothers carrying either 
excision allele.  
Because Tre1 is expressed just before and during active migration of the salivary gland, we 
asked if loss of Tre1 affects gland migration as it does germ cell migration. Overall salivary 
morphology and placement were normal in Tre1 null embryos. The only phenotype we observed 
were minor apical membrane irregularities, which were present in only a small fraction of 
mutant embryos. Indeed, the only consistent phenotype we observed was the irregular patterns 
of MT and SAS apical staining. The absence of overt salivary gland migration phenotypes in the 
Tre1KO that we expected based on the severe germ cell migration defects may reflect differences 
between single cell and multi-cell migration.  Whereas the main facets of single and multi-cell 
migration remain the same – sending out protrusions, integrin-mediated attachment to a 
substrate, contraction of the cell body, and forward movement by retraction of the lagging end 
– a key difference is the junctional attachments that exist between the cells in multi-cell 
migration (Ilina and Friedl, 2009). The salivary gland is not only a multi-cellular tissue, but it also 
migrates as a fully polarized epithelium, a markedly different structure from a cell cluster. Thus, 
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if most of the cells “decide” to move in a given direction, the entire tissue is likely to move.  If so, 
the irregularities observed at the apical surface in the Tre1 mutants reflect some non-consensus 
in these migration decisions. Importantly, the SG receives input from multiple different tissues, 
including the visceral and somatic mesoderm, the fat body, and the CNS, in order to migrate to 
the correct position. It remains unclear when and how many signals are made by these 
surrounding tissues, so removing only a single signal may not be expected to have major 
consequences (Vining et al 2005; Harris and Beckendorf, 2007, Kolesnikov and Beckendorf, 
2005).   
Another difference between germ cell migration and salivary gland migration is in the 
number of cells it takes to create a functional tissue. The salivary gland is composed of about 
140 cells per placode, and as the gland invaginates and migrates, there is no cell death or 
division. Moreover, in embryos with fewer cells in the salivary gland placode, the gland fails to 
form correctly (Lammel et al 2000). This is in contrast to germ cell migration, where if even a 
single pole cell reaches the gonad as a primordial germ cell, that cell will proliferate to fill the 
germ cell niche. Thus, the gonad forms correctly and the organism is fertile (Robertson et al 
1999). In this way, collective cell migration is more of an all-or-nothing endeavor, which is 
potentially why there appear to be so many inputs and redundancies in the salivary gland 
migration system.  Indeed, one reason why salivary gland migration is unaltered in Tre1KO may 
be because of redundancy with another salivary gland expressed GPCR, mthl5, or redundancy 
with other signaling pathways such as Slit or Robo (Kolesnikov and Beckendorf, 2005). Such 
possibilities can now be explored with the null Tre1 allele that we have generated. 
An alternative hypothesis is that tre1 does not function in SG migration at all and is instead 
required for the organization of apically localized proteins, such as Ebi1.  This would be 
consistent with the reported roles for Tre1 in both germ cells and in neuroblasts, and with the 
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high levels of Tre1-GFP accumulation at the apical surface.  Recently, a genetic interaction was 
found between Tre1 and tao-L, a microtubule destabilizing protein (Pflanz et al 2015).  While no 
direct mechanism has been described, the authors hypothesize that activated Tre1 activates the 
Tao-L kinase, which causes the formation of lammelipodia-like structures. Tao-L is not expressed 
in the salivary gland, but this finding nonetheless supports the idea of Tre1 being involved in 
cytoskeletal regulation of migrating tissues. The method that was used to identify Ebi1 as a Tre1 
interactor also identified Tre1 itself. This suggests that Tre1 oligamerizes with itself, which may 
aid in concentrating the receptor apically (Gurevich and Gurevich, 2008).  
Tre1 is thought to affect in germ cell migration by changing the localization of Rho1, Gβ13f, 
and E-Cadherin, which alters cell polarity and adhesion to enable migration across the 
endoderm (Kunwar et al 2008). Whereas these observations explain the trapped germ cell 
phenotype, it does not easily explain why germ cells are subsequently found scattered 
throughout the embryo. Importantly, we did not observe the same changes in E-Cadherin 
localization in Tre1KO embryos that had been reported with the excision alleles, but this could 
simply be because E-Cadherin is a finicky antibody we may have missed the time window when 
those differences can be observed. If E-Cadherin relocalization is delayed or altered and the 
germ cells cross the endoderm later than normal, they may miss interactions with the migrating 
somatic gonadal precursors (SGP). This might explain why germ cells are scattered in the 
embryo. Another possibility is that Tre1 plays a separate role in germ cell guidance once the 
germ cells are through the midgut and this second function may not be disrupted in the excision 
alleles.  
Several factors affect germ cell migration after exit from the midgut.  Wunen and Wunen2 
are lipid phosphate phophohydrolases that dephosphorylate extracellular lipid phosphates such 
as phosphatidic acid and lysophosphatidic acid.  Germ cells, through an unknown mechanism, 
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migrate towards phosphorylated lipid phosphates, so the expression of wun and wun2 in the 
rear of the germ cells and in the soma drives germ cells away (Renault, et al 2004; Starz-Gaiano 
et al 2001). The HMG-CoA reductase (Hmgcr) pathway also contributes to germ cell migration. 
hmgcr is expressed in the somatic gonadal precursors (SGP), the destination for the germ cells 
after traversing the endoderm. The Hmgcr pathway results in the farnesylated or 
geranylgeranylated proteins (Ding et al 2008). One theory is that Hmgcr modifies a protein, 
which is then secreted through an ABC transporter to attract the germ cells (Ricardo and 
Lehmann 2009; Santos and Lehmann 2004). Another theory is that Hmgcr targets Gγ1, which 
promotes hedgehog (Hh) trafficking, and that Hh is the germ cell attractant made in the SGP 
(Deshpande et al 2005; Deshpande et al 2009). Both possibilities could be true, but transporter-
Hh mutants have not yet been investigated for a genetic interaction.  
Ectopic expression of Tre1 in both the embryonic trachea and the wing disc result in defects 
that are consistent with cell moving in the wrong direction, perhaps in the direction of a source 
for the unknown Tre1 ligand.  Alternatively, ectopic expression of Tre1 may have dominant 
negative effect in these tissues. In the wing, over-expression of Gαo inhibits the activity of Gαs 
by sequestering Gβ13f and Gγ1 (Katayaneva et al 2010). Tre1 activation could do something 
similar. In any case, finding the endogenous ligand for the widely expressed Tre1 protein would 
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The Methuselah family is the third largest family of G-protein coupled receptors (GPCRs) in 
Drosophila, yet most members of this family are uncharacterized. Recently, mist (mthl1) was 
identified as the receptor for fog, which causes activation of the Rho signaling pathway that 
ultimately results in the cell shape changes that drive gastrulation. methuselah like 5 (mthl5) is 
transiently expressed in the salivary gland during tissue invagination. The initial trigger for the 
apical constriction that precedes gland invagination remains unknown. Because mthl5 and mist 
share a high level of sequence identity, we investigated if mthl5 can direct the cell shape 
changes that accompany internalization of the salivary gland. We created mthl5 null alleles using 
CRISPR/Cas9 and as well as constructs for overexpression of mthl5. We found that salivary gland 
cells lacking mthl5 do not decrease the size of their apical membrane prior to and during 
invagination but nonetheless invaginate to form internalized salivary glands with abnormally 
shaped lumens. Moreover, E-Cadherin, which is known to play a role in cell invagination (Wang 
et al 2013), is more diffuse in mthl5 null flies. Staining of glands with Mthl5 antiserum reveals 
that the protein localizes to the apical surface of salivary gland cells during invagination, but that 
at later stages of gland migration, Mthl5 localizes to the basolateral membranes. We next 
questioned if Mthl5 and Mist share a ligand. Fog is expressed in the salivary gland at the same 
time as mthl5. Both knock-down and over-expression of fog cause defects in the salivary gland 
apical membrane, and related defects are seen with knock-down and over-expression of mthl5.  
Altogether, these data suggest that Fog acts through Mthl5 to drive salivary gland invagination. 
Currently, we are investigating if Fog and Mthl5 activate the Rho signaling pathway in the 






G-protein coupled receptors (GPCRs) are among the largest classes of protein families in all 
higher organisms (Kobilka 2007). All GPCRs share a seven-transmembrane architecture, allowing 
them to interact with the extracellular environment and transmit pertinent information to the 
inside of the cell. Despite a common membrane organization, GPCRs are quite different from 
one another in amino acid sequence.  These differences allow GPCRs to sense astoundingly 
diverse ligands, from light to hormones to peptides. When a GPCR binds a ligand, it undergoes a 
conformational change that is transduced to the inside of the cell, resulting in activation of the 
heterotrimeric G-proteins (Gα, Gβ, and Gγ). In turn, G-proteins activate second messenger 
cascades that alter cell behavior. Unsurprisingly, aberrant activation or silencing of GPCR 
signaling can result in deleterious cellular behavior, contributing to diseases such as cancer or 
deaf-blindness (O’Hayre et al, 2014). The involvement of GPCR signaling in such a wide range of 
diseases has made the family a focus of intense biomedical research, with nearly 40% of all drug 
development targeting GPCRs.  
 The GPCR superfamily is subdivided into subfamilies based on sequence similarity. One such 
family is the Secretin family, whose members are characterized by their long extracellular N-
terminus (Yona et al 2008).  The N-terminus is believed to assist in the recognition and binding 
of peptide and protein hormones. Insects encode a unique subfamily of Secretin GPCRs not 
found in humans or worms (Harmar 2001), known as the Methuselah (Mth) family, which is 
largely uncharacterized. Sixteen Mth family members are encoded in the Drosophila genome 
(Figure 1A) but only two of these family members have been characterized to any degree. Mth, 
the founding member of the family, was identified in a screen for mutations that increased adult 
lifespan (Lin et al 1998). Through a heterologous expression system, Mth was subsequently 
found to bind Stunted (Sun), a subunit of the F1-F0-ATP synthase, and activate calcium signaling 
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(Cvejic et al 2004). Supporting this interaction, mutations in Sun also increase lifespan in adult 
flies.  Sex Peptide (SP) was later identified as a Mth ligand in HEK293 cells, but it remains unclear 
if the interaction holds in vivo (Ja et al 2009).  
The other member of the Drosophila Mth/Secretin family that has been characterized is 
Mist, or Methuselah-like 1 (Mthl1; Manning et al 2013). As opposed to the Mth studies, the 
receptor was identified long after the ligand. The ligand Folded Gastrulation (Fog) had been 
identified as one of the key molecules driving embryonic gastrulation (Costa et al 1994). Loss of 
fog results in defects in gastrulation, a phenotype attributed to a failure of mesodermal cells to 
constrict apically. Other components of the Fog signaling pathway were identified by either 
shared phenotypes or genetic interactions.  They include the Gα subunit concertina (cta; Parks 
and Wieschaus, 1991) and the G-protein related kinase 2 (Gprk2; Fuse et al 2013), implicating a 
GPCR as a key mediator for gastrulation. Mist was identified through an RNAi cell culture screen 
as the receptor for Fog (Manning et al 2013). Importantly, this interaction holds in vivo; 
mutations in mist also cause mild gastrulation defects.  With its known ligand, downstream Gα 
protein and a regulating kinase, Mist is the best-characterized Drosophila Secretin family 
member.  
Whereas gastrulation is one of the earliest coordinated cell invagination event in the 
Drosophila embryo, many other cells and tissue undergo invagination later in development. One 
such organ is the salivary gland (Myat and Andrew, 2000a). The salivary gland begins as a 
placode of polarized columnar epithelial cells on the surface of the embryo that invaginates and 
moves dorsally until it contacts the visceral mesoderm. There, it reorients and begins posterior 
migration, continuing until the gland reaches its final position along the anterior-posterior axis 
of the embryo (Vining et al 2005). Much like in gastrulation, salivary gland invagination involves 
cell shape changes (Myat and Andrew, 2000b).  After placode formation, cells in the dorsal-
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posterior quandrant of the placode begin to apically constrict and internalize. This constriction is 
linked to changes in Myosin activity, and mutations in myosin upstream activators like Rho and 
Rho kinase have salivary gland invagination defects (Roper 2012; Xu et al 2008). Salivary gland 
invagination completely fails in embryos with loss-of-function mutations in the gene encoding 
the winged helix transcription factor Fork head (Fkh). In fkh mutant embryos, the salivary glands 
remain as placodes on the embryo surface (Myat and Andrew, 2000a). The molecules 
downstream of Fkh that drive salivary gland invagination have yet to be characterized.   
Since the known receptor that drives invagination of the mesoderm – Mist – is not 
expressed in the salivary gland, it is likely that another member of the Mth family could function 
as a GPCR for salivary gland internalization.  An excellent candidate GPCR is methuselah-like 5 
(mthl5), which is expressed early during salivary gland invagination and disappears during gland 
migration (Fig 1C). Mthl5 is most closely related to the Mth family members Mthl15, Mthl14, 
and Mist. Beyond a reported expression pattern, very little is known about mthl5 (Patel et al, 
2012). Based on its expression pattern and its homology to Mist, a family member required for 






MATERIALS AND METHODS 
Fly Strains 
The mthl5 CRISPR sites were chosen using the CRISPR finder developed by the Perrimon lab 
(http://www.flyrnai.org/crispr/). Oligos were ligated into the pU6-BSA-gRNA plasmid (Baena-
Lopez et al, 2013) after BsaI digestion. Constructs were injected into lines y[1] P{vas-Cas9.S}ZH-
2A w[1118] flies by Rainbow Transgenic Flies, Inc (Camarillo, CA). Cloning of the oligos into the 
appropriate vector and the initial fly crosses were performed by Arun Sridharan, an 
undergraduate in the lab. UAS-mthl5 was generated by Gateway cloning (Invitrogen, Carlsbad, 
CA) of the complete mthl5 open reading frame into the pTW UAS vector. This construct was 
then injected into w1118 recipient flies by Rainbow Transgenic Flies, Inc (Camarillo, CA) and 
transgenic animals were identified by the white+ eye color marker. Df(3R)BSC514, 
Df(3R)Exel7310, and fogs4  were obtained from the Bloomington Stock Center (Bloomington, 
Indiana). UAS-fog was a gift from the Perrimon Lab (Hacker et al 1998). ). twi-Gal4 was used to 
drive UAS-mthl5 in the mesoderm (Greig and Akam, 1993). fog and mthl5 RNAi lines were 
obtained from the Vienna Drosophila Resource Center (VDRC; Vienna, Italy). fkh-Gal4 was 
created by our laboratory (Henderson and Andrew, 2000). en-Gal4 (Weiss et al., 2001) was used 
to express UAS-fkh (Maruyama et al., 2011) in the ectodermal stripes. 
 
Mthl5 antibody generation 
Genomic fragments of the first 648 base pairs (corresponding to N-terminal extracellular 
216 amino acids) were cloned in-frame into the pET15b expression vector (Novagen) using the 
In-Fusion HD Cloning Kit (Clontech). The construct was transformed into E Coli. Protein was 
induced during log growth phase with 0.1M IPTG and grown over-night at 16⁰C. Inclusion body 
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preps were performed to isolate the induced protein, which was subsequently used to inoculate 
guinea pigs (Covance).  
 
Immunohistochemistry and in situ hybridizations 
In situ hybridization and immunohistochemistry were performed as previously described 
(Lehmann and Tautz, 1994; Reuter et al., 1990). mist and mthl14 in situ probes were made by 
cloning genomic fragments into pCR-TOPO-II vector (Invitrogen). Antibody concentrations used 
in this study are as follows: GPαMthl5 (1:500), RbαFork head (1:2000; a gift from S. Beckendorf, 
Berkeley, CA, USA),    RtαCrebA (1:1,000; Andrew et al., 1997), GPαSage (1:500; Fox et al 2013), 
RbαCrebA (1:10,000; Fox et al., 2010), RbαSAS (1:500; a gift from D. Cavener, Penn State 
University, PA, USA), RbαGFP (1:500, Invitrogen), mααSpectrin (1:2; Developmental Studies 
Hybridoma Bank, Iowa City, IA), RbαNrxIV (1:5000; H. Bellen, Baylor College of Medicine, 
Houston, TX, USA), mαCrumbs (1:100, DSHB), RtαDE-Cad (1:10, DSHB), and mαβgalactosidase 
(Promega, 1:10,000). All secondary antibodies (Vector Labs and Molecular Probes) were used at 
a 1:500 dilution. HRP images were developed using the Vectastain ABC kit (Vector Laboratories). 
Confocal images were obtained using a Zeiss LSM 510 or 700 Meta confocal microscope, using a 
Plan-Neofluor 63x and 100x, 1.3 oil objective and the Zeiss LSM software. All other images were 
obtained using a Zeiss Axiophot microscope configured with a Nikon Coolpix 4500 digital camera 
or a Janoptik ProgResC14 Plus opitical imaging system.  Images were taken using a Plan-Neofluor 
20x, 0.50 objective.  Images were rotated and cropped using Inkscape, an open-source vector 






mthl5 is transiently expressed in the early salivary gland 
Sixteen mth family members are encoded in Drosophila. Protein sequences corresponding 
to these genes were used to generate a rooted phylogenetic tree based on Clustal W2 
alignments (Figure 1A). Twelve family members separated into the previous described Mth 
superclade, with Mthl14, Mthl5, Mthl15, and Mist separating into different clades. Notably, Mist 
separates into a distinct clade on its own, Mthl14, Mthl15 and Mthl5 are in another, with Mthl5 
and Mthl15 segregating together into an even closer grouping.  
The mthl5 gene maps to the right arm of chromosome 3 and is entirely contained within an 
intron of the uncharacterized CG31368 gene (Figure 1B).  mthl5 has six exons, with the start 
codon in the first exon and the stop codon in exon 6.  mthl5 is expressed in a dynamic pattern 
during embryonic development (Figure 1C). mthl5 transcript is detected in several invaginating 
tissues, including the salivary gland (arrowheads), mesodermal crest cells, and trachea. In the 
salivary gland, mthl5 is expressed prior to (st 10) and during salivary gland invagination (late st 
11, early st 12), and disappears when active migration begins (late st 12 and later). mthl5 
expression is also detected in the wing and leg haltere imaginal discs (st 14), as well as in regions 
in the head.  
 
Loss of mthl5 disrupts salivary gland morphology 
Because of the early salivary gland expression of mthl5, we asked if its loss affects salivary 
gland morphology.  Two deficiency lines that remove mthl5 were obtained.  Df(3R)BSC514 
removes 48 genes and Df(3R)Exel7310 removes 13 genes. When in trans to one another, the 
two deficiencies remove only eight genes, including mthl5 (Figure 1E). By stage 14, the wild-type 
salivary gland is fully internalized and is positioned along the anterior-posterior axis. The apical  
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Figure 1: mthl5 is expressed in the early stages of salivary gland formation. A. Mthl5 (red 
asterisk) is a member of the Methuselah (Mth) subfamily of Secretin GPCRs in Drosophila. 
Mthl15, Mthl5, Mthl14, and Mist are separate from the main Mth family superclade (green). B. 
mthl5 is encoded on the third chrosomome, completely with the fourth intron of CG31368. 
mthl5 transcript is indicated by the gray box; coding exons are indicated by the orange boxes.  
For CG31368, transcript is indicated by the green boxes; coding exons are indicated by the blue 
boxes. mthl5 is encoded on the antisense strand, so this depiction is reversed from the 
orientation in the genome.C. mthl5 is expressed dynamically during embryogenesis. Lateral 
views are shown for each developmental stage, except for Stage 11, which is a ventral-lateral 
view. During Stage 10, mthl5 is expressed in the nascent salivary gland placode (arrowhead). By 
Stage 11, the expression has expanded to include mesodermal crest cells, the trachea and head. 
By late stage 12, expression in the salivary gland is no longer detected (open arrowhead). At 
Stage 14, expression is largely down-regulated in the embryo, except in the leg and wing 
imaginal disk primordia.  By Stage 15, mthl5 expression is not detected in the embryo. D-D’. 
Deficiencies removing mthl5 show defects in the salivary gland apical membrane. Crb staining in 
wild-type embryos is regular and smooth, but is often inflated and irregular in the deficiency 
lines. Quantification of the irregularities is shown in (D’). E. Df(3R)514 and Df(3R)Exel7310 in 







membrane, as revealed by staining with the apical marker Crumbs (Crb), is smooth and has an 
even width (Figure 1D). In embryos homozygous for either deficiency or with the two 
deficiencies in trans to one another, the apical lumens of the salivary glands are inflated and the 
apical membrane is quite irregular (Figure 1D, E). These phenotypes are observed in over 80% of 
salivary glands from deficiency embryos, consistent with mthl5 playing a role in salivary gland 
morphogenesis.  
 
Creation of a mthl5 null allele 
To create a clean null allele of mthl5, the CRISPR/Cas9 system was used. Two CRISPR 
constructs targeting mthl5 were injected simultaneously, one targeting the first coding exon, 
one targeting the fifth coding exon (Figure 2A), with the goal of creating a large deficiency. Of 
the three individual mutant lines generated, two had small lesions near the Exon 5 targeted site 
(Fig 2B). Line 6F4 was a seven bp deletion just upstream of the PAM site, whereas line 3F1 was a 
deletion of three base pairs plus an insertion of four base pairs. PCR amplification of the region 
immediately flanking Exon 5 of the 2F3 allele repeatedly failed, so a large genomic region of 
mthl52F3 was amplified instead (Figure 2C). This PCR amplification product was approximately 
two kb shorter than that generated with wild-type genomic DNA, suggesting that a large 
deletion had occurred. Sequencing the entire gene revealed that in the mthl52F3 allele, the 
region between the first exon-intron boundary and the targeted Exon five PAM site was deleted 
(Figure 2D). The altered ORFs for the mthl53F1and mthl56F4 encode a large N-terminal portion of 
Mthl5, including the first five of the seven transmembrane domains, before going out of frame 
(pink) and truncating (Figure 2D’, E). The mthl52F3 allele encodes only the 44 most N-terminal 
residues of Mthl5 plus 40 out of frame residues. Thus, mthl52F3 is likely to be null (Figure 2D’, E).  
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Figure 2: Creation of mthl5 mutant alleles via CRISPR/Cas9. A.  mthl5 was targeted by two 
CRISPR constructs. The first construct targets sequences in the first coding exon; the second 
construct targets sequences in the fifth coding exon. PAM sites are highlighted in yellow. B. 
Mutations generated by the exon 5 CRISPR construct. The wild-type sequence is shown with the 
CRISPR construct sequence highlighted in gray and the PAM site in yellow. The 6F4 allele is a 
small deletion upstream from the PAM site and the 3F1 allele is a mutation of several basepairs 
upstream from the PAM site. C. The 2F3 allele is a large deletion removing about 2 kb of the 
mthl5 gene. PCR analysis of embryonic genomic DNA using primers amplifying the 4.4kb region 
around mthl5 is shown. In the 2F3 allele, the amplified fragment is closer to 2kb. D-D’. Transcript 
and protein structure in the mthl5 alleles. D. The 2F3 allele was sequenced confirming a large 
deletion in the mthl5 gene, extending from a site near the beginning of intron 1 and extending 
through to the CRISPR target site in exon 5. D’. Wild-type mthl5 encodes a 496 residue protein 
with a GPCR domain containing the seven transmembrane domains. The proteins encoded by 
the mthl5 mutant alleles are shown with the out-of-frame regions in pink. E. Topology cartoon 
of Mthl5 indicated where each mutant allele goes out of frame. Cysteine residues that provide 
structure to the large extracellular N-terminus of Mthl5 are show in blue. F. Variable transcript 
levels are observed in mthl5 mutants alleles. As a control, expression of mthl5 from a non-
mutant line from the CRISPR/CAS9 mutagenesis is shown (mthl51F1). Heterozygous embryos are 







Each mutant line generated by CRISPR was analyzed for mthl5 transcripts. Heterozygous 
embryos all showed mthl5 expression in the salivary gland placode at stage 10 (Figure 2F, top 
panels). Their homozygous siblings (identified by the absence of balancer chromosome lacZ  
expression) retain variable levels of transcript (Figure 2F, bottom panels).  mthl53F1 and mthl56F4 
had approximately wild-type levels of expression, consistent with the small number of 
nucleotides deleted in each of these alleles. mthl52F3 had considerably lower levels of mthl5 
expression, consistent with the large amount of mthl5 DNA deleted in this allele.  
 
Loss of mthl5 causes salivary gland defects 
Salivary glands were examined for defects in the mthl5 CRISPR mutants. All homozygous 
lines showed irregularities in the apical membrane, as revealed by Crb staining at stage 13 
(Figure 3A). The main defects were bulges and irregular apical membrane, which is normally 
smooth and of even diameter in wild-type glands.  The penetrance of the mutant phenotypes 
was reduced relative to the deficiencies, suggesting that something else removed by both 
deficiencies may also affect salivary gland morphology. To determine the nature of the alleles, 
the phenotypes of each mthl5 allele was assessed either in trans to a mthl5 deficiency or a wild-
type chromosome. The quantification of the apical membrane irregularities (Figure 3A’) 
revealed that mthl52F3 behaves as a null allele. The mthl53F1 and mthl56F4 alleles also act as nulls 
although they may have some mild dominant negative effects, since the homozygotes have 
more severe defects than when each allele is in trans to a deficiency.   
To look more closely at earlier stages when mthl5 is first expressed and when the salivary 
glands undergo invagination, embryos were stained with E-Cadherin (E-Cad).  E-Cad localizes to 
the adherens junctions of epithelial cells and is an indicator of apical domain size. In wild-type 
salivary glands, just after the start of invagination, the cells closest to the invagination pit have 
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decreased apical size and sharp intense E-Cad outlining the apical membrane (Figure 3B). In the 
mthl52F3 mutant salivary glands, the levels of E-Cad appear less intense than in wild-type (Figure 
3B’). To quantify the E-Cad staining, line scans starting from the invagination pit and moving 
towards the anterior domain of the placode were performed. Wild-type salivary gland cells had 
a higher E-Cad pixel intensity than in the mthl52F3 cells (Figure 3C, compare y-axis of blue and  
red lines). The peaks of intensity in the mthl52F3 cells were also farther apart within three cell 
lengths of the pit when compared to the same region of wild-type salivary glands. Altogether, 
these data suggest that, with loss of mthl5, the apical domains of cells do not constrict as much 
as in wild-type, resulting in the less intense Ecad staining at AJs.  
 
Localization and overexpression of Mthl5 in salivary gland cells 
To learn where in the cell Mthl5 localizes, antiserum was generated to the long extracellular 
N-terminal domain of Mthl5. Unfortunately, this antiserum failed to recognize endogenous 
levels of Mthl5, so it was not useful for examining protein levels in wild-type embryos or in the 
mthl5 CRISPR mutants. However, the antiserum did detect over-expressed Mthl5 (Figure 4A, A’). 
Using the fkh-Gal4 salivary gland driver, UAS-mthl5 was expressed in the salivary gland. Prior to 
invagination, the Mthl5 antiserum recognized Mthl5 in puncta throughout the salivary gland 
placode (Figure 4A’). During invagination (Figure 4B-B’’), Mthl5 was in still localized in puncta 
but with strong enrichment at the apical plasma membranes, where it colocalized with the 
apical Crb protein (yellow, Figure 4B’’). This apical localization of Mthl5 is consistent with a role 
for this protein in salivary gland invagination.  
Interestingly, at later developmental stages, localization of overexpressed Mthl5 was 
different. During stage 13, (when endogenous mthl5 transcripts are no longer detected), Mthl5 
still colocalized with apical markers (Figure 4C’’), but, by stage 14, Mthl5 localized exclusively to  
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Figure 3: Salivary gland defects are observed with loss of mthl5. A-A’. mthl5 mutant alleles 
show irregularities in the salivary gland apical membrane at stage 13. The number of 
irregularities are quantified in A’. B-B’. Changes in ECad enrichment are observed in mthl5  
alleles. C-C’. ECad staining in wild-type and mthl52F3 embryos. The yellow line extends from the 
invagination pit (left) towards the anterior end of the embryo (arrowhead). Note: the lines are 
representative and are not the exact portion those quantified in (C). C. Quantification of the 






Figure 4. Over-expression of mthl5 in the salivary gland causes mislocalization of proteins in 
the basolateral domain. A-B’’. Confocal images are shown of fkh-Gal4 driving UAS-mthl5 
expression in the salivary gland. A-A’. Before invagination, Mthl5 is localized in cytoplasmic 
puncta and at the membranes (lateral views). B-B’’ During invagination, Mthl5 is enriched 
apically at the invagination pit (ventral views). B’’ is an XY orthogonal view of the invaginating 
gland. C-D’’ Mthl5 translocates from the apical and lateral membranes to the basolateral 
membranes. C-C’’ Stage 13 embryos show Mthl5 in the lateral and apical membranes (C). The 
apical localization overlaps with SAS staining (C’,C’’)  By stage 14, the Mthl5 staining no longer 
colocalizes with SAS and is exclusively located at the basolateral membranes. E-F’’. Over-
expression of Mthl5 causes mislocalizatoin of a septate junction protein. E-E’’ Wild type Nrx is 
located apically to the lateral αSpec staining. F-F’’mthl5 expression driven by fkh-Gal4 results in 
Nrx mislocalization (F’). Apical surface protein localization is not affected by mthl5 
overexpression (H). G-I.  Over-expression of mthl5  by fkh-Gal4 increases the number of nuclei 
around the lumen of the gland but the changes are not statistically significant. Quantification is 







basal and lateral membranes (Figure 4D) and no longer colocalized with the apical marker SAS 
(Figure 4D’’).  This apical to basal movement of Mthl5 did not affect localization of SAS (Figure 
4G-H’); it did, however, cause mis-localization of the septate junction protein Nrx-IV (Figure 4E- 
F’). Invertebrate septate junctions are roughly equivalent to vertebrate tight junctions in that 
they contain homologous proteins and provide epithelial barrier function. In contrast to tight  
junctions, which are found just apical to adherens junctions, septate junctions are located just 
basal to adherens junctions. Late mthl5 over-expressing salivary glands have Nrx-IV spread 
throughout the lateral membrane instead of localizing just basal to the adherens junctions as 
they are in wild-type (Figure 4E’, F’). The localization of the lateral protein αSpectrin (αSpec) 
remained unchanged (Figure 4G, H).  Altogether, these findings suggest that when mthl5 is 
expressed during later stages than normal, it localizes to a different domain where it can affect 
some aspects of cell polarity, perhaps through the recruitment of cytoskeletal proteins whose 
localization is known to be affected by GPCR signaling (Kunwar et al 2008; Schwabe et al 2005). 
The changes in the basolateral domain protein localization observed in the mthl5 over-
expressing salivary glands prompted us to ask if there were any defects associated with mthl5 
overexpression. As the gland invaginates from a placode, the cells rearrange from a plate-like 
structure of ~144 cells on the embryo surface to an elongated tube, roughly eight cells in 
circumference and 18 cells long. To determine if SGs overexpressing mthl5 formed tubes of 
normal dimensions, the number of nuclei around the tube at a proximal, medial, and distal 
positions was counted (Figure 4G-I).  Although there were slightly more cells around the tube in 






Fog as a ligand for both Mist AND Mthl5 
As with most GPCRs, mthl5 is classified as an orphan receptor since its ligand is unknown. 
Because Mthl5 is a member of the Mth superfamily, we wondered if any information regarding 
other Methuselahs could direct us towards a possible ligand. Candidate ligands for only two 
members of the Mth family have been identified:  Sex peptide as a potential ligand for Mth and 
Folded gastrulation (Fog) as a known ligand for Mist (Mthl1). Mthl5, Mthl14, Mthl15 and Mist do 
not fall into the large superclade of Mth proteins (Figure 1A), so perhaps some of these 
receptors share Fog as an activating ligand. To determine if Fog could be a ligand for Mthl5, we 
first looked at its expression pattern. fog is expressed in the ventral furrow at Stage 5, as is mist, 
consistent with both genes’ role in gastrulation (Figure 5A). Interestingly, fog is also expressed in 
the salivary gland during stage 11, coinciding nicely with mthl5’s expression pattern. mist is not 
expressed in the salivary gland, suggesting that there is another receptor for Fog in the salivary 
gland.  The best candidate for the salivary gland Fog GPCR is Mthl5 since it is expressed in the 
salivary gland at the right time. mthl14, a Mth family member that separates into the same 
clade as mthl5 is not expressed in either the ventral furrow or the salivary gland (mthl14) and 
mthl15 is not expressed in embryos based on RNAseq data (Flybase). These data were 
encouraging, and further suggested that Fog could be a potential Mthl5 ligand. 
In the ventral furrow, both fog and mist are controlled by the mesodermal transcription 
factors Twist and Snail (Twi and Sna; Manning et al 2013; Seher et al 2007). When Mthl5 binds 
Fog, the Gα12/13 protein Concerntina (Cta) is activated (Parks and Wieschaus, 1991), which then 
activates Rho1 via RhoGEF2 activation (Figure 5B; Barrett et al 1991; Nikolaidou and Barrett, 
2004). Activated Rho1 leads to the cell shape changes that drive gastrulation. Rho1 and 
RhoGEF2 have previously been shown to be important for salivary gland invagination (Xu et al 
2008), although it was unknown how these proteins become activated. twi is not expressed in 
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the salivary gland at stage 12, but the transcription factor Fkh is. Thus, we asked if mthl5 and/or 
fog expression in the salivary gland is/are regulated by Fkh. Indeed, our previous microarray 
analysis revealed that mthl5 transcript levels decreased by 2.4 fold in fkh mutant embryos 
(Maruyama et al 2011). To determine if fkh is necessary for mthl5 expression in the salivary 
gland specifically, transcript levels of mthl5 were compared between fkh mutant embryos and 
wild type (Figure 5G-G’). mthl5 transcripts are observed in the salivary gland of fkh mutant 
embryos, although at a lower level than in their heterozygous sibling controls. These data  
suggest that fkh contributes to the salivary gland expression of mthl5, but is not absolutely 
necessary. Similar in situ analysis of fog expression in fkh mutants has shown that fog expression 
disappears in a fkh mutant (SeYeon Chung, unpub.), suggesting that fkh is necessary for wild-
type levels of both mthl5 and fog expression.  
 To learn if Fkh could activate expression of mthl5 and fog in ectopic domains, UAS-fkh was 
driven with an en-Gal4 driver, which is expressed in ectodermal stripes. During stage 12, 
endogenous mthl5 is expressed in the salivary gland placode and in a subset of mesodermal cells 
(Figure 5C). In embryos ectopically expressing fkh in ectodermal stripes, mthl5 is also observed 
in the striped en domain (Figure 5D). The same striped expression is observed at stage 14 
(Figure 5C’, D’). Similarly, fog expression is also observed in stripes in the en-Gal4>UAS-fkh 
embryos (Figure 5E-F’). Therefore, Fkh is sufficient to drive expression of both mthl5 and fog. 
fog mutants were examined for a possible role in salivary gland development. Loss of fog 
causes major defects in embryonic development since gastrulation fails. In fog mutants, salivary 
glands form, but typically stay at or near the surface of the embryo (Figure 6B’), often 
completely failing to invaginate. Because the failure of salivary glands to invaginate could be 
linked (at least partially) to the failure of the mesoderm to invaginate, we looked more 
specifically for a role for salivary gland-expressed fog. To do this, salivary gland specific RNAi of  
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Figure 5: Fkh regulates mthl5 and fog expression in the salivary gland. A. Expression of fog, 
mist, mthl5, and mthl14 in stage 5 and stage 11 wild-type embryos. Ventral furrow expression is 
indicated at stage 5. Closed arrowheads indicate expression, open arrowheads indicate lack of 
expression. During stage 11, salivary gland expression is indicated in the same way. B. Model of 
the apical constriction pathway in the mesoderm and salivary gland. In the mesoderm, fog and 
mthl5 expression are downstream of Twi. In the mesoderm, Fog binds Mist (open arrow) and 
then activates RhoGEF2 through the Gα Cta black arrow). RhoGEF2 then activates Rho, which 
activates Rho kinase (Rok), which phosphorylates and activates myosin leading to apical 
constriction. In the salivary gland, we imagine a similar pathway wherein Fog binds Mthl5 (open 
arrow) and Mthl5 then activates downstream signaling (gray arrows).  Our hypothesis is that Fkh 
controls expression of Fog and Mthl5 in the salivary gland. C-F’. Ectopic expression of fkh via en-
Gal4 drives ectopic mthl5 and fog expression.  Wild-type mthl5 is expressed in the salivary gland 
placode and mesoderm at stage 11 (C). At Stage 14, expression is very limited (C’). When fkh is 
driven in the striped Engrailed (En) domain, expression of mthl5 is detected in stripes (red 
arrowheads; D, D’). Much like mthl5, fog is expressed in the salivary gland placode in wild-type 
embryos at stage 12 (E) and at low levels at stage 14 (E’). Ectopic fog is detected in stripes when 






Figure 6. Modulation of mthl5 and fog levels cause salivary gland defects. A-D Knockdown, 
loss-of-function (LOF), and over-expression of mthl5 or fog. A-A’ Control embryos showing 
smooth apical membranes as revealed by Crb staining. B-C RNAi of fog (B) and mthl5 (C) both 
show widened regions of the apical membrane (arrowheads). B’-C’ Loss-of-function (LOF) alleles 
of fog (B’) and mthl5 (C’).  The defects seen in the fogs4 allele are quite severe possibly due to 
accompanying defects in gastrulation. The mthl5 null allele shows rough and widened apical 
membranes. B’’-C’’ Over-expression of fog (B’’) and mthl5 (C’’) causes widened apical 
membranes. D. Over-expression of both fog and mthl5 together also causes widened apical 
membranes. E. Quantification of the defects seen in A-D.  F. Mix-expression of mthl5 by Twi-







fog was carried out. Knockdown of fog in the salivary gland using the fkh-Gal4 driver causes 
bulges and irregularities in the salivary gland much like those observed with mthl5 CRISPR 
mutations and mthl5 deficiencies (Figure 6B). Very similar phenotypes were observed with 
mthl5 knockdown using fkh-Gal4 to drive mthl5 RNAi (Figure 6C).  These findings are fully 
consistent with the hypothesis that Fog is the Mthl5 ligand in the salivary gland. 
When mthl5 is over-expressed in the salivary gland, mild apical membrane irregularities are 
observed (Figure 6C’’), whereas over-expression of fog causes the lumen to be wider than  
normal (Figure 6B’’). Over-expression of both mthl5 and fog in the salivary gland causes defects 
similar to those seen in fog over-expression (Figure 6D), suggesting that Fog is the limiting 
factor. Quantification of these data is shown in Figure 5E.  The wider lumens observed with Fog 
overexpression in the SG could suggest that more cells internalize at earlier stages, consistent 
with the idea that Fog acts through Mthl5 to drive apical constriction and salivary gland 
invagination.   
Finally, we asked if there were any defects associated with ectopic expression of mthl5 in 
the ventral furrow using twi-Gal4. The goal of this experiment was to ask if providing ectopic 
mthl5 in the mist domain would block Mist signaling by sopping up Fog.  Twi-Gal4>UAS-mthl5 
embryos develop normally and salivary gland invagination is not affected (Figure 6L). Thus, 
either endogenous Mist is still able to bind sufficient Fog to drive gastrulation in the background 
of mthl5 mis-expression, or Mthl5 may activate the same signaling pathway as Mist to drive 
mesodermal invagination. Driving mthl5 in the ventral furrow in a mist mutant background 






mthl5 is a member of the Methuselah family of Secretin GPCRs. The Methuselah family is 
the third largest family of GPCRs encoded in the Drosophila genome, and yet only two of its 
sixteen members have been characterized to any extent. mist, or mthl1, is the best 
characterized Mth family member, and has been identified as the receptor for Fog. mist and fog 
are expressed in an overlapping region in the ventral furrow, and loss of either mist or fog 
causes defects in gastrulation. Because defective gastrulation is an easily recognized phenotype, 
many players in the Fog pathway had been identified before mist was characterized. The first 
clue that a GPCR was vital to gastrulation was the discovery that Concertina, a Gα subunit, also 
shows gastrulation defects (Parks and Wieschaus, 1991). The GPCR kinase Gprk2 also affects 
gastrulation (Fuse et al 2013), as does the Gα GEF Ric-8 (Peters and Rogers, 2013). Downstream 
of Cta, it was shown that RhoGEF2 strongly affected ventral furrow formation (Barrett et al 
1997), and that apical myosin levels were lower in a RhoGEF2 mutant (Nikolaidou and Barrett, 
2004). Further work showed that Rho kinase was activated downstream of Fog signaling, and 
that Fog caused myosin to localize apically prior to the observed cell shape changes (Dawes-
Hoang et al, 2005). Mist provided the link between Fog and the Cta-RhoGEF-Rho-Rok-Myosin 
signaling pathway.  
Here, we show that many of the same signaling pathway components are expressed in the 
salivary gland. fog was known to cause defects in embryonic salivary glands (Lammel and 
Saumweber, 2000), although the defects are not specific to the salivary gland itself. Rho and Rok 
were known to be involved in gland invagination, as is a negative regulator of RhoGAPS (Xu et al, 
2008; Kolesnikov and Beckendorf, 2007). Myosin is also dynamically involved in gland 
invagination (Roper, 2012). Each placode is surrounded by a myosin cable, and myosin changes 
from a cortical to a medial position in cells near the invagination pit. Moreover, cells in the 
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salivary gland placode undergo cell shape changes similar to those observed in ventral furrow 
formation (Myat and Andrew, 2000b). In fkh mutant embryos, these cell shape changes do not 
occur, reminiscent of the absence of cell shape changes in the ventral furrow in snail and twist 
mutant embryos (Grau et al 1984). The link in the salivary gland between fkh and the cell shape 
changes and between Fog, Rho, and myosin was unknown until this work. 
Of the sixteen Mth family members, four separate away from the main Mth superclade. 
Mist and Mthl5 are both in the Mth family offshoot. mthl5 is not expressed in the ventral 
furrow, as fog and mist are, but it is expressed in the salivary gland during gland invagination 
and dorsal movement. Interestingly, spatiotemporal expression of fog matches that of mthl5 in 
the salivary gland, and the known Fog ligand, encoded by mist is not expressed in this region. 
Our studies indicate that Fog is also a ligand of Mthl5. We created both loss-of-function alleles 
via CRISPR/Cas9 as well as constructs for mthl5 over-expression. Loss of fog and loss of mthl5 
cause salivary gland defects and RNAi of either give nearly identical defects. fog mutants have 
severe defects due to incomplete gastrulation – the embryos appear twisted and the salivary 
glands form but do not invaginate. While the failure of gland invagination could be due to the 
gross morphological defects in the embryo, it could also be from altered signaling from the 
mesoderm to the salivary glands. It would be interesting to determine if loss of mist and mthl5 
phenocopies a loss of fog for both mesoderm and salivary gland formation.  Over-expression of 
fog also causes enlarged salivary gland lumens, where over-expression of mthl5 causes only mild 
defects, suggesting that ligand activation is necessary. Both mthl5 and fog salivary gland 
expression go down in fkh and can be activated by ectopic fkh expression, further implicating 
Mthl5 in the Fkh/Fog signaling pathway required to internalize the salivary gland. 
Close examination of loss of mthl5 showed that E-Cadherin dynamics are altered. During 
salivary gland migration, E-Cadherin is strongly localized to the membrane, where it can be used 
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to track the cell shape changes that occur prior to salivary gland invagination (Booth et al 2014). 
In mthl5 mutants, E-Cadherin is not as strongly localized to the membrane, and the apical 
domains are larger than in wild-type salivary gland placodes. In dorsal fold formation, 
invagination of the cells is preceded by a ventral shift of E-Cad (Wang et al 2013), and a similar 
observation has been made in the salivary gland, at least for the first cell that internalizes 
(SangJoon Kim, unpublished results). Lack of apical constriction is also observed when the 
microtubule network is disrupted in the salivary gland (Booth et al 2014), a phenotype mediated 
by altered myosin dynamics in the gland placode. Apical constriction is also affected by loss of 
fkh (Seyeon Chung, unpublished results). Altogether, these data support a hypothesis that mthl5 
plays a role in the cell shape changes that drive salivary gland internalization. Further 
investigations into E-cad localization/accumulation and myosin dynamics in the mthl5 mutant 
are being done now to link mthl5 to these processes.  
A final test of whether Mthl5 is the Fog receptor in the salivary gland will be done by 
expressing mthl5 in S2 cells and then exposing these cells to secreted Fog protein. This approach 
is similar to that used by Manning et al (2013) to identify Mist as a Fog receptor. However, so 
far, we have been unable to obtain reliable mthl5 expression in S2 cells. We will also over-
express fog in a mthl52F3 embryo to see if the fog over-expression phenotypes are mediated 
through Mthl5. We are now attempting to express mthl5 and fog, alone and together in the 
wing imaginal disc, a system often used to examine apical constriction, cell shape changes, and 
folding (Zimmerman et al 2010). Our hypothesis is that expression of both genes will lead to cell 
shape changes, whereas expression of each component alone will not. We hope that these 
experiments will conclusively demonstrate that Mthl5 is a receptor for Fog, and therefore fully 
implicate mthl5 in the signaling pathway driving salivary gland invagination.  
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It should be noted that even with loss of mthl5 and knock-down of fog, the salivary gland 
still invaginates. This finding suggests that redundant mechanisms exist within the salivary gland 
to drive invagination. Another GPCR, Tre1, is expressed in the salivary gland at stage 12, and 
may function with mthl5 during this stage of development.  Moreover, apical constriction is not 
the only mechanism necessary for internalization. Over-expression of Crb in the salivary gland 
prevents apical constriction, but the glands invaginate, albeit with defects in their morphology 
(SeYeon Chung and Sangjoon Kim, unpublished). In the trachea, apical constriction is paired with 
an additional cell division that drives internalization (Kondo and Hayashi, 2013). fkh is the only 
known component to completely block salivary gland migration, so the characterization of other 
Fkh targets as well as studies of the interaction of these targets with mthl5 and fog  would add 
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Members of the Fox family of transcription factors have been well-characterized for their 
role in several developmental processes. In Drosophila, there are nineteen Fox family members. 
foxL1, previous known as fd64a, is expressed in several different types of musculature during 
embryonic development. In later stages of embryonic development, we discovered that foxL1 is 
expressed in Ventral Intersegmental 5 (VIS5), a relatively undescribed muscle found in all three 
of the thoracic segments. Because the salivary gland closely associates with this muscle during 
lates stages of posterior migration, we asked if FoxL1 and its targets contribute to salivary gland 
guidance. To explore this hypothesis, we generated a foxL1 knockout via homologous 
recombination, a null allele via CRISPR/Cas9, as well as a foxL1 over-expression construct. Loss 
of foxL1 does not overtly affect salivary gland migration, but over- and mis-expression of foxL1 
cause a variety of salivary gland irregularities. Moreover, mis-expression of foxL1 in all muscles 
also causes gross muscle abnormalities. This raised the possibility that foxL1 affects salivary 
gland migration by disrupting the scaffolding that the salivary gland uses as a track for migration 
and by providing an ectopic source of signaling molecules. To more closely examine potential 
defects in the musculature, we created an mCherry knock-in allele of foxL1, which I am currently 
characterizing. We also identified sema2a, a known secreted signaling molecule, as a target of 
FoxL1.  We plan to perform a microarray using our foxL1 null alleles to identify more targets that 






Cell migration is a critical process that occurs throughout life; it can involve single cells, 
groups of cells or even entire organs. For example, during embryogenesis, neural crest cells 
migrate long distances as individuals to ultimately populate many different tissues and organs in 
response to normal developmental cues.  Cells also migrate as a population in order to close 
wounds.  Whereas both of these processes would be considered beneficial to an organism, cell 
migration can also be detrimental, such as when single cancer cells or clumps of cancer cells 
metastasize to invade different tissues.  To simplify studying this complicated process, the 
Drosophila salivary gland provides a unique model system.  Each paired gland comprises 
approximately 140 epithelial cells, which form tubes from plate or placode of polarized 
primordial cells.  Salivary gland cells neither divide nor die during the entire process of 
morphogenesis.   Moreover, the salivary gland migrates as a fully polarized intact tissue to arrive 
at its final position in the embryo.  These features, as well as the ease of genetic manipulation, 
make the salivary gland an ideal model for understanding the complex process of cell/tissue 
migration.   
The migration of the salivary gland has been described in detail (Chung et al., 2014). Each 
salivary gland starts out as a placode of polarized epithelial cells on the surface of the embryo.  
The cells undergo apical constriction to invaginate into the embryo and form a monolayered 
epithelial tube, with the apical surfaces facing the lumen and the basal surfaces contacting other 
tissues.  The salivary gland moves dorsally as it internalizes until reaching a turning point during 
mid-embryogenesis when it reorients and migrates posteriorly to reach its final position by the 
end of embryogenesis. Integrin signaling is essential for migration of the salivary gland (Bradley 
et al., 2003) and previous work from our lab has shown that the salivary gland contacts multiple 
distinct tissues during its posterior migration, including the visceral mesoderm and fat body at 
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early stages (Vining et al., 2005). Salivary gland migration is affected by several signaling 
pathways.  Netrin, expressed in the central nervous system and visceral mesoderm, acts through 
its salivary gland expressed receptor Frazzled to attract the gland (Kolesnikov and Beckendorf, 
2005).  Conversely, Slit, secreted by the midline glia, interacts with Robo, expressed in the 
salivary gland, to act as a repellent.  The PDGF receptor and its ligands are also involved in 
salivary gland placement (Harris et al 2009). However, much remains to be discovered regarding 
the ligands, receptors, downstream signaling pathways, and relevance of tissue-tissue contacts 
in guiding salivary gland movement.  
The Fox family transcription factors play major roles in the development in all higher 
organisms (Weigel and Jackle, 1990; Hannenhalli and Kaestner, 2009). Fox proteins (forkhead 
box) are members of a well-conserved family of winged-helix transcription factors with many 
diverse functions, ranging from regulation of organ development and growth, to vocal learning 
(Lee et al 2005; Haesler et al 2004).  These proteins have also been implicated in cancer 
metastasis where their transcriptional targets include cell cycle regulators, growth factors, and 
cell adhesion molecules (Myatt and Lam, 2007). There are 19 Fox family members in Drosophila, 
44 in mouse, and 50 in human (Jackson et al, 2010). Fkh, the single Drosophila member of the 
FoxA protein subfamily, was the first Fox gene cloned (Weigel et al 1989). In the salivary gland, 
fkh is expressed early in the gland placode and continues to be expressed for as long as the 
organ persists (Myat and Andrew, 2000). Loss of fkh results in salivary gland cell death; when 
the glands are kept alive, the cells in the fkh mutants fail to undergo apical constriction and the 
salivary glands do not invaginate. Whereas fkh is unable to specify glands by itself, it does 
maintain its own expression and expression of many genes that implement the salivary gland 
cell fate choice (Maruyama et al 2011). fkh is also expressed the hindgut, Malpighian tubules, 
and proventriculus (among other tissues), and induces expression of salivary gland specific 
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genes by collaborating with the salivary gland specific transcription factor Sage, with some 
contribution from the Senseless transcription factor (Fox et al 2013). In mammals, FoxA is 
considered a pioneer transcription factor because it binds chromatin early in an ATP-
independent manner and then attracts other transcription factors to those sites (Zaret and 
Carroll, 2011), a role not supported by studies in flies (Abrams et al., 2006). 
The 18 other Drosophila Fox genes show dynamic expression throughout development (Lee 
and Frasch, 2004). The expression pattern of fd64a is particularly intriguing due to its expression 
in the somatic visceral muscles that directly contact the salivary gland during late embryonic 
stages.  The closest mouse homologue of Fd64a is FoxL1 (Figure 1A), which is expressed in the 
mouse mesenchyme and is necessary for proper gut development (Katz et al 2004). FoxL1 
regulates gut morphology by limiting the amount of Syndecan-1 and Perlcan secreted by the 
mesenchyme, which in turn regulates levels of Wnt signaling in the gut epithelium (Perreault et 
al 2001). Because the salivary gland uses multiple inputs and signals to direct its journey to its 





MATERIALS AND METHODS 
Fly Strains 
The FoxL1 knockout line was created via homologous recombination, as described 
by Gong and Golic (2003). The FoxL1 CRISPR sites were chosen using the flyCRISPR 
Optimal Target Finder (http://flycrispr.molbio.wisc.edu/tools). Oligos were ligated into 
the pU6-BSA-gRNA plasmid (Baena-Lopez et al, 2013) after BsaI digestion. p-mCh-C1 was 
a gift from the Inoue lab (Johns Hopkins University School of Medicine). Constructs were 
injected into lines w[1118]; PBac{y[+mDint2]=vas-Cas9}VK00027 flies by Rainbow 
Transgenic Flies, Inc (Camarillo, CA). UAS-fd64a was generated by Gateway cloning 
(Invitrogen, Carlsbad, CA) into the pTW UAS vector. This construct were then injected 
into w1118 flies by Rainbow Transgenic Flies, Inc (Camarillo, CA). Df(3L)BSC369, 
Df(3L)BSC368, 5053-Gal4, and caps02937 were obtained from the Bloomington Stock 
Center (Bloomington, Indiana). UAS-Sema2a-TM-GFP was a gift from the Kolodkin lab 
(Wu et al 2011). twi-Gal4 (Greig and Akam, 1993), SNS-Gal4 (Kocherlakota et al.,2008), 
and RP298-Gal4 (Menon and Chia, 2001) were obtained from Elizabeth Chen’s Lab 
(Johns Hopkins University School of Medicine). bap-Gal4 was from Manfred Frasch 
(University of Erlangen-Nuremberg). fkh-Gal4 was created by our laboratory (Myat and 
Andrew, 2000). Homozygous lethal lines were balanced over Cyo-Ftz-LacZ or TM6-Ubx-
LacZ embryos, and mutant chromosomes were identified by lacZ staining. 
Fd64a antibody generation 
The full-length ORF of fd64a was cloned in-frame into the pET15b vector (GE 
Novagen) using the In-Fusion HD Cloning Kit (Clontech). The construct was transformed 
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into E Coli.  Protein was induced during log growth phase with 0.1M IPTG and grown 
over-night at 16⁰C. Inclusion body preps were performed to isolate the induced protein 
and injected into rats (Covance).  
Immunohistochemistry and in situ hybridizations 
In situ hybridization and immunohistochemistry were performed as previously 
described (Lehmann and Tautz, 1994; Reuter et al., 1990). An mcherry in situ probe was 
made by cloning the genomic fragment into pCR-TOPO-II vector (Invitrogen). Antibody 
concentrations used in this study are as follows: mαDm0 (ADL1011:1000; Drosophila 
Studies Hybridoma Bank, Iowa City, IA), RtαFoxL1 (1:1000), RbαSG2 (1:500), RtαCrebA 
(1:1,000; Andrew et al., 1997), RbαForkhead (1:2000; a gift from S. Beckendorf, 
Berkeley, CA, USA), RbαMHC (1:500; Kiehart and Feghali, 1986), mαSema2a (1:250, 
DSHB), RtαTropomyosin (ab50567, 1:100; Abcam), βPS, RbαVg (1:10; Sean Carroll, 
University of Wisconsin, Madison), GPαSage (1:500; Fox et al 2013), RbαCrebA 
(1:10,000; Andrew et al., 1997), RbαSAS (1:500; a gift from D. Cavener, Penn State 
University, PA, USA), RbαGFP (1:500; Invitrogen, mααSpectrin (1:2; DSHB), mαCrumbs 
(1:100, DSHB), RtαDE-Cad (1:10, DSHB), and mαβgalactosidase (Promega, 1:10,000). Vg 
staining was performed overnight at room temperature. The FoxL1 signal was amplified 
through biotinyl tyramide amplification (TSA Biotin System, Perkin Elmer). All secondary 
antibodies (Vector Labs and Molecular Probes) were used at a 1:500 dilution. HRP 
images were developed using the Vectastain ABC kit (Vector Laboratories). Confocal 
images were obtained using a Zeiss LSM 510 or 700 Meta confocal microscope, using a 
Plan-Neofluor 63x and 100x, 1.3 oil objective and the Zeiss LSM software. All other 
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images were obtained using a Zeiss Axiophot microscope configured with a Nikon 
Coolpix 4500 digital camera or a Janoptik ProgResC14 Plus opitical imaging system.  
Images were taken using a Plan-Neofluor 20x, 0.50 objective.  Images were rotated and 
cropped using Inkscape, an open-source vector graphic editor. All images were obtained 






FoxL1 is expressed in a subset of somatic muscles that contact the migrating salivary gland 
Fd64a is one of 19 Fox family members in Drosophila (Figure 1A, dark lines). Fd64a is most 
closely related to mammalian FoxL1 and will heretofore be referred to as FoxL1. Like many of 
the Fox family members, FoxL1 has a dynamic expression pattern during embryonic 
development (Figure 1B-F’). At stage 9, FoxL1 is expressed in somatic mesodermal precursors 
(SMP) and hindgut visceral mesoderm (HVM) precursors (Figure 1B-B’).  The SMP cells migrate 
anteriorly through stage 12 (Figure 1C), and by stage 13, FoxL1 is expressed in ten bilateral 
clusters of somatic mesoderm (Figure 1D).  The HVM expression of FoxL1 continues for the 
duration of embryonic development (Figure 1C-F’). FoxL1 is also expressed in a small cluster of 
cells in the head region (Figure 1D-E).  During stage 14, FoxL1 is upregulated in a group of cells in 
the second and third thoracic segment; expression in these cells continues through stage 15 and 
is subsequently lost (Figure E-F’). The salivary gland migrates directly between two areas of 
FoxL1 expression during stage 15 (Figure 1G).  
An antibody to full-length FoxL1 was generated and used to stain embryos; the staining 
pattern with the antiserum recapitulates the in situ expression pattern. Consistent with the role 
of FoxL1 as a transcription factor, Fox1 staining is nuclear.  As seen with the RNA, the salivary 
gland migrates in direct contact with FoxL1 expressing cells (Figure 1H). This expression pattern 
suggested that FoxL1 may influence salivary gland placement.  
 
Loss of FoxL1 does not overtly affect salivary gland placement 
Deficiency lines removing FoxL1 were obtained to ask if FoxL1 has a role in salivary gland 
placement. Wild-type salivary glands at stage 15 have a smooth and even apical membrane, 
which can be seen with a variety of apical membrane and junctional markers that localize either  
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Figure 1: FoxL1 is a member of the Fox family of transcription factors and it expressed 
throughout the Drosophila embryo. A. Phylogenetic tree of mouse (Mm) and fly (Dm) 
Fox transcription factors. Fd64A/FoxL1 (asterisk) is most closely related to FoxL1. B-F’’ 
Fly FoxL1 is expressed dynamically during embryogenesis. B- F are lateral views; B’-F’ are 
dorsal/ventral views; B’’- F’’ are FoxL1 antibody staining. B-B’’’ FoxL1 is expressed in 
precursors to the somatic muscles (SMp) and in the hindgut visceral mesoderm (HVMp) 
at stage 9. C-C’’’During stage 12, the mesodermal precursors move with the extending 
germ band. D-D’’’ By stage 13, FoxL1 expression is observed in the hindgut visceral 
mesoderm and in ten bilateral sets of somatic abdominal muscles. E’E’’’ FoxL1 staining 
begins to wane in the abdominal muscles but appears in the second and third thoracic 
segments during embryonic stages 14 and 15. F-F’’’ G-H The salivary gland migrates 
directly adjacent to regions of FoxL1 expression. G. FoxL1 is expressed in the second and 
third thoracic segments and in a cluster of cells dorsal to the gland. The salivary gland 
(outlined) contacts both regions of expression. H. FoxL1 is localized to the nuclei, and 







in or close to the apical surface, including Stranded at Second (SAS) and Crumbs (Crb).  Wild-
type salivary glands align relatively parallel to the body wall, along the anterior-posterior axis 
(Figure 2A-A’). Salivary glands from both deficiency lines that remove FoxL1 showed irregular 
apical membranes that were often rough and curved (Figure 2B-C’), indicating potential 
migration defects. Df(3L)BSC369 embryos also had other defects, including irregular visceral 
mesoderm and gut formation (Figure 2C). Each of these lines removes well over twenty genes, 
indicating that the phenotypes observed are not necessarily due to loss of FoxL1. In trans to one 
another, however, the deficiencies remove only 13 other genes (Figure 2G) and still resulted in 
overt highly penetrant salivary gland defects (Figure 2D-D’,F). Along with the expression data, 
these results support a potential role for FoxL1 in salivary gland migration. Therefore, we 
decided to more thoroughly investigate the role FoxL1 plays in embryonic development. 
Because null alleles of FoxL1 did not exist, we created a FoxL1 null allele by homologous 
recombination (Figure 2H). The FoxL1 coding region was replaced with the white+ eye color 
open reading frame (ORF) by homologous recombination with a clone containing four kb 
upstream and four kb downstream of the FoxL1 ORF. Several null alleles were generated, which 
will heretofore be referred to as FoxL1KO. PCR with primer pairs outside the region of 
recombination and within the white+ ORF were used to verify insertion of white+ into the FoxL1 
locus (colored arrows, Figure 2H). The candidate FoxL1KO lines yielded PCR products of the 
expected sizes, whereas wild-type embryos did not, indicating the presence of white+ in the 
correct genomic region (Fig 2I).  FoxL1KO lines were also tested for transcript and protein 
expression (Figure 2J-K’’). Heterozygous FoxL1KO lines had both somatic mesodermal and 
thoracic FoxL1 expression (Figure 2J-J’), which was absent in their homozygous siblings (Figure 
2K-K’). Correspondingly, FoxL1 protein expression was also absent in the homozygous FoxL1KO 
lines (Figure 2J’’-K’’).  
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Figure 2: Creation of FoxL1 null allele. A-E’ Salivary gland apical membrane staining at 
stage 15 in FoxL1 alleles. A- E are lateral views; A’- E’ are ventral views. A-A’ Wild-type 
embryos have even and smooth apical membranes. B-C’ In the FoxL1 deficiency lines 
that remove FoxL1 and other genes, the apical membranes are rough and irregular. D-D’ 
The deficiencies in trans to one another also result in apical membrane irregularities. E-
E’ FoxL1KO lines have relatively normal apical membranes. F. Quantification of apical 
membrane irregularities in FoxL1 mutant alleles. G. Genes removed in the 
Df(3L)BSC368/Df(3L)BSC369 embryos.  H. Scheme of FoxL1 knockout to replace the 
FoxL1 ORF with white+ via homologous recombination. Homology arms are 
approximately four kilobases each. I. Agarose gel confirming presence of white+ inserted 
in the FoxL1 genomic region. Primers are indicated by the colored half arrows in I. J-K’’ 
FoxL1KO lacks FoxL1 transcript and protein. J-K’ FoxL1KO heterozygotes (as indicated by 
the balancer chromosome) retain FoxL1 staining, which is lost in homozygous 
knockouts. L-M Measurements of the distance from the body wall to the salivary gland 
tip, normalized to embryo width. Measurements were taken for both glands. M. 








Using a single selected null allele, the effects of FoxL1 loss on salivary gland migration were 
investigated. The defects seen in FoxL1KO were neither as severe nor as penetrant as observed 
with the deficiency lines (Fig 2E-E’,F). Although the apical membrane staining is a sensitive read-
out for overall salivary gland morphology, placement and migration, we hypothesized that FoxL1 
could affect gland placement in a different way. Because late embryonic FoxL1 expression is 
observed in thoracic body wall segments (Figure 1H), glands were examined from a ventral view 
and assayed for their position relative to the embryonic body wall (Figure 2L-L’). The distance 
from the body wall to the salivary gland tip was measured for both glands and divided by the 
width of the embryo to generate a normalized ratio of the distance from gland tip to body wall. 
No significant difference was observed between wild-type embryos and FoxL1KO embryos 
(Figure 2M).  Therefore, by the assays used, loss of FoxL1KO had only very minor effects on 
salivary gland placement. 
 
Hindgut morphology is normal in FoxL1 mutants 
FoxL1 is also expressed at or near the hindgut (Figure 3A, A’). Co-staining with FoxL1, Crb (a 
marker for the apical surface of epithelial cells), and Fkh (a transcription factor expressed in the 
hindgut endoderm; Figure 3B) reveals that FoxL1 is not expressed in the hindgut endoderm, but 
is instead expressed in cells that cover the endoderm. These cells are most likely the hindgut 
visceral mesoderm, although staining in a heartless or wingless mutant background (which lack 
the HVM) would be necessary to confirm this localization (San Martin and Bate, 2001). To ask if 
FoxL1 is required for hindgut morphology, wild-type and FoxL1KO homozygous embryos were 
stained with Crb and the cross-sectional area of the small intestine, the portion of the hindgut 
outlined in Figure 3C, was measured. No significant difference in the small intestine area was  
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Figure 3: Loss and overexpression of FoxL1 does not affect hindgut morphology. A-A’  
Lateral (A) and ventral (A’) views showing FoxL1 transcript around the hindgut at Stage 
17.  B-B’ FoxL1 staining surrounds the hingut ectoderm (Fkh) and the hindgut tube (Crb). 
C-C’’ Small intestine of the hindgut in FoxL1 alleles. C. Wild type embryos. Small 
intestine is outlined. C’ FoxL1KO. C’’ Twi>FoxL1 mis-expression. D. Quantification of the 







observed in the FoxL1 loss-of-function background, suggesting that FoxL1 does not overtly affect 
the development or morphology of this portion of hindgut. 
The effect of FoxL1 over-expression was also examined. Since a full-length cDNA of FoxL1 
was not available, one was generated using genomic DNA as a template. First, the genomic 
region of the FoxL1 ORF was subcloned into a TOPO vector.  Two consecutive rounds of deletion 
PCR were then used to remove each intron (Figure 6A). Deletion of the introns was confirmed 
using diagnostic digests, which revealed a size shift and the loss of a restriction site (Figure 6B). 
The FoxL1 cDNA was further confirmed by sequencing the entire ORF. This clone was 
subsequently used to create the UAS-FoxL1 line. Overexpression of FoxL1 in the mesoderm 
using twist-Gal4 also did not affect hindgut morphology (Figure 3C). 
 
FoxL1 is expressed in muscle VIS5/muscle 33 
FoxL1 is expressed in a subset of ventrally-positioned somatic muscles in both the thoracic 
and abdominal segments of the embryo. The musculature of the Drosophila embryo is organized 
into approximately thirty muscle fibers in each segment (Figure 4A). Slight differences exist 
between the abdominal and thoracic segments, most notably near the mouthparts and anus. In 
the first through third thoracic segments (T1-T3), an extra muscle is found that is proposed to 
span all three segments and attach to the mouthparts (Figure 4A, pink trapezoid). This muscle is 
known as muscle 33 or Ventral Intersegmental 5 (VIS5), and it is the most internally localized 
muscle. The other muscles, which are found in both the thoracic and abdominal segments, are 
external and adjacent to VIS5 (yellow layer) or external and in direct contact with the body wall 
(green layer).  
To verify that FoxL1 is expressed in muscles, embryos were costained with FoxL1, MHC (a 
muscle marker), and Dm0 (a nuclear lamina marker; Figure 4B-C’’’). FoxL1 expression aligns with  
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Figure 4: Identification of VIS5 as the thoracic muscle expressing FoxL1. A. Schematic 
of thoracic segment two and three muscles. Top: Lateral view of muscle organization. 
Green muscles are the most external, followed by blue, yellow, and pink. Bottom: 
ventral view of muscle organization. Lateral transverse (LT) muscles are outlined. B-C’’’ 
FoxL1 is expressed in the ventral muscles. B-B’’’ Lateral view of musculature and FoxL1 
staining. Arrowheads indicate the LT muscles. C-C’’’ Ventral views of Fd4a and 
musculature. FoxL1 is expressed in the most internal muscles, which are directly next to 
the outlined salivary gland. D-D’’ FoxL1 is not expressed in VLM1. D. 5053-Gal4 drives 
nuclear LacZ in VLM1 (red). D’-D’’ Costaining of LacZ and FoxL1 in the thoracic and 
abdominal muscles. E-E’’ FoxL1 is not expressed in VLM1 or the ventral oblique muscles, 
marked by a Caps-LacZ reporter. E-E’’ Costaining of LacZ and FoxL1 in the thoracic and 
abdominal muscles.  F-F’ FoxL1 is not expressed in VLM1-4, marked with Vg (red). G-G’’ 
FoxL1 is expressed in VIS5. CrebA (Salivary gland nuclei), FoxL1, and MHC (muscle) 
staining shows that FoxL1 is expressed in muscles directly next to the migrating salivary 
gland (G’’), the most internal muscles (G’).  H-H’’ VIS5 has muscle attachments sites 
offset from VLM attachment sites. H’ FoxL1 staining. H’ βPS staining showing muscle 
attachment sites. VLM attachments are marked with open arrowheads. Additional 
attachments sites are marked with white arrowheads. H’’ Merge, showing the muscle 
attachment sites that are offset from the VLM attachment sites correspond to FoxL1 
staining. Musculature is shown with MHC staining in gray.   I. VIS5 (pink) is an individual 







the negative space in MHC staining (Fig 4B) and corresponds to predicted nuclear staining 
(Figure 4B’). FoxL1 appears to be expressed in or near the ventral longitudinal muscles (VLM), 
which are ventral to the vertically aligned lateral transverse muscles (Figure 4A). This 
assignment is further supported by examination of ventral views of the muscles, which border 
the salivary gland, a ventrally-positioned structure (Figure 4C-C’’’).  
In the thoracic segments, there are three individual VLMs, whereas in the abdominal 
segments there are four. To determine if FoxL1 is indeed expressed in these muscles, costaining 
with a variety of specific VLM markers was performed. 5053-Gal4 drives nuclear lacZ staining in 
only VLM1 (Figure 4D). No overlap between FoxL1 and LacZ was observed in either the thoracic 
or abdominal segments (Figure 4D’-D’’). A Capricious (Caps) reporter was used to mark VLM1 
along with a subset of the ventral oblique muscles (VO) and the dorsal oblique and anterior (DO 
and DA) muscles. Again, no overlap was observed in T2/T3 or with the abdominal muscles 
expressing FoxL1. Finally, Vestigial was used to mark all of the VLM muscles (Figure 4F). Due to 
technical constraints, staining of Vg in the abdominal segments with FoxL1 staining was not 
obtained. In T2/T3, however, both antibodies worked, and no overlap between the markers was 
observed (Figure 4F’). We conclude that FoxL1 is not expressed in the VLM muscles. 
Based on staining with the available muscle markers described above, it appears that FoxL1 
is expressed in VIS5. As noted before, FoxL1 is expressed in the musculature near the salivary 
gland (Figure 4G). Analysis in the Z-axis reveals that FoxL1 is in muscle cells directly contacting 
the salivary gland (Figure 4G’), the most internal muscle group (Figure 4G’’). In T2/T3, this 
corresponds to VIS5. However, VIS5 was previously described as one large muscle spanning all 
three thoracic segments. Nuclei in Drosophila muscles move to the edges of the muscles (Folker 
et al 2012). Given the placement of FoxL1-expressing nuclei, two possibilities arose: (1) FoxL1 is 
not expressed in the VLMs or VIS5, or (2) VIS5 is not one large muscle. To test the second 
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hypothesis, embryos were stained with FoxL1, MHC, and βPS, which marks muscle attachment 
sites (Figure 4H-H’’). Muscle attachment sites in the VLM region correspond to the abdominal 
segment boundaries. Indeed, muscle attachment sites are present at the segment boundaries in 
the thorax and are found slightly offset from the boundaries of other thoracic muscles (Figure 
4H’, arrowheads), indicating separate attachment sites for the most internal muscles (XZ view). 
Therefore, we conclude that that an individual VIS5 muscle is present in each of the three 
thoracic segments, and that FoxL1 is expressed in VIS5 of the second and third thoracic 
segments (Figure 4I). 
 
Creating a new, tagged, allele of FoxL1 to assay for muscle phenotypes 
Since we had no good markers to evaluate FoxL1 function in the muscles that normally 
express FoxL1, we decided to replace the coding region of FoxL1 with a fluorescent tag using the 
CRISPR/Cas9 system (Figure 5A, D). We first used the system to generate small nucleotide 
deletions in the FoxL1 gene.  A PAM site was selected that targeted the second exon of FoxL1, 
which corresponds to a region approximately 150 nucleotides downstream from the start codon 
(Figure 5A).  Several new FoxL1 alleles were generated (Figure 5A’), with a variety of small 
deletions near the PAM site. The line with the cleanest disruption of FoxL1, FoxL110.5 deleted two 
base pairs (Figure 5A’), resulting in a truncation of FoxL1 (Figure 5A’’). The first 54 amino acids 
of FoxL1 are in frame, followed by an out-of-frame region of 11 residues, followed by a 
nonsense mutation. The resulting protein is predicted to be 65 residues and ends before the 
Forkhead box DNA binding domain.  
The FoxL110.5 allele was tested for transcript and protein expression. Compared to 
heterozygous siblings, FoxL110.5 had similar levels of FoxL1 transcript (Figure 5B-C’’). Importantly,  
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Figure 5: Creation of FoxL1 alleles using CRISPR/Cas9. A-A’’ Creation of null alleles 
using CRISPR. A. FoxL1 genomic region. The PAM site and the sequence of the CRISPR 
region are shown in yellow and gray, respectively. The PAM site is located in the first 
coding exon. A’ Three alleles created by the CRISPR site result in small deletions near 
the PAM site. A’’ FoxL110.5 results in a protein truncation before the Fkh DNA binding 
domain. B-C’’’ FoxL110.5 is protein null. B-C’’ Stage 14 embryos; B-C FoxL110.5 
heterozygotes (B) and homozygotes (C) have FoxL1 transcript. Only the hetrozygotes 
(B’) have protein. Stage 16 embryos are shown in B’’-C’’’. D. FoxL1 CRISPR creating a 
knock-in of mCherry.  CRISPR region is shown in gray; PAM in yellow. In the homologous 
recombination construct, two kb of FoxL1 directly flanking the PAM site were cloned 
into p-mCH-C1 flanking the mCherry ORF. The PAM site was mutated to prevent 
(re)targeting (*), residues were added to keep mCherry in frame, and a stop codon was 
added at the end of mCherry (red). D’ FoxL1Mch creates a fusion protein. D’’ PCR with 
primers indicated in D (half arrow) confirming insertion of mCherry. E-F’’’ The FoxL1Mch 
expression pattern reflects the spatiotemporal profile of the endogenous FoxL1 
transcript. G-H’ FoxL1Mch has FoxL1 transcript but not protein expression. I-J’ FISH of 
FoxL1Mch shows mCherry expression in the abdominal segments muscles and VIS5. 







protein expression was completely absent in FoxL110.5 in both the abdominal and thoracic 
segments (Figure 5B’-C’’), indicating that FoxL110.5 is protein null.  
The same PAM site was used for homologous recombination. The template for homologous 
recombination was the p-mCh-C1 vector, which had two two kb homology arms of the FoxL1 
genomic region flanking the coding region for the mCherry fluorescent protein. The region of 
homology began directly on either side of the PAM site. Additionally, the PAM site in the vector 
was altered so that (1) it would no longer be a target for the CRISPR construct, and (2) would 
keep the mCherry gene in frame with the start of FoxL1. A stop codon was also inserted at the 
end of the mCherry ORF. Our goal was for the recombined region to both report on FoxL1 
expression and create a null allele. Individual lines were isolated that all had mCherry inserted in 
frame with FoxL1, resulting in a fusion protein that included the 80 N-terminal residues of FoxL1, 
a short linker region, and full length mCherry (Figure 5D’). PCR with primers within mCherry and 
in the homology arms was used to confirm the insertion of mCherry (Figure 5D, arrows; Figure 
5D’’).  An in situ probe to mCherry was also tested on these lines, and it accurately reports on 
the FoxL1 expression pattern at each developmental stage (Figure5E-F’’’). Like FoxL110.5, 
FoxL1Mch contains low levels of FoxL1 transcript, but is protein null (Figure 5G-H’). 
Salivary gland migration was examined in both FoxL110.5 and FoxL1Mch (Figure 5K). The same 
types of minor apical membrane irregularities were seen with the new alleles as were seen with 
the FoxL1KOallele, but at a slightly higher penetrance. Because of the differences in penetrance, 
future analysis will be conducted with transheterozygotes of FoxL110.5 and FoxL1KO.  FoxL1Mch 
was used to examine muscle morphology. Two separate mCherry antibodies were tested on this 
line, and neither generated a positive signal, and no mCherry signal was observed in live 
embryos (data not shown). This suggests either that the antibodies are not compatible with the 
fixative used, that the fusion protein is being degraded or that the small N-terminal region of 
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FoxL1 is somehow disrupting mCherry 3D structure. While this issue is being resolved, I 
performed FISH plus antibody staining (Figure 5I-J’). At stage 13, mCherry is observed in one 
muscle per segment in the abdominal segments (Figure 5I’’).  At this stage the muscles have not 
yet formed their final pattern. Shortly after stage 13, the staining of mCherry (or FoxL1) in these 
muscles disappears. Closer examination will be necessary to determine if this muscle dies or just 
loses FoxL1/mCherry expression. At later stages, mCherry is observed in VIS5 (Figure 5J-J’). 
Additional experiments must be completed to fully understand the shape and placement of VIS5 
in these embryos, but it must be noted that in FoxL1Mch, the expression of mCherry indicates 
that VIS5 is present in both T2 and T3. If there are defects in this muscle, they may be subtle and 
will require detailed examination. 
 
FoxL1 over-expression disrupts the morphology of multiple tissues 
The absence of any overt effects with loss of FoxL1 on salivary gland positioning despite the 
proximity of the muscle staining suggested that perhaps FoxL1 regulates expression of 
redundant signals used for salivary gland navigation.  To test this possibility, FoxL1 was 
expressed using a variety of Gal4 lines and salivary gland migration was examined. Mis-
expression of FoxL1 in muscle 12 (5053-Gal4; Figure 6E-E’) or in the visceral mesoderm (bap-
Gal4; Figure 6D-D’) had very little effect on salivary gland placement or apical morphology (Fig 
6I). On the other hand, mis-expression of FoxL1 in all fusion competent myoblasts (SNS-Gal4; 
Figure G-G’), in muscle founder cells (RP298-Gal4; Figure 6F-F’), or in all muscle types (Twi-Gal4; 
Figure 6H-H’) all caused significant irregularities in the salivary gland apical membrane, 
consistent with migration defects.  These drivers are expressed early and result in persistent 
FoxL1 expression (data not shown).  
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Figure 6: FoxL1 mis-expression results in salivary gland irregularities. A. Creation of 
FoxL1 cDNA through two rounds of deletion PCR. B. PCR confirming deletion of FoxL1 
introns. C-H’’ Apical membrane staining of wild-type (C - H), FoxL1 mis-expression (C’ -  
H’) or sema2aTM-GFP (C’’ -  H’’). Gal4 drivers are indicated at the left margin. I. 
Quantification of apical membrane irregularities. J-K’ Muscle staining of embryos mis-
expressing FoxL1.  J’. Mis-expression of FoxL1 in all muscle by Twi-Gal4 causes severe 
defects in muscle organization (white bracket) compared to wild-type embryos (black 
bracket; J). Mis-expression of sema2a-TM-GFP does not cause the same defects 
(bracket; J’’), nor does mis-expressing FoxL1 with other drivers (brackets; K-K’). L-L’’ Mis-







Mis-expression of FoxL1 in the fusion competent myoblasts, founder cells, or pan-
musculature could be driving the transcription of a signal that affects the salivary gland, or it 
could be driving the transcription of a signal that affects muscle formation itself.  To examine 
the musculature in these different overexpression situations, embryos were stained with an 
antibody to the Myosin Heavy Chain (MHC; Figure 6J-K’). By stage 16, the VLM muscles are 
organized into four parallel fibers that run along the anterior-posterior length of the embryo 
(bracket; Figure 6J). In Twi-Gal4>UAS-FoxL1 embryos, the entire musculature is severely 
disorganized (Figure 6J’). This could suggest that the salivary gland defects are due to the 
impairment of the scaffold provided by the musculature. Since, however, muscle architecture is 
not affected in RP298-Gal4>UAS-FoxL1 or SNS-Gal4>UAS-FoxL1 embryos (Figure 6K, K’), the 
salivary gland defects seen in these embryos may not due to alterations of the scaffolding alone, 
and,  instead, may be due to ectopic expression of a FoxL1-dependent signal(s) that is 
redirecting migration of the salivary gland . 
Notably, while scoring the Twi-Gal4>UAS-FoxL1 embryos, we observed that these embryos 
often had malformed guts with holes or lesions in the various compartments (Figure 6L-L’’). 
Wild-type and Twi-Gal4>UAS-FoxL1 embryos were stained with Labial, which marks the 
cuprophilic cells that populate the second gut compartment (Tremml and Bienz, 1992). At stage 
15, these cells are located near the second gut constriction (Figure 6L). Many Twi-Gal4>UAS-
FoxL1 embryos are Labial negative, indicating that the second gut compartment is not being 
correctly specified (Figure 6L’). Whether this phenotype is due to impaired muscle function or 
impaired signaling has yet to be determined.  
Mis-expression of FoxL1 in the salivary gland caused major gland defects, most notably an 
inflated apical lumen (Figure 6C’). This phenotype warranted a closer examination. Whereas 
nuclear positioning and apical/lateral polarity (Figure 7A-B’’’) were not affected with FoxL1  
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Figure 7: Mis-expression of FoxL1 in the salivary gland and in all muscles cause 
changes in salivary gland organization.  A-B’’’ Confocal imaging of wild-type (A-A’’’) and 
FoxL1 mis-expression (B-B’’’) in the salivary gland. The shape of the apical membrane 
and lumen is deformed in fkh>FoxL1, as revealed by the YZ sections (A’, A’’’; B’, B’’’).  C-
D’’ ECadherin staining of WT (C-C’) and Fkh>FoxL1 salivary glands. E-F’’ Apical 
membrane length in wild-type, twi-Gal4>UAS-FoxL1, and twi-Gal4>UAS-sema2aTM-GFP 
embryos. The ends of the glands are marked with arrowheads. Mis-expression of FoxL1 
by Twi-Gal4 causes abnormally long apical membranes (E’’, F’’), a phenotype not 
observed with sema2a-TM-GFP mis-expression (C’, D’). G-H Quantification of cell 







misexpression, the YZ plane reveals that the lumen of the gland is very narrow at stage 14 
(Figure 7B’), but then inflates to an overly large size by stage 16 (Figure 7B’’’). This is in contrast 
to control salivary gland lumens, which maintain an even size from stage 14 to stage 16 (Figure 
7A’, A’’’).  The cells in fkh-Gal4>UAS-FoxL1 also appear more cuboidal than the wild-type 
columnar gland cells (Figure 7A’’, B’’) and more cells surround the lumen (Figure 7A’’’, B’’’) 
Interestingly, E-Cadherin levels appear to be upregulated in FoxL1 expressing salivary glands 
(Figure 7C-D’).   
The gland defects when FoxL1 was mis-expressed in all muscles were examined more 
closely. The glands become over-elongated and often extend into the region of the gut 
compartments in Twi-Gal4>UAS-FoxL1 embryos (Figure 7C, C’’). Both the number of nuclei 
around these abnormally long glands and the width of the cells of the gland were quantified 
(Figure 7D-D’’). Whereas neither data set is significantly different by standard deviation 
measures, two trends were observed. One, the number of nuclei around the tube in Twi-
Gal4>UAS-FoxL1 glands was constant from the proximal to the distal end of the tube (Figure 7E). 
Two, the cells in Twi-Gal4>UAS-FoxL1 glands are slightly elongated (along the long axis of the 
tube) compared to control glands (Figure 7F).   These phenotypes suggest that modulation of 
FoxL1 levels in muscles affects cell re-arrangement and cell morphology within the salivary 
gland, perhaps by providing an attractive signal towards which the gland extends. 
 
Sema2a functions downstream of FoxL1 
The non-autonomous effect of FoxL1 overexpression on salivary gland morphology suggests 
that it controls expression of genes that encode secreted signals. One excellent candidate target 
of FoxL1 is sema2a, which encodes a member of the Semaphorin family of signaling molecules. 
Sema2a is known to function as a repellent for axon guidance (Ayoob et al 2006). sema2a is 
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expressed in T3 (Figure 8A-A’’), in a region that overlaps  FoxL1 expression. Sema2a protein is 
observed in the same area (Figure 8B-B’’); and co-staining with FoxL1 and Sema2a revealed that 
secreted Sema2a is expressed in VIS5 of T3, where FoxL1 is also expressed (Figure 8D-D’’).  To 
ask if sema2a is a target of FoxL1, both sema2a RNA and Sema2a protein were examined in the 
FoxL1KO line.  Indeed, transcript and protein were missing in the VIS5 muscle of T3 in the FoxL1 
null embryos, indicating that sema2a is indeed a target of FoxL1 (Figure 8E-F’’).  
As with FoxL1, both loss-of-function and misexpression of sema2a were tested for salivary 
gland defects. The sema2aB65 mutants showed no overt defects in the salivary gland (Figure 8G-
G’). However, as with FoxL1, over-expression of sema2a caused significant salivary gland defects 
(Figure 6C’’-H’’).  Mis-expression using RP298 (Figure 6F’’), SNS (Figure 6G’’), or Twi (Figure 
6H’’)-Gal4 caused significant irregularities in the apical membrane of the salivary gland (Figure 
6I). Defects were also observed by over-expressing sema2a in the salivary gland. However, mis-
expression of sema2a in all muscles did not cause the same defects as mis-expression of FoxL1 
(Figure 6K’’; Fig 7C’, 7D’). One reason for the discrepancy in the phenotypes may be that FoxL1 
regulates other signals in addition to Sema2a (Figure 8I).  
Interestingly, both Sema2a and the receptor for Sema2a, PlexB, are expressed in the salivary 
gland (Melissa Vining, unpublished); Sema2a is expressed in the distal half of the salivary gland 
and PlexB is expressed in all salivary gland cells. Perhaps the salivary gland expression of Sema2a 
and/or the Sema2a receptor somehow account for the normal salivary gland appearance in 
sema2a and FoxL1 null alleles.  To explore this possibility, we examined the salivary gland apical 
membrane in plexB knockdown embryos and in embryos lacking both sema2a and FoxL1. 
Indeed, these embryos showed an increase in salivary gland apical membrane irregularities 
(Figure 8G’’-H). These defects suggest that FoxL1, Sema2a and otherdownstream signals play a 
role in guiding salivary gland migration. 
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Figure 8: sema2a is a target of FoxL1.  A-B’’ Sema2a is expressed in T3. A-A’’ sema2a 
transcript is seen in the third thoracic segment. A,B lateral; A’, B’ ventral, A’’, B’’ higher 
magnification showing the sema2a expression is directly next to the salivary gland. B-B’’ 
Sema2a antibody staining reflects the transcript expression. C-C’’ FoxL1 staining 
showing expression in VIS5 of T2 and T3. D-D’’ Sema2a is expressed in VIS5 of T3. E-F’’ 
Sema2a staining is lost in FoxL1KO. E-E’’ sema2a transcript is shown; F-F’’ Sema2a 
antibody staining is shown. G-G’’’ Salivary gland staining of WT (G), sema2a null allele 
(G’), RNAi knockdown of plexB (G’’), and sema2a, FoxL1 double null allele (G’’’). H. 
Quantification of apical membrane irregularities. I. Sema2a is also expressed in the 
salivary gland based on in situ expression in earlier embryos (not shown) and on nuclear 









FoxL1 is one of the 19 members of the Fox family of transcription factors encoded in 
Drosophila. FoxL1 is dynamically expressed in different subsets of somatic mesodermal cells 
throughout embryogenesis. At early stages, FoxL1 is expressed in mesodermal precursors that 
migrate anteriorly during germ-band extension. FoxL1 is expressed in ten bilateral clusters of 
cells In the abdominal segments during embryonic stage 13. The abdominal clusters of FoxL1-
expressing cells remain unidentified, since staining did not colocalize with any of the existing 
somatic muscle markers available. This cluster of cells could be precursors to a muscle 
homologous to VIS5 in the abdominal segments. A muscle analogous to VIS5 is made in the first 
abdominal segment, but it is absent in the other segments. One hypothesis is that the precursor 
is formed in the other abdominal segments, but later dies, potentially due to lack of a cofactor 
that is present in the thoracic and first abdominal segment. Our attempts to co-stain these 
clusters with antibodies that label dying cells were unsuccessful due to the different fixation 
protocols required for each antibody. Cell death is not known to occur in muscles during normal 
embryogenesis (Bate 1990), so another possibility is that these clusters of cells are fusion 
competent muscle cells and fuse into a different muscle fiber.  
Drosophila muscles form by fusion of founder cells (FCs), which specify individual muscles, 
and fusion competent myoblasts (FCMs), which are a more naïve cell type that then adopts the 
identity of the FC they fuse with (Baylies et al 1998). Fusion occurs in two rounds during 
development. The first round of fusion happens around stage 12-13, while the second round, 
which contains the majority of fusion events, occurs during stages 14-15 (Beckett et al 2007). 
FoxL1 may mark FCMs in the abdominal segment that fuse during the first round of fusion. Co-
staining of FoxL1 with an FCM marker such as Lameduck would address this hypothesis.  
mCherry expression in FoxL1mCh reveals that the FoxL1-positive muscles appear to form a fiber 
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(Figure 6I’’’), which would argue against FoxL1 being expressed in a naïve cluster of FCM cells. 
FCs are specified through the combined interaction of transcription factors (Baylies et al 1998).  
Different combinations of transcription factors specify different FCs, while loss of one type of 
transcription factor can cause an FC to form a different type of muscle (Frasch 1999). FoxL1 
expression may aid in specification of a specific type of muscle in the abdominal segments, 
whereas loss of FoxL1 may cause this muscle to be specified differently. More careful analysis of 
the abdominal muscles and the counting of nuclei may be necessary to determine the role of 
FoxL1 in these muscle cells.  Meanwhile, the identify and fate of the ten bilateral clusters of 
FoxL1 positive abdominal muscle cells remains elusive. 
 FoxL1 is also expressed in VIS5 muscle in the somatic muscles of the thoracic segments. 
Because it is not expressed until later in development in VIS5, FoxL1 is unlikely to be acting as a 
FC marker for this muscle. However, because the internal muscles are the last to fuse with FCMs 
(Richardson et al 2008), we cannot rule out this possibility. Our analysis has shown that VIS5 is 
an individual muscle in the three thoracic segments, not one large muscle spanning three 
segments as previously suggested (Bate, 1990).  This finding was revealed by two observations. 
One, FoxL1 RNA does not extend into the first thoracic segment, suggesting a barrier between 
T1 and T2, and two, the presence of muscle attachment sites for the most internal muscles in T2 
and T3. Staining with FoxL1 showed that it is expressed in the most internal ventral muscles of 
the thoracic segments, which correspond to VIS5.  The only known role of VIS5 is that it 
expresses Sema2a, which affects muscle innervations, but only when misexpressed (discussed 
more below; Kolodkin et al 1993). Very few reagents exist to study the VIS5. Starvin (Stv) was 
reported to be expressed in VIS5 (Coulson et al 2005), as well as the tendon cells and the 
esophagus. Loss of stv causes retraction or bunching of the muscles in the thoracic segments, 
and delayed growth, likely due to feeding difficulties. The authors do not show co-staining of Stv 
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with any other VIS5 markers, and I was unable to replicate the staining seen with the Stv 
antibody with a stv in situ probe (data not shown). No other VIS5 specific markers exist. To have 
VIS5 specific marker, we used CRISPR/Cas9 to knock mCherry in the FoxL1 ORF. This line 
accurately mimics FoxL1 expression with mCherry, and provides a way to further investigate 
VIS5 and the other tissues that express FoxL1. Unfortunately, mCherry protein could not be 
detected with the two antibodies we tested. 
The expression of FoxL1 in the thoracic segments is interesting because the salivary gland 
migrates directly between cells that express FoxL1. The salivary gland contacts VIS5 on its 
ventrolateral surface beginning in stage 14. The migrating salivary gland also contacts a FoxL1 
positive cluster of muscles in the head during stage 13. Due to this expression pattern, we 
hypothesized that FoxL1 influenced gland positioning during migration by providing an attractive 
signal. Staining of the salivary gland showed no major defects in gland morphology or placement 
with either FoxL1 null allele. However, mis-expression of FoxL1 in the salivary gland caused an 
increase in E-cad levels and an inflation of the gland lumen. This increase of E-cad may enhance 
cell-cell adhesion in the salivary gland, thus preventing the cell rearrangements that normally 
contribute to the correct lumen size. Interestingly, pan-mesodermal expression of FoxL1 causes 
the musculature to clump. One hypothesis is that over-expression of FoxL1 is causing increased 
E-Cad levels in the muscles, causing them to adhere to one another instead of spreading into 
fibers. Alternatively, cells expressing FoxL1 may simply be highly attracted to one another and 
this increase in cell attraction may result in the increased levels of E-Cad. 
Myotubes in Drosophila get to their correct location using guidance cues such as Robo-Slit 
and Wnt-Frizzled (Kramer et al 2001; Ghazi et al 2003).  These same signaling pathways are used 
by the salivary gland to direct its final positioning (Kolesnikov and Beckendorf, 2005). Mis-
expression of FoxL1 in all muscle activate a variety of signaling pathways in the salivary gland to 
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contribute to its mis-migration. During Stage 17, the glands become quite long and extend 
almost to the middle of the embryo. This phenotype is reminiscent of loss-of-function biniou 
mutants (Vining et al 2005). Biniou, another Fox family member, specifies the longitudinal 
visceral mesoderm, which migrates anteriorly to separate the salivary glands from the circular 
visceral mesoderm. bin mutants have long salivary glands because the gland maintains contact 
with the cVM and becomes elongated as the gut retracts. Mis-expression FoxL1 may phenocopy 
bin mutants by disrupting the differentiation of the gut, thus driving gland elongation. In support 
of this, the guts of Twi>FoxL1 embryos contain lesions and do not express markers for the 
second gut constriction. Markers for gut differentiation, such as Teashirt, should be tested in 
Twi>FoxL1 embryos to test this hypothesis. 
One target of FoxL1 that we identified is sema2a. sema2a is expressed in VIS5 of T3 
(Kolodkin et al 1993). The Semaphorin family is a class of cysteine-rich signaling molecules that 
act as repellents for axons (Cohen et al 2005).  Five semaphorins are encoded in Drosophila, and 
Sema2a is one of two secreted members of the family. Over-expression of sema2a repels 
neurons, and this phenotype is mediated through its receptor PlexinB (Ayoob et al 2006). 
Interestingly, loss-of-function of sema2a does not significantly impact neuron guidance, but loss 
of plexB does.  The salivary gland expresses both plexB and sema2a, which was revealed through 
the sema2aP0321 lacZ reporter.  Similarly to the neurons, loss of sema2a does not significantly 
affect salivary gland migration, but knock-down of plexB does. This finding suggests that PlexB 
has ligands in addition to Sema2a, ligands whose expression is independent of FoxL1.  We plan 
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This chapter is modified from: Fox, R.M., Hanlon, C.D., and Andrew, D.J. (2010). The 
CrebA/Creb3-like transcription factors are major and direct regulators of secretory capacity. 





Secretion occurs in all cells, with relatively low levels in most cells and extremely high levels in 
specialized secretory cells, such as those of the pancreas, salivary and mammary glands. How 
secretory capacity is selectively upregulated in specialized secretory cells is unknown. Here, we 
report that the CrebA/Creb3-like family of bZip transcription factors functions to upregulate 
expression of both the general protein machinery required in all cells for secretion and of cell-
type specific secreted proteins. Drosophila CrebA directly binds the enhancers of secretory 
pathway genes and is both necessary and sufficient to activate expression of every secretory 
pathway component gene examined thus far. Microarray profiling reveals that CrebA also 
upregulates expression of genes encoding cell type-specific secreted components. Finally, we 
find that the human CrebA orthologues, Creb3L1 and Creb3L2, have the ability to upregulate the 




The human pancreas secretes liters of enzymes daily to aid in food digestion, whereas the 
bovine mammary glands produce eight liters of milk each day, largely for human consumption. 
To do this, secretory organs must adapt to the increased need for protein secretion that occurs 
during development, differentiation, or changing physiological conditions. An important 
question is how changes in secretory capacity are coordinated to allow for efficient targeting, 
folding, modification and delivery of secreted products. A few transcription factors have been 
discovered to upregulate genes in the secretory pathway including Xbp1, which is expressed and 
required in B cells as they differentiate into antibody secreting plasma cells (Shaffer et al., 2002) 
and which also regulates secretory function in a subset of specialized secretory organs (Lee et 
al., 2005; Shaffer et al., 2004). The bZip transcription factor ATF6 activates expression of 
chaperone proteins required for efficient protein folding (Adachi et al., 2008) as well as many of 
the lipid components of secretory organelles (Bommiasamy et al., 2009). Two other bZip 
transcription factors, Creb3L1/OASIS and Creb3L2/BBF2H7 (herein referred to as Creb3L1 and 
Creb3L2), are required for efficient bone deposition and cartilage matrix secretion, respectively 
(Murakami et al., 2009; Saito et al., 2009). A major question is whether these transcription 
factors function more broadly to upregulate the entire secretory pathway in multiple specialized 
cell types or if their function is restricted to the upregulation of only a subset of secretory genes 
in a few specialized cells.  
The Drosophila salivary gland (SG) provides an excellent model for identifying and studying 
the factors required for secretory function. The SG is the largest secretory organ in Drosophila 
and the processes of morphogenesis and differentiation have been well characterized (Kerman 
et al., 2006). The SG comprises two large secretory tubes, each containing ~100 polarized 
epithelial cells that are specialized for the production and delivery of secreted proteins. 
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Consistent with the high level secretory activity of the SG, at least 34 secretory pathway 
component genes (SPCGs) are highly expressed in the secretory cells (Abrams and Andrew, 
2005), and this expression requires at least two transcription factor genes, fork head (fkh) and 
CrebA (Andrew et al., 1997; Myat et al., 2000).  
Salivary gland expression of fkh and CrebA is activated in the most posterior head segment, 
(parasegment two), by the homeotic gene Sex combs reduced (Scr) and two more generally 
expressed homeotic cofactor genes extradenticle (exd) and homothorax (hth) (Henderson and 
Andrew, 2000).  Dpp signaling in dorsal cells blocks expression of fkh and CrebA, limiting their 
activation to only the ventral cells of parasegment two (Henderson et al., 1999).  Shortly after 
activation of fkh and CrebA, expression of Scr, exd and hth disappears in the salivary gland 
(Henderson and Andrew, 2000); continued expression of both fkh and CrebA is maintained by 
Fkh (Abrams and Andrew, 2005). Thus, we propose that Fkh plays a primarily indirect role in 
SPCG expression through its role in maintaining expression of CrebA (Abrams and Andrew, 
2005). Consistent with this idea, the loss of fkh affects only late SPCG expression, whereas loss 
of CrebA affects both early and late SPCG expression. It is unknown, however, if CrebA directly 
regulates SPCG expression or if additional downstream factors are also involved.  
Here, we show that CrebA is both necessary and sufficient for high level SPCG expression in 
the secretory tissues of the Drosophila embryo. We show that direct binding of CrebA to a 
consensus motif identified upstream of the 34 originally characterized SPCGs is required for 
elevated SPCG expression in the secretory tissues. Through microarray analysis, we find that 
over half of the 383 genes that require CrebA encode identifiable secretory pathway 
components. Surprisingly, CrebA targets include not only components of the general secretory 
machinery that function in all cells but also cell-type specific secreted cargo. Moreover, 
phenotypes associated with loss of CrebA are consistent with the role of this gene in secretion. 
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Finally, we confirm Creb3L1 and Creb3L2 as the closest mammalian orthologues to Drosophila 





MATERIALS AND METHODS 
Fly Strains 
The CrebAwR23 protein null allele was used for all loss-of-function analysis (Andrew et al., 
1997). UAS-CrebB and CrebBS162 were obtained from the Bloomington Stock Center: HS-FLP and 
P{ovoD} FRT2A (79D)/TM3 were obtained from Elizabeth Chen. Recessive lethal lines were 
balanced over lacZ or GFP balancers, to allow identification of homozygous mutants. UAS-
Creb3L1-FL/T and UAS-Creb3L2-FL/T were generated by Gateway (Invitrogen, Carlsbad, CA) 
mediated cloning and recombination into the pTW untagged UAS vector (Drosophila Gateway 
Collection, Carnegie Institute, Baltimore, MD). engrailed (en)-Gal4, and breathless (btl)-Gal4 
were used to express UAS-CrebA (Rose et al., 1997), UAS-Creb3L1 FL, UAS-Creb3L1 T, UAS-
Creb3L2 FL or UAS-Creb3L2 T constructs in epidermal stripes (en-Gal4) (Weiss et al., 2001) or the 
trachea, salivary duct and midline (btl-Gal4) (Shiga, 1996). 
 
Electrophoretic mobility shift assays 
Plus and minus strand oligonucleotides of ~30 bases were designed and synthesized (IDT 
DNA; Coralville, IA) for each binding site and included the nine nucleotide consensus motif 
flanked by ~10 nucleotides of genomic sequence at both the 5’ and 3’ ends.  The plus strand of 
32P using the manufacturer’s protocol (Invitrogen, Carlsbad, CA) 
and was annealed to the minus strand by heating the DNA to 95C for 5 min. and then cooling to 
room temperature (RT). Unlabeled double stranded oligos were prepared similarly for 
competition experiments.  DNA binding reactions were performed as described (Smolik et al., 
1992) with the exception that all competitor oligonucleotides were added at concentrations of 
20, 60 and 100X. Binding reactions were run on a 4% polyacrylamide gel at 30 mAmps for ~2 
hours and prepared for autoradiography using standard methods.   
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Site-directed mutagenesis of SPCG enhancer-lacZ reporters 
Primers for putative CrebA binding sites (Abrams and Andrew, 2005) were designed to 
mutate the five core nucleotides of the CrebA binding motif G/TACGT to ACAAC using the 
Stratagene Primer Design program. Sites were subsequently mutated using the QuikChange 
Multi Site-Directed Mutagenesis kit (Stratagene, Cedar Creek, TX) and the mutated constructs 
were injected into w1118 flies (Rainbow Transgenics, Newbury Park, CA).  
 
Chromatin-Immunoprecipitation and quantitative PCR 
The Chromatin IP followed the protocol of Birch-Machin et al. ((Birch-Machin et al., 2005). 
reverse primers, and iQ SYBR Green Supermix (BioRad). Experiments were performed in 
triplicate, including those from an input control. Samples were normalized to actin5c and fold 
change over the no-primary antibody control was calculated using the ddCt method (Livak and 
Schmittgen, 2001). Error bars represent the standard deviation of ddCt.  
 
Transmission electron microscopy 
CrebA mutant embryos were identified by the absence of GFP staining from the TM3 
balancer chromosomes. Stage 16 wild-type and CrebA mutant embryos were processed for TEM 
using standard protocols and examined on a Philips EM120 microscope. To determine secretory 
vesicle size, area measurements were collected using ImageJ software (NIH), and statistical 






Immunohistochemistry and in situ hybridizations 
In situ hybridization and immunohistochemistry were performed as previously described 
(Lehmann and Tautz, 1994; Reuter et al., 1990). Antibody concentrations used in this study are 
as follows: α-CrebA (1:1,000) (Andrew et al., 1997), α-Crumbs (1:100) (Developmental Studies 
Hybridoma Bank, Iowa City, IA) and αβgalactosidase (Promega, 1:10,000). All secondary 
antibodies (Vector Labs and Molecular Probes) were used at a 1:500 dilution. The fluorochrome 
Alexa 568 was used for HeLa cell experiments, and nuclei were labeled with DAPI. Confocal 
images were obtained using a Zeiss LSM 510 Meta confocal microscope, using a Plan-Neofluor 
40x, 1.3 oil objective and the Zeiss LSM software. All other images were obtained using a Zeiss 
Axiophot microscope configured with a Nikon Coolpix 4500 digital camera.  Images were taken 
using a Plan-Neofluor 20x, 0.50 objective.  Images were rotated and cropped using Adobe 
photoshop. All images were obtained at room temperature. 
 
Generation of CrebA maternal-zygotic mutants 
CrebA23w- was recombined onto a third chromosome containing FRT2A (79D) and then 
crossed to flies carrying hsFLP; P{ovoD} FRT2A (79D).  After 72 hours, larvae were heat-shocked 
for one hour at 37°C on consecutive days until pupae formation.  Female flies carrying both 
CrebA23w- FRT2A(79D) and P{ovoD} FRT2A (79D) were crossed to CrebA23w-/TM6B, Ubx-lacZ 








Microarray experiments to identify CrebA target genes in Drosophila 
Three samples of sorted stage 11-16 CrebA homozygous (GFP balancer negative) mutant 
embryos and wild-type OR embryos were isolated using a COPAS Select embryo sorter (Union 
Biometrica). Total RNA was isolated using TriZOL:Chloroform extraction and precipitated with 
isopropanol. The Qiagen RNeasy kit was used for RNA clean up. Total RNA (100ng) was labeled 
according to standard Affymetrix protocols and hybridized to the Drosophila genome 2.0 chip.  
Following scanning, intensity values were normalized by RMA (Irizarry et al., 2003a; Irizarry et 
al., 2003b) (Partek Inc., St. Louis, MO) and statistical analysis was performed using Spotfire 
software (TIBCO, Palo Alto, CA). CrebA target genes were identified based on a 1.5 fold change 
in gene expression, with a p-value < 0.05.  This fold change was selected since many known, 
confirmed, CrebA target genes fall into the range from 1.5-2.0x. 
 
HeLa cell culture, transfection, and immunofluorescence 
cDNAs corresponding to the full length Creb3L1 and Creb3L2 were purchased from Open 
Biosystems (Accession numbers BC01578 and BC110813, respectively) and the full length and 
truncated (Creb3L1: amino acids 1-375, Creb3L2: amino acids 1-379) versions were cloned into 
pCDNA3.1/Hygro (Invitrogen) for transient transfection. DNA (1 μ
co-transfection marker pEGFP-C1 [Invitrogen]) was transfected into cells using the Fugene6 
transfection reagent according to the manufacturer’s protocol (Roche). Immunofluorescent 
staining was performed using established protocols (Sbodio and Machamer, 2007). Primary 
antibodies for Creb3L1 (Accession number NP_443086) and Creb3L2 (Accession number 
NP_919047) were purchased from Aviva Systems Biology (San Diego, CA), and used at a dilution 
of 1:500. Fluorescent secondary antibodies (Molecular Probes) were used at a dilution of 1:500. 
Co-staining with an ER marker (DM286, gift from Chris Nicchitta) and the nuclear marker DAPI, 
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confirmed both the ER localization and nuclear localization of the full length and truncated 
Creb3L proteins, respectively (data not shown).  
 
Cell sorting, RNA extraction and microarray analysis from HeLa cells 
HeLa cells were co-transfected with both Creb3L1 T and EGFP approximately 20 hours prior 
to sorting (as above). As a control, HeLa cells were mock transfected with Fugene6 reagent, and 
sorted using identical conditions. Cells were sorted on a FACSaria flow cytometer, and at least 
200,000 cells were isolated. RNA was extracted using the Qiagen RNeasy kit. Total RNA (100ng) 
was labeled and hybridized to the Affymetrix Human Gene 1.0 array according to standard 
Affymetrix protocols. Following scanning, raw data was normalized by RMA (Irizarry et al., 
2003a; Irizarry et al., 2003b) (Partek Inc., St. Louis, MO) and statistical analysis was performed 
using Spotfire software (TIBCO, Palo Alto, CA). 
 
Accession numbers 





CrebA binds directly to SPCG enhancers in vitro and in vivo 
Drosophila CrebA expression is elevated in many secretory organs in the embryo, with 
highest expression in the developing SG, proventriculus, late trachea and epidermis (Fig. 1A; 
Andrew et al., 1997). In these tissues, CrebA is required for the high level expression of 34 
known secretory pathway component genes (SPCGs) (Abrams and Andrew, 2005). A MEME 
analysis (http://meme.sdsc.edu/meme/website) of the enhancer regions upstream of these 
genes revealed a conserved motif similar to the previously characterized CREB response 
element (CRE) (Montminy and Bilezikjian, 1987) and unfolded protein response elements (UPRE) 
(Wang et al., 2000) that bind the mammalian CREB proteins (Fig. 2A) (Abrams and Andrew, 
2005). To ask if the more distantly related CrebA protein binds these sites in vitro, we performed 
electrophoretic mobility shift assays (EMSA) with ~30 nucleotide double-stranded oligomers 
corresponding to 18 putative CrebA binding sites found within the CrebA-dependent enhancers 
of five representative SPCGs: SrpRα, Sec61β, Spase25, p24.1, and δCop (Fig. 1C). Each gene 
encodes a protein found in a distinct complex functioning at a different step in early secretion 
(Fig. 1B). Using purified CrebA protein, we observed strong binding in all cases, as revealed by 
the decreased mobility of CrebA:DNA complexes relative to unbound DNA (Fig. 2B; Fig. S1). The 
binding is specific; whereas unlabeled competitor oligomers corresponding to the same 
sequence as the labeled probe competed for CrebA binding in 17 of the 18 sites tested, 
unlabelled competitor oligos in which the five core nucleotides of the consensus motif were 
changed did not compete (Fig. 2B, Fig. S1). We then performed Chromatin Immunoprecipitation 
(ChIP) followed by quantitative RT-PCR to determine if CrebA binds the enhancer regions 
upstream of these SPCGs in vivo. Chromatin was extracted from 0-24 hr embryos and 
immunoprecipitated with either CrebA antiserum or CrebA preimmune serum as a negative  
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Figure 1. CrebA is expressed in secretory tissues and regulates SPCG expression. (A). 
Endogenous CrebA protein is detected in the salivary glands (white asterisks), epidermis 
(arrowheads), and proventriculus (black arrow) beginning at stage 11 (lateral view) and 
continuing through stage 16 of embryonic development (images of stage 13, 15 and 16 are 
ventral views).  Elevated expression is also detected in the trachea, but is not visible in these 
images. (B) Cartoon representation of the protein complexes represented by the five enhancers 
characterized in this study. (C) In situ hybridizations show loss of SG (black asterisks), 
proventriculus (white arrow) and epidermal expression (arrowheads) in the CrebA mutant.  All 






Figure 2.  CrebA directly activates SPCG expression. (A) The CrebA consensus motif identified 
upstream of 34 SPCGs by MEME analysis (Abrams and Andrew, 2005). (B) EMSAs reveal that 
CrebA binds to radio-labeled double stranded (ds) oligonucleotides containing the CrebA 
consensus motif (green sequence). Unlabeled wild type (wt) ds oligonucleotides compete for 
CrebA binding, whereas unlabeled ds oligonucleotides containing mutated consensus motifs 
(red sequence, mut), do not. (C) Chromatin-Immunoprecipitation (ChIP) analysis using CrebA 
specific antibodies, followed by quantitative PCR, reveals that SPCG enhancer regions exhibit 
increased CrebA occupancy when compared to control genes. This figure shows the average 
from one representative trial (out of three). Of note, Spase25-2 showed lower occupancy in one 
-2 showed higher occupancy in the other two trials. ddCt indicates the relative 
abundance of a gene (or DNA fragment) normalized to a housekeeping gene (actin5c) and 







control. All tested SPCG enhancers were preferentially pulled down with the CrebA antibody 
(Fig. 2C). These findings indicate that CrebA binds to the conserved CrebA consensus site both in 
vitro and in vivo. 
 
CrebA directly activates SPCG expression 
To ask if the CrebA binding sites are required for CrebA-dependent expression of SPCGs in 
vivo, we generated multiple independent transgenic lines in which all of the CrebA consensus 
motifs within the SPCG enhancers were mutated. Transgenic lines carrying wild-type SPCG 
enhancers driving lacZ -type embryos, which was 
significantly reduced in CrebA mutants (Abrams and Andrew, 2005). When stained in parallel 
with the wild-type constructs, most lines carrying mutated CrebA binding sites for SrpRα, p24.1, 
Sec61β, and δCop had significantly reduced levels of SG βgal expression when visualized in 
otherwise wild-type embryos (Fig. 3). Surprisingly, most of the mutant Spase25 enhancer lines 
(8/10) l expression similar to the wild-type Spase25 enhancer. The residual SG 
SrpRα, p24.1, Sec61β, and δCop and 
the strong βgal expression from the mutated enhancer of Spase25 suggests that although CrebA 
directly activates expression of most SPCGs through the sites that bind CrebA in vitro, there may 
also be some activation by CrebA-dependent downstream transcription factors or CrebA may 
also directly activate SPCG expression through divergent binding sites still contained within the 
enhancer regions of the mutated SPCGs. Altogether, these results indicate that CrebA is 
required for SPCG expression, and that full expression of most SPCGs is dependent on the CrebA 
consensus binding motif identified through the MEME analysis. 
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Figure 3. SPCG expression in vivo requires the CrebA consensus motif. (A) The structures of the 
lacZ reporter gene constructs are represented above each gene name with putative CrebA 
binding sites represented by orange circles. LacZ reporter lines show high level SG expression in 
wild-type embryos (top panels), which is significantly reduced in CrebA mutants (second row 
panels). Mutation of the CrebA response element (CRE) results in significant reduction of βGal 
expression for SrpRα, Sec61β, p24.1, and δCop but not for Spase25 (lower panels) in otherwise 
WT embryos. Three individual transgenic lines are shown for each reporter. Asterisks denote SG 
location in the mutant lines. Scale bars = 125μm. (B) Table showing the number of independent 
transgenic lines analyzed for each mutated enhancer and the relative level of lacZ expression 







CrebA is sufficient to induce SPCG expression 
We next asked if CrebA can induce high level SPCG transcription in cells that normally only 
express low or undetectable levels of these genes. UAS-CrebA (Rose et al., 1997) was expressed 
using either the breathless-Gal4 (trachea, midline, salivary duct) or engrailed-Gal-4 (epidermal 
stripes) drivers (Shiga, 1996; Weiss et al., 2001). In wild-type embryos, CrebA expression is not 
detected in the midline cells, the salivary duct, or in the engrailed domains, and only moderate 
levels are detected in the trachea (Fig. 4A). Ectopic expression of CrebA resulted in elevated 
levels of expression of all five of the SPCGs in all locations (Fig. 4A). Neither loss nor ectopic 
expression of CrebB, the most closely related Drosophila gene, had any effect on SPCG 
expression (Fig. 4B and data not shown). Thus, expression of CrebA alone is sufficient to 
upregulate SPCG expression in multiple distinct embryonic cell types, suggesting a major role for 
this transcription factor in upregulating secretory capacity. 
 
CrebA regulates additional secretory pathway genes as well as secreted cargo 
To ask if CrebA is a general regulator of SPCGs, we performed microarray analyses 
comparing RNA from wild-type and CrebA mutant embryos (Fig. 5, Table S1). Not only did we 
observe a significant reduction in the expression levels of the majority of the SPCGs previously 
analyzed in CrebA mutant embryos (changes of 1.5 fold or greater) but we discovered that many 
additional genes encoding proteins known or suspected to function in secretion were similarly 
affected. Gene Ontology (GO) clustering was performed using DAVID, a program that weighs the 
enrichment of a specific GO term in a given data set relative to the frequency of that term in the 
entire genome (Dennis et al., 2003; Huang da et al., 2009). This analysis revealed that in the 
absence of CrebA, the GO terms associated with secretory pathway function (i.e. co-
translational protein targeting to the membrane, secretory pathway and protein transport) are 
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Figure 4. CrebA is sufficient to induce SPCG expression.  (A) UAS-CrebA expression in ectopic 
domains using either the btl-Gal4 or the en-Gal4 driver results in activation of all tested SPCGs. 
btl-Gal4 drives UAS-CrebA expression and, consequently, SPCG expression in the trachea and 
CNS midline (arrowheads) of late stage 11 embryos (ventral views, Rows 1, 2). en-Gal4 drives 
UAS-CrebA expression and, consequently, SPCG expression in epidermal stripes of early stage 11 
embryos (lateral views, Rows 3, 4). (B) Ectopic expression of UAS-CrebB by the en-Gal4 driver 






Figure 5. CrebA activates additional secretory pathway genes as well as secreted cargo. (A) 
Volcano plot showing changes in expression level and statistical significance of CrebA target 
genes. Transcripts elevated 1.5x or more in CrebA mutants are labeled red. Transcripts reduced 
1.5x or more are labeled blue or green. Closed circles indicate significance with a p-value <0.05. 
Open circles indicate non-statistically significant changes. (B) Pie charts showing predicted 
functions of all 383 genes downregulated in CrebA mutants in the microarray experiments. The 
116 secretory pathway genes are further categorized according to known function and/or 
localization (blue box). Unknown genes (89) were further subdivided according to predicted 
localization as ascertained by WoLF PSORT analysis. (C) In situ hybridizations validate CrebA 
regulation of new target genes identified by microarray analysis. Overexpression of CrebA using 
the en-Gal4 driver is sufficient to induce ectopic expression of four of the five newly identified 







 the most highly enriched in the data set with enrichment of at least 3-fold compared to the 
entire Drosophila genome (Fig. 5B; Table S2). Unexpectedly, many genes predicted to encode 
secreted cargo also showed significantly reduced expression in CrebA mutants, including larval 
cuticle proteins, mucins and several secreted enzymes. Indeed, more than half of the ~40 genes 
most affected by loss of CrebA encode known or predicted secreted proteins, including mucins 
and constituents of the larval cuticle. These data indicate that CrebA not only upregulates genes 
encoding the general secretory machinery found in all cells but also activates genes encoding 
cell-type specific secreted proteins.  DAVID analysis of the genes upregulated in CrebA mutants 
did not reveal enrichment for any specific pathway or biological function, suggesting that CrebA 
functions primarily as a transcriptional activator of genes in the secretory pathway. 
In addition to known secretory pathway genes, we identified 89 CrebA target genes 
encoding proteins of unknown function, i.e. with no associated GO terms. A WoLF PSORT 
analysis (http://wolfpsort.org/) of these proteins revealed that almost half (44) contain a signal 
sequence and are predicted to be secreted, with an additional 14 containing transmembrane 
domains and predicted to localize to the ER or plasma membrane (Fig. 5B).  Thus, it is likely that 
many of these uncharacterized genes encode either novel secretory pathway components or 
secreted gene products. 
Using in situ hybridization, we confirmed that several genes identified as potential CrebA 
targets in the microarray analysis require CrebA for expression in the SG, proventriculus, and/or 
epidermis (Fig. 5C).  Interestingly, many of them have predicted roles in the secretory pathway.  
Although CG4848 does not contain GO annotation, it encodes a Vps51/Vps67 domain protein 
closely related to mammalian Cog1, a member of the conserved oligomeric Golgi complex 
required for protein glycosylation. Cct1 encodes choline phosphate cytidyltransferase, an 
enzyme that functions in the lipid biogenesis pathway.  CG1969 encodes a glucosamine 6-
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phosphate N-acetyltransferase, a cytoplasmic enzyme involved in the metabolism of glutamate. 
CG5021 and CG14576 encode unknown proteins, but CG5021 has significant hydrophobic 
stretches suggesting multiple membrane spans, and CG14576 has an N-terminal signal sequence 
indicating that it likely travels through the secretory pathway and is secreted. Similar to the 
previously tested SPCGs, expression of CrebA using the en-Gal4 driver was sufficient to induce 
ectopic expression of a majority of these genes; the exception is CG14576, which we know 
requires additional cell-type specific transcription factors for its expression (see discussion). 
Thus, the microarray screen has revealed many new CrebA target genes known or likely to 
encode components of the secretory pathway as well as the specific protein products that are 
processed and delivered via this pathway.   
 
Loss of CrebA leads to defects consistent with secretory dysfunction 
Despite the critical role of CrebA in upregulating secretory function, CrebA mutants do not 
display major morphological SG defects; the SGs form normally and are only mildly crooked at 
late stages (Andrew et al., 1997). Transmission electron microscopy (TEM) of CrebA mutant SGs 
revealed three overt changes: (1) the lumen size was significantly smaller than that of wild type 
glands and was accompanied by reduced amounts of electron dense luminal material (Fig. 6A); 
(2) the mitochondria were concentrated to a region apical to the nucleus in contrast to wild-
type SGs where mitochondria were distributed throughout the cell (Fig. 6B); (3) the secretory 
vesicles were much fewer and smaller than those of wild-type SGs (Fig. 6C-E). The TEM analysis 
also suggested reduced levels of ER, a change that could not be quantified from the TEMs. 
Although most of the SG defects revealed by TEM analysis are fully consistent with a role for 
CrebA as a general activator of secretory function, the change in mitochondrial localization was  
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Figure 6. Characterization of CrebA mutant SGs reveals decreases in secretion and changes in 
organelle positioning. (A) Low magnification (980x) TEM images of stage 15 SGs (wild-type, top; 
CrebA mutant, bottom) show a reduction in lumen size and content in the CrebA mutant (left 
 
clustering of mitochondria in the bottom panel (CrebA mutant). (C) High magnification (15000x) 
images of the apical regions of a single SG cell with arrows pointing to secretory vesicles (wild-
type, top; CrebA 
number per cell in an individual slice for wild type and CrebA mutant SGs (top). Average area of 
the secretory vesicles, determined using ImageJ software, for an individual slice, for WT and 








unexpected; whether or not this change is linked to CrebA secretory function remains to be 
determined.  
To ask if CrebA is provided maternally and functions earlier in embryogenesis, we generated 
homozygous CrebA mutant germ-line clones using the FLP-DFS technique (Chou and Perrimon, 
1996).  Consistent with the absence of detectable germ-line expression (Rose et al., 1997; 
Smolik et al., 1992), maternal loss of CrebA did not exacerbate the CrebA zygotic loss-of-function 
phenotypes. Indeed, cuticle preparations of CrebAmat-zyg- animals revealed the same phenotypes 
as observed with zygotic mutants (Fig. 7A-D).  Also, staining with the apical marker Crumbs, 
revealed that, as observed with only zygotic loss of CrebA, maternal-zygotic loss of CrebA did not 
result in overt defects in early embryos (Fig. 7E-H). Thus, CrebA is not required for the basal 
levels of secretion that occur in most cell types and instead functions to selectively upregulate 
secretory capacity in specialized secretory cells, both through its effects on genes encoding the 
general machinery and on genes encoding secreted cargo.  
 
CrebA is related to the mammalian proteins Creb3L1 and Creb3L2 
BLAST analysis of the Drosophila CrebA protein against the human genome revealed its two 
closest orthologues to be Creb3L1 (Honma et al., 1999; Nikaido et al., 2001) and Creb3L2 (Kondo 
et al., 2007; Saito et al., 2009) (Fig. 8A), consistent with earlier reports that Creb3L2, originally 
named BBF2H7, is most similar to Drosophila CrebA, originally named BBF-2 (Abel et al., 1992; 
Smolik et al., 1992; Kondo et al., 2007; Storlazzi et al., 2003). Creb3L1 and Creb3L2 share ~25% 
overall similarity with CrebA, with 97% similarity (84% identity) and 79% similarity (71% identity) 
within the DNA binding domains of CrebA with Creb3L1 and Creb3L2, respectively (Fig. 8B). Both 
human proteins also contain C-terminal transmembrane domains and are bound to the ER 
membrane (Kondo et al., 2007; Omori et al., 2002). During ER stress, Creb3L1 and Creb3L2 
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Figure 7. CrebA is not supplied maternally. (A-D) Cuticle preparations of larvae just prior to 
hatching from the vitelline membrane reveal that animals missing both the maternal (mat-) and 
zygotic (zyg-) contributions of CrebA are similar to animals missing only zygotic function (note 
the near complete absence of ventral denticles in B and C, and the loss of mouthpart 
pigmentation in the enlarged views, A’ – D’). Paternally-supplied zygotic CrebA+ is sufficient for 
maternal CrebA mutant larvae to finish embryonic development and hatch.  (E-H) Staining with 
the Crumbs antibody reveals no overt morphological changes associated with either the 
maternal, zygotic  or maternal and zygotic loss of CrebA.  All embryos are early stage 15. All 






Figure 8. The CrebA human orthologues Creb3L1 and Creb3L2 are sufficient to upregulate the 
secretory pathway genes. (A) A rooted phylogenetic tree reveals the relationships among 
members of the CREB/ATF family of transcription factors from Drosophila melanogaster (Dm), 
Caenorhabditis elegans (Ce) and Homo sapiens (Hs). The red box highlights Drosophila CrebA 
and its closest family members. (B) Sequence alignment of the CrebA family. The truncated 
forms of Creb3L1 and Creb3L2 contain all N-terminal residues up to the site 2 protease cleavage 
point. (C) Human Creb3L1 and Creb3L2 upregulate SPCGs. The top row shows wild-type 
expression of each SPCG tested. Overexpression of UAS-Creb3L1 (FL or T), and UAS-Creb3L2 (FL 
or T) using the en-GAL4 driver resulted in robust mRNA expression in epidermal stripes (first 
column). Overexpression of the full-length forms did not affect SPCG expression, whereas 
expression of the active truncated forms induced high-level expression of every SPCG tested. 
-length (FL) or truncated (T) 
forms of the Creb3L1 or Creb3L2 cDNAs. For both, the full-length protein is detected in the ER, 
Microarray analysis of HeLa cells expressing the active truncated form of Creb3L1 compared to 
control HeLa cells reveals a significant increase in the expression of many SPCGs. Genes 
represented in red (increased) or blue (decreased) show a fold change of at least 1.25. Open 







 undergo regulated intramembrane proteolysis (RIP), wherein their transcription factor domains 
are released into the cytoplasm and subsequently translocated to the nucleus to activate 
transcription (Kondo et al., 2005; Kondo et al., 2007; Saito et al., 2007). The roles of both 
Creb3L1 and Creb3L2 as sensors and mediators in the unfolded protein response have been 
described and both are expressed in many secretory organs (Kondo et al., 2005; Kondo et al., 
2007; Murakami et al., 2009; Omori et al., 2002; Saito et al., 2009; Saito et al., 2007).  
 
Creb3L1 and Creb3L2 activate SPCG expression in Drosophila and human cells 
To determine if human Creb3L1 and Creb3L2 have the same activity as CrebA, we generated 
UAS-lines that allow for Gal4 driven expression of both the full length (FL) and truncated (T) 
forms of Creb3L1 and Creb3L2 in Drosophila embryos. The truncated forms correspond to the 
fully processed proteins and should be functionally analogous to Drosophila CrebA (Kondo et al., 
2005; Kondo et al., 2007). With the en-Gal4 driver, we detected high level expression of both 
forms of Creb3L1 and Creb3L2 in the epidermal stripes corresponding to engrailed expression 
(Fig. 8C). Importantly, we also detected robust expression of all five of the SPCGs we tested in 
the engrailed domain with expression of the truncated forms of both Creb3L1 and Creb3L2 but 
not with full-length Creb3L1 and Creb3L2, findings fully consistent with the robust localization of 
the truncated proteins to nuclei and of the full-length proteins to the ER (Kondo et al., 2005; 
Kondo et al., 2007). We conclude that human Creb3L1 and Creb3L2 can activate SPCG 
transcription in a heterologous system, suggesting a general and direct role for this family of 
bZip transcription factors in mediating high-level secretory capacity. 
To ask if Creb3L1 can also upregulate SPCG expression in human cells, we carried out a 
microarray analysis of HeLa cells expressing the truncated form of Creb3L1 and control non-
expressing cells. It should be noted that HeLa cells are not specialized for secretion, therefore 
244 
 
this experiment would determine if the overexpression of Creb3L1 alone can upregulate the 
secretory pathway in cells that are not dedicated to high-level protein secretion. Thus, it was 
exciting to discover that the most highly upregulated genes in Creb3L1 T expressing HeLa cells 
had GO terms including Golgi vesicle transport, secretory pathway, and secretion (Table S3, S4). 
The upregulated set of genes exhibited at least 3-fold enrichment in the prevalence of these 
terms as compared to the human genome (Table S4). Thus, like its Drosophila orthologue, 






Here, we provide evidence that the CrebA/Creb3-like bZIP transcription factors are direct 
and major regulators of secretory capacity. Drosophila CrebA directly activates high-level 
expression of secretory pathway component genes through a site we found to be conserved 
among the enhancers of 34 CrebA-dependent SPCGs. Moreover, ectopic expression of CrebA in 
multiple tissues is sufficient to activate high-level expression of every SPCG tested. Microarray 
analysis indicates that CrebA is required for full expression of ~400 genes including almost 200 
implicated in secretion. The secretory target genes include general machinery required for 
secretion in all cells as well as cell-type specific secreted cargo, such as the cuticle proteins and 
mucins. Phenotypic characterization of CrebA mutant SGs revealed a range of expected 
secretory defects, including reduced luminal secretory content and a decrease in the size and 
frequency of apical secretory vesicles, as well as unexpected changes in organelle distribution. 
We demonstrated that active forms of the closest vertebrate orthologues Creb3L1 and Creb3L2 
activate the Drosophila SPCGs when expressed in embryos.  Active Creb3L1 can also induce 
expression of multiple components of the secretory pathway when expressed in HeLa cells, a 
non-secretory cell type.  
CrebA is the single Drosophila member of the Creb3-like family of transcription factors that 
includes five different proteins in mammals (Creb3/Luman, Creb3L1/Oasis, Creb3L2/BBF2H7, 
Creb3L3/CrebH and Creb3L4/Creb4) and two in worms (C27D6.4 and F57B10.1) (Fig. 7A). This 
singularity means that the fly protein is likely to play a more pivotal role in the regulation of 
secretion since there is no possibility of compensation for its activity by other family members. 
Each member of the Creb3-like family has a unique expression pattern with some overlap 
amongst family members.  Creb3/Luman is most highly expressed in the brain, with expression 
detected in the liver, intestine, colon and skeletal muscles (Audas et al., 2008). Creb3L1 is 
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expressed in osteoblasts, prostate, pancreas, ovary, testis, the gut, lungs, kidney and salivary 
glands (Nikaido et al., 2001; Omori et al., 2002).  Creb3L2 is expressed in chondrocytes, heart, 
lung, liver, kidney, adrenal gland, bladder, submandibular gland, brain, ovary, pancreas, spleen, 
testis and prostate (Kondo et al., 2007). Creb3L3/CrebH is almost exclusively detected in the 
liver (Chin et al., 2005), whereas Creb3L4/Creb4 expression is elevated in the prostate, thymus, 
brain, pancreas, skeletal muscle and peripheral leukocytes (Cao et al., 2002). Unlike the 
Drosophila and worm orthologues, all five members of the Creb3-like family are ER-bound 
transcription factors previously implicated as sensors in the unfolded protein response (UPR) 
(Kondo et al., 2005; Kondo et al., 2007; Liang et al., 2006; Saito et al., 2007; Stirling and O'Hare, 
2006; Zhang et al., 2006). Recently published phenotypes of the knock-out mutations in each of 
the two genes most closely related to CrebA, Creb3L1 and Creb3L2, suggest a more physiological 
role for these genes during normal development, with a major defect being failure to secrete 
the extracellular matrix in the cell types expressing the highest levels of each gene (Murakami et 
al., 2009; Saito et al., 2009). These data support a model wherein one or more of the remaining 
members of the family may largely compensate for the loss of secretory capacity associated 
with the loss of any one family member. Indeed, our findings that the expression of only a single 
Creb3-like family member in HeLa cells, a non-secretory cell type, is sufficient to activate 
expression of multiple components of the secretory machinery further supports this hypothesis. 
Among the many secretory genes induced in HeLa cells by Creb3L1 are genes encoding multiple 
components of CopII vesicles: Sec16A, Sec23A, Sec24A, Sec24D, Sec31A and Sar1A. The reduced 
expression of one or more of these genes could explain the ER trapping of ECM proteins 
observed with the loss of either Creb3L1 or Creb3L2.  
Our microarray analysis of CrebA mutants revealed that CrebA upregulates transcription of 
secretory cargo, specifically expression of multiple components of the insect cuticle, several 
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mucin-like proteins (secreted highly-glycosylated proteins rich in serine and threonine), as well 
as multiple secreted proteins of unknown function. Although unexpected, this finding parallels 
the finding that mouse Creb3L1 directly upregulates the Type I collagen gene, col1a1, a major 
secreted component of bone ECM (Murakami et al., 2009). Our data also suggests that CrebA 
may function in parallel with tissue-specific regulators to control high-level expression of organ-
specific cargo. An example is CG14756, which encodes an SG specific secreted protein of 
unknown function. Loss of CrebA results in a 3.2 fold decrease in the expression of this gene 
based on the microarray analysis, but unlike the CrebA targets that show more general 
expression in all secretory tissues, expression of CG14756 could not be induced by CrebA in 
other cell types, suggesting the additional requirement for tissue-specific transcription factors 
for its activation (Fig. 4). Indeed, expression of CG14756 is absolutely dependent on Fkh (R. 
Maruyama and D.J.A., unpublished), and the region immediately upstream of CG14756 contains 
a good consensus Fkh binding site ~150 bp upstream of three clustered CrebA consensus 
binding sites. Thus, we propose that the CrebA/Creb3-like family enhances secretory capacity by 
coordinately upregulating expression of the general secretory machinery and of tissue-specific 
secreted cargo, with the expression of cargo genes likely mediated through cooperation with 
tissue-specific factors.  
More than 30% (116 of 383) of genes identified in the CrebA microarray experiments had 
GO terms associated with roles in the secretory pathway (Fig. 4), and WoLF PSORT predictions 
suggested that more than half of the unknown targets are likely to have roles in secretion. 
Indeed, genes not implicated in the secretory pathway may, nonetheless, participate in 
secretion. Several of the ion channel/transporter genes have human orthologues known to 
function in secretory pathway organelles, as an example, CG10449 (Drosophila catsup, human 
SLC39A7) encodes a Golgi localized zinc transporter (Huang et al., 2005). Also, 26 of the target 
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genes that did not have GO annotations have highly conserved human orthologues, several of 
which are involved in secretion. For example, CG4293 and CG7011 encode proteins similar to 
ERGIC2 and ERGIC3, respectively, proteins localized to the ER-Golgi intermediate compartment 
that function in protein folding and trafficking (Nishikawa et al., 2007). Thus, it is likely that 
many of the newly identified CrebA target genes encode proteins that function in secretory 
organelles, highlighting the potential of the microarray studies to reveal new genes with key 
roles in the efficient production and delivery of products through the secretory pathway.  
Altogether, our studies reveal that CrebA and its human orthologues Creb3L1 and Creb3L2 
activate transcription of components that function at all steps in secretion. Coordinate 
upregulation of secretory components by one (or a very few) transcription factors allows for 
easily adjustable levels of secretory capacity in a variety of cell types, as nicely exemplified in the 
Drosophila embryo where levels of CrebA and corresponding SPCG expression correlate with the 
levels of secretory activity in the different tissues. Furthermore, our microarray analysis 
combined with the recent studies of Creb3L1 and Creb3L2 in specialized cell types (osteoblasts 
and chrondrocytes) (Murakami et al., 2009; Saito et al., 2009) suggest that CrebA family proteins 
also upregulate expression of tissue-specific secreted content, highlighting the significance of 
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Supplemental Table 1: Names and Signaling Information for Drosophila NOG GPCRs 
 
Name Symbol CG Output G-alpha Assay ligand * **
 GABA-B receptor subtype 3 GABA-B-R3 CG3022 C1 31
 GABA-B receptor subtype 1 GABA-B-R1 CG15274 ↑ Ca2+, ↓ cAMP (Mezler 2001) HEK293 cells, Xenopus GABA C1 31
 GABA-B receptor subtype 2 GABA-B-R2 CG6706 ↑ Ca2+, ↓ cAMP (Mezler 2001) HEK293 cells, Xenopus GABA C1 31
mangetout mtt CG30361 ↑ IP via Gαi, Gαo (Mitri 2004) HEK293 cells L-canavanine 28
Glutamate Receptor mGluR CG11144 PTX sensitivity (Raymond 1999) Xenopus glutamate
poor gastrulation pog CG31660 31
CG31760 CG31760 CG31760 31
CG44153 CG44153 CG44153
CG12290 CG12290 CG12290 A5b 24
CG32447 CG32447 CG32447 31
CG15744 CG15744 CG15744
frizzled fz CG17697 Gαs (NiCHO cellsls 2013) Gαs genetic interaction Wnt D1 32
frizzled 2 fz2 CG9739 Wnt D1 32
frizzled 3 fz3 CG16785 Wnt D1 32
frizzled 4 fz4 CG4626 Wnt D1 32
smoothened smo CG11561 ↓ cAMP (Ogden 2008) Gαi Cl8 cells, genetic interaction D1 32
Ca-independent α-latrotoxin Cirl CG8639 B4 27
starry night stan CG11895 D2 27
CG11318 CG11318 CG11318 B3 27
CG15556 CG15556 CG15556 B3 26
hector hec CG4395 B1 UN
Diuretic hormone 31 Dh31-R CG32843 B2 25
Diuretic hormone 44 receptor 2 Dh44-R2 CG12370 ↑ cAMP (Hector 2009) HEK293 cells Diuretic hormone 44 B2 25
Diuretic hormone 44 receptor 1 Dh44-R1 CG8422 ↑ Ca2+, ↑ cAMP (Johnson 2004) HEK293 cells Diuretic hormone 44 B2 25
Pdfr CG13758 CG13758 ↑ cAMP, ↑ Ca2+ (Hyun 2005, Agrawal 2013) S2 cells, RNAi screen pigment-dispersing factor B1 25
methuselah-like 4 mthl4 CG6536 B5 26
methuselah-like 3 mthl3 CG6530 B5 26
methuselah-like 2 mthl2 CG17795 B5 26
methuselah mth CG6936 ↑ Ca2+  (Cvejic 2004) HEK293 cells Sun, SP, SPAM B5 26
methuselah-like 12 mthl12 CG32853 B5 26
methuselah-like 7 mthl7 CG7476 B5 26
methuselah-like 6 mthl6 CG16992 B5 26
methuselah-like 11 mthl11 CG31147 B5 26
methuselah-like 13 mthl13 CG30018 B5 26
methuselah-like 10 mthl10 CG17061 B5 26
methuselah-like 15 mthl15 CG31720 26
Mist mthl1 CG4521 G12/13 (Manning 2013) cta S2 cells Fog 26
methuselah-like 5 mthl5 CG6965 26
methuselah-like 14 mthl14 CG32476 26
methuselah-like 9 mthl9 CG17084 B5 26
methuselah-like 8 mthl8 CG32475 B5 26
bride of sevenless boss CG8285 D2 30
roughoid ru CG1214
rhomboid rho CG1004






CG4313 CG4313 CG4313 21
moody moody CG4322 Gαi, Gαo (Schwabe 2005) Gαi, Gαo localization 21
Trapped in endoderm 1 Tre1 CG3171 Gαi, Gαo (Yoshiura 2012) Gαi, Gαo physical & genetic interaction A5a
CG7497 CG7497 CG7497 A5b 18
CG13995 CG13995 CG13995 A5b 23
Myosuppressin receptor 1 MsR1 CG8985 ↓ cAMP (Johnson 2003) HEK293 cells dromyosupressin A5a 5
Myosuppressin receptor 2 MsR2 CG43745 ↓ cAMP (Johnson 2003) HEK293 cells dromyosupressin A5a
CG13299 CG13299 CG13229 A5a 5
Sex peptide receptor SPR CG16752 ↑ Ca2+ (Yapici 2008), Gαq, Gαi, Gαo CHO cells SP 5
CG33639 CG33639 CG33639 A5a UN
FMRFamide Receptor FMRFaR CG2114 ↑ Ca2+ (Cazzamali 2002) CHO cells FMRFamides A5a
Proctolin receptor Proc-R CG6986 ↑ Ca2+ (Egerod 2003) CHO cells  proctolin A5b 5
CNMamide Receptor CNMaR CG33696 ↑ Ca2+ (Jung 2014) CHO cells CNMa 5
CG15614 CG15614 CG15614
Leucine-rich repeat-GPCR3 Lgr3 CG31096 A4b 7
CG34411 CG34411 CG34411 A4b 7
rk rickets CG8930 ↑ cAMP (Luo 2005) 293T cells burs and pburs A4b 7
Leucine-rich GPCR1 Lgr1 CG7665 ↑ cAMP (Sudo 2005) 293T cells GPA2/GPB5 7
CG13575 CG13575 CG13575 A4i 11
Tachykinin-like receptor at 99D TkR99D CG7887 ↑ Ca2+ (Poels 2007) S2 cells tachykinins A4f 11
Tachykinin-like receptor at 86C TkR86C CG6515 ↑ IP (Monnier 1992) NIH 3T3 cells tachykinin A4f 11
Leucokinin receptor Lkr CG10626 ↑ Ca2+ ( Radford 2002) S2 cells Drosokinin A4f 11
RYamide receptor RYa-R CG5811 ↑ Ca2+ (Ida 2011) CHO cells dRYamide-1 and dRYamide-2
CHO cellslecystokinin-like  17D1 CCKLR-17D1 CG42301 ↑ cAMP (Chen 2012) genetic dsk-1, 2 8
CHO cellslecystokinin-like  17D3 CCKLR-17D3 CG32540 ↑ Ca2+ , PTX sensitive (Kubiak 2002) CHO cells, HEK293, SH-EP dsk-1 8
SIFamide receptor SIFaR CG10823 ↑ Ca2+ (Jorgensen 2006) CHO cells SIFamide A4i
short neuropeptide F receptor sNPF-R CG7395 ↑ Ca2+ (Mertens 2002); ↓ cAMP (Vecsey 2014) Gαo CHO cells RX1RX2 amide C-term short NPFs 11
Neuropeptide F receptor NPFR CG1147 ↓ cAMP (Garczynkski 2002) CHO cells NPF A4f 11
Pyrokinin 2 receptor 2 PK2-R2 CG8795 ↑ Ca2+  (Rosenkilde 2003) CHO cells pyrokinin-2 A4e 5
Pyrokinin 2 receptor 1 PK2-R1 CG8784 ↑ Ca2+  (Rosenkilde 2003) CHO cells pyrokinin-2 A4e 5
Pyrokinin 1 receptor PK1-R CG9918 ↑ Ca2+ (Cazzamali 2005) CHO cells pyrokinin-1 A4e 5
Capability receptor CapaR CG14575 ↑ Ca2+ (Park 2002) Xenopus oocyte CAP2b-1 A4i 5
ETHR ETHR CG5911 ↑ Ca2+ (Park 2003) CHO cells ETH1, MasETH, MasPETH A4i 5
Allatostatin C receptor 2 AstC-R2 CG13702 A4g 1
Allatostatin C receptor 1 AstC-R1 CG7285 A4g 1
Allatostatin A receptor 2 AstA-R2 CG10001 ↑ Ca2+, PTX sensitive (Larsen 2001) CHO cells DST-As A4a 2
Allatostatin A receptor 1 AstA-R1 CG2872 ↑ Ca2+, PTX sensitive (Larsen 2001) CHO cells DST-As 2
CCHamide-2 receptor CCHa2-R CG14593 ↑ Ca2+ (Hansen 2011) CHO cells CCHamide-1, 2 4
CCHamide-1 receptor CCHa1-R CG30106 ↑ Ca2+ (Hansen 2011) CHO cells CCHamide-1, 2 4
Trissin receptor TrissinR CG34381 ↑ Ca2+ (Ida 2011) CHO cells Trissin A4i





ninal E ninaE CG4550 ↑ PLC activity (Running Deer 1995) Gαq Drosophila extract light A1 14
Rhodopsin 2 Rh2 CG16740 ↑ Ca2+  (Lee 1990; Cook 1999) Gαq localization light A1 14
Rhodopsin 6 Rh6 CG5192 ↑ Ca2+  (Lee 1990; Cook 1999) Gαq localization light A1 14
Rhodopsin 3 Rh3 CG10888 ↑ Ca2+  (Lee 1990; Cook 1999) Gαq localization light A1 14
Rhodopsin 4 Rh4 CG9668 ↑ Ca2+  (Lee 1990; Cook 1999) Gαq localization light A1 14
Rhodopsin 5 Rh5 CG5279 ↑ Ca2+  (Lee 1990; Cook 1999) Gαq localization light A1 14
Rhodopsin 7 Rh7 CG5638 ↑ Ca2+  (Lee 1990; Cook 1999) Gαq localization light A1 14
Dopamine 1-like receptor 2 Dop1R2 CG18741 ↑ Ca2+, ↑ cAMP (Feng 1996)  Xenopus oocytes dopamine A2b 24
Octopamine in mushroom bodies Oamb CG3856 ↑ Ca2+, ↑ cAMP (Han 1998) HEK293, S2 cells octopamine A2d 24
CG18208 CG18208 CG18208 24
Dopamine 1-like receptor 1 Dop1R1 CG9652 ↑cAMP (Gotzes 1994) HEK293 cells dopamine A2b 24
Dopamine 2-like receptor Dop2R CG33517 ↓ cAMP, PTX sensitive (Hearn 2002) HEK293 cells dopamine 24
5-hydroxytryptamine  7 5-HT7 CG12073 ↑ cAMP (Saudaou 1992) NIH 3T3 cells serotonin and more A2a 22
Octopamine-Tyramine receptor Oct-TyrR CG7485 ↓ cAMP, ↑ Ca2+ (Robb 1994) CHO cells octopamin, tyramine 24
5-hydroxytryptamine 1B 5-HT1B CG15113 ↑ IP; ↓ cAMP (Saudou 1992) NIH 3T3 cells serotonin A2a 22
5-hydroxytryptamine 1A 5-HT1A CG16720 ↑ IP; ↓ cAMP (Saudou 1992) NIH 3T3 cells serotonin A2a 22
Tyramine receptor II TyrRII CG16766 ↑ cAMP (Bayliss 2013) CHO cells octopamine, dopamine A2e 22
Tyramine receptor TyrR CG7431 ↑ Ca2+ (Cazzamali 2005) CHO cells tyramine A2e 22
Octopamine β2 receptor Octβ2R CG33976 ↑ cAMP (Maqueira 2005) CHO cells octopamine 20
Octopamine β1 receptor Octβ1R CG6919 ↑ cAMP (Balfanz 2005) HEK293, Flp-In-293 octopamine A2e 20
Octopamine β3 receptor Octβ3R CG42244 ↑ cAMP (Maqueira 2005) CHO cells octopamine
5-hydroxytryptamine 2A 5-HT2a CG1056 A2a 24
5-hydroxytryptamine 2B 5-HT2B CG42796 A2e 24
muscarinic AcetylCHO, A-type mAChR-A CG4356 ↑ Ca2+ (Millar 1995) S2 cells carbamylCHO,acetylCHO, muscarine A2c 23
muscarinic AcetylCHO, B-type mAChR-B CG7918 ↑ Ca2+ (Collin 2013) CHO cells A2c 23
CG13579 CG13579 CG13579 A5b UN
Dopamine/Ecdysteroid receptor DopEcR CG18314 ↑ cAMP (Srivastava 2005) CHO cells 20-hydroxyecdysone, dopamine A2e UN
Crustacean cardioactive peptide CCAP-R CG33344 ↑ Ca2+ (Cazzamali 2003) CHO cells crustacean cardioactive peptide 6
AkhR AkhR CG11325 ↑ Ca2+ (Park 2002) Xenopus oocyte AKH
CrzR CrzR CG10698 ↑ Ca2+ (Park 2002) Xenopus oocyte corazonin A4d 6
Adenosine receptor AdoR CG9753 ↑ cAMP, ↑ Ca2+ (Dolezelova 2007) Gas CHO cells A3 23
CG12796 CG12796 CG12796 A2e 24
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Supplemental Table 2: Odorant receptor family and information 
 
  
Name Symbol CG G-alpha/Output ligand
Odorant receptor 42b Or42b CG12754 ethyl acetate and pentyl acetate
Odorant receptor 59b Or59b CG3569 DEET, methyl acetate
Odorant receptor 59c Or59c CG17226 many 
Odorant receptor 98a Or98a CG5540 many 
Odorant receptor 22b Or22b CG4231 esters
Odorant receptor 22a Or22a CG12193 ↑ Ca2+ via Gαi/Gαo (Raja 2014) ethyl butyrate, methyl hexanoate, esters, and others
Odorant receptor 85a Or85a CG7454 ethyl 3-hydroxybutyrate 
Odorant receptor 43b Or43b CG17853 ethyl butyrate 
Odorant receptor 42a Or42a CG17250 butanol, ethyl acetate, propyl acetate, pentyl acetate, pyrazines
Odorant receptor 7a Or7a CG10759 E2 hexenal
Odorant receptor 33b Or33b CG16961 pentyl acetate and pyrazines
Odorant receptor 33a Or33a CG16960 many 
Odorant receptor 33c Or33c CG5006 ethyl acetate, cyclohexanone, fenchone 
Odorant receptor 23a Or23a CG9880 many 
Odorant receptor 59a Or59a CG9820 ethyl acetate, anisole, hexanoic acid, and pyrazines
Odorant receptor 19a Or19a CG18859 valencene, 1-octen-3-ol
Odorant receptor 19b Or19b CG32825 many 
Odorant receptor 2a Or2a CG3206 many 
Odorant receptor 94a Or94a CG17241 many 
Odorant receptor 94b Or94b CG6679 many 
Odorant receptor 71a Or71a CG17871 4-methyl phenol 
Odorant receptor 46a Or46a CG33478 4-methyl phenol
Odorant receptor 85b Or85b CG11735 2-heptanone, amyl acetate, and butyl acetate
Odorant receptor 85c Or85b CG17911 many 
Odorant receptor 85d Or85d CG11742 isoamyl acetate, 2-heptanone 
Odorant receptor 67a Or67a CG12526 benzaldehyde and acetophenone
Odorant receptor 67c Or67c CG14156 ethyl lactate 
Odorant receptor 92a Or92a CG17916 many 
Odorant receptor 49a Or49a CG13158 butanol and 2-heptanone
Odorant receptor 85f Or85f CG16755 many 
Odorant receptor 69a Or69a CG33264 many 
Odorant receptor co-receptor Orco CG10609 many 
Odorant receptor 88a Or88a CG14360 male and female pheromones
Odorant receptor 65c Or65c CG32403 many 
Odorant receptor 65b Or65b CG32402 many 
Odorant receptor 65a Or65a CG32401 male pheromone (11-cis-vaccenyl acetate)
Odorant receptor 47b Or47b CG13206 male and female pheromones
Odorant receptor 67d Or67d CG14157 male pheromone (11-cis-vaccenyl acetate)
Odorant receptor 83c Or83c CG15581 farnesol and others 
Odorant receptor 45b Or45b CG12931 anisole
Odorant receptor 24a Or24a CG11767 pyrazines, pentanol, hexanol, octanol,  and many others
Odorant receptor 10a Or10a CG17867 ethyl hexanoate, ethyl benzoate, benzaldehyde, and acetophenone
Odorant receptor 22c Or22c CG15377 hexanol, pentyl acetate, benzyl acetate, and 2-heptanone
Odorant receptor 74a Or74a CG13726 octanol, anisole, and 2-heptanone
Odorant receptor 35a Or35a CG17868 butanol, pentanol, hexanol, octanol, propyl acetate, butyl acetate, esters
Odorant receptor 13a Or13a CG12697 octanol, nonanol, and pentyl acetate
Odorant receptor 47a Or47a CG13225 pentyl acetate
Odorant receptor 98b Or98b CG1867 ethyl benzoate 
Odorant receptor 9a Or9a CG15302 2-pentanol 
Odorant receptor 82a Or82a CG31519 geranyl acetate 
Odorant receptor 45a Or45a CG1978 hexanol, pentyl acetate, benzyl acetate, and 2-heptanone
Odorant receptor 1a Or1a CG17885 butanal, heptanal, and 2-heptanone
Odorant receptor 63a Or63a CG9969 butyl acetate, isoamyl acetate, and hexanoic acid
Odorant receptor 67b Or67b CG14176 ethyl acetate, pentyl acetate, methyl caproate, and many others
Oderant receptor 85e Or85e CG9700 ethyl acetate, cyclohexanone, fenchone
Odorant receptor 83a Or83a CG10612 pentanol, ethyl acetate, and propyl acetate
Odorant receptor 30a Or30a CG13106  propyl acetate and anisole
Odorant receptor 49b Or49b CG17584 2-mthylphenol 
Odorant receptor 43a Or43a CG1854 acetophenone, benzaldehyde, benzyl alcohol, hexanol, cyclohexanone, and others
Odorant receptor 56a Or56a CG12501 geosmin
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Supplemental Table 3: Gustatory receptor family and information 
 
  
Name Symbol CG G-alpha/Output ligand Assay
Gustatory receptor 36b Gr36b CG31744
Gustatory receptor 36a Gr36a CG31747
Gustatory receptor 36c Gr36c CG31748
Gustatory receptor 59d Gr59d CG30330
Gustatory receptor 59c Gr59c CG30186
Gustatory receptor 10a Gr10a CG32664
Gustatory receptor 59b Gr59b CG30191
Gustatory receptor 59a Gr59a CG30189
Gustatory receptor 47a Gr47a CG12906
Gustatory receptor 58c Gr58c CG13491
Gustatory receptor 85a Gr85a CG31405
Gustatory receptor 58b Gr58b CG13495
Gustatory receptor 58a Gr58a CG30396
Gustatory receptor 22c Gr22c CG31929
Gustatory receptor 22b Gr22b CG31931 bitter
Gustatory receptor 22f Gr22f CG31932
Gustatory receptor 22e Gr22e CG31936
Gustatory receptor 22d Gr22d CG31930
Gustatory receptor 22a Gr22a CG31662
Gustatory receptor 77a Gr77a CG32433
Gustatory receptor 10b Gr10b CG12622
Gustatory receptor 93c Gr93c CG31173
Gustatory receptor 93b Gr93b CG31336
Gustatory receptor 92a Gr92a CG31208
Gustatory receptor 93d Gr93d CG31335
Gustatory receptor 93a Gr93a CG13417 bitter, caffiene
Gustatory receptor 97a Gr97a CG33083
Gustatory receptor 94a Gr94a CG31280
Gustatory receptor 64d Gr64d CG14987 sweet taste
Gustatory receptor 64c Gr64c CG32256 sweet taste
Gustatory receptor 64b Gr64b CG32257 sweet taste
Gustatory receptor 61a Gr61a CG13888 glucose
Gustatory receptor 64a Gr64a CG32261 maltose, sucrose
Gustatory receptor 5a Gr5a CG15779 Gαs (Ueno 2006) trehalose genetics
Gustatory receptor 64f Gr64f CG32255 sucrose, maltose, and glucose
Gustatory receptor 64e Gr64e CG32258 sweet taste
Gustatory receptor 63a Gr63a CG14979 Gαq (Yao 2010) CO2 in vivo recordings
Gustatory receptor 21a Gr21a CG13948 Gαq (Yao 2010) CO2 in vivo recordings
Gustatory receptor 8a Gr8a CG15371  L-canavanine
Gustatory receptor 9a Gr9a CG32693
Gustatory receptor 89a Gr89a CG14901 bitter
Gustatory receptor 98a Gr98a CG13976
Gustatory receptor 98d Gr98d CG31061
Gustatory receptor 98c Gr98c CG31060
Gustatory receptor 98b Gr98b CG31059
Gustatory receptor 28a Gr28a CG13787
Gustatory receptor 28b Gr28b CG13788 ↑ Ca2+  (Xiang 2010) larval reporter
Gustatory receptor 33a Gr33a CG17213 pheromone, DEET
Gustatory receptor 66a Gr66a CG7189 pheromone, DEET, L-canavanine, caffeine 
Gustatory receptor 43a Gr43a CG1712 ↑ Ca2+  (Miyamoto 2012) fructose In vivo calcium imaging
Gustatory receptor 59e Gr59e CG33151
Gustatory receptor 59f Gr59f CG33150
Gustatory receptor 57a Gr57a CG13441
Gustatory receptor 47b Gr47b CG30030
Gustatory receptor 68a Gr68a CG7303 mating pheromone
Gustatory receptor 32a Gr32a CG14916 mating pheromone, bitter
Gustatory receptor 2a Gr2a CG18531
Gustatory receptor 39a Gr39a CG31622 mating pheromone, bitter
Gustatory receptor 39b Gr39b CG31620








Figure S1: EMSAs of additional CrebA binding sites.  For each SPCG, the enhancer region is 
presented with orange circles representing predicted CrebA binding sites.  Green circles indicate 
gel shifts shown in Fig. 1.  In each case, site 1 is to the left.  Lanes are numbered from 1-10, or 1-
11, and the key is listed at the bottom of the page. CrebA binds to each site and is competed 
away by unlabeled oligonucleotides that correspond to the same sequence, in a majority of 
examples.  When the binding sequence is mutated (red) in the unlabled oligos, they are no 











Supplemental Table 1:  List of genes regulated by CrebA and associated human orthologues 
Table S1  
CrebA targets - GO Human Homolog Fold change 
   
Ion Channels/transporters/binding proteins   
CG34123 - TRPA1-like channel/thermotaxis TRPM3 -1.50 
CG5427 (Oatp33Ea) - Organic anion transporter  -1.54 
CG9467 - voltage gated potassium channel  KCTD3 -1.59 
CG6356 - organic cation transporter  -1.62 
CG7571 (Oatp74D) - Organic anion transporter  -1.66 




CG10620 (Tsf2) - iron ion transmembrane transporter 
activity MFI2 -1.82 
CG9261 (nrv2) - sodium:potassium-exchanging 
ATPase activity  -1.90 
CG6672 - zinc ion transmembrane transporter activity SLC30A7 -2.07 
CG2177 - metal ion transmembrane transporter 
activity SLC39A9 -2.23 
CG15094 - high affinity inorganic phosphate:sodium 
symporter activity  -3.28 
CG18039 (KaiRIA) - ionotropic glutamate receptor 
activity  -3.44 
CG32373 - EGF-like Ca+2 ion binding  -1.51 
CG30104- hydrolase activity, acting on ester bonds  -1.67 
CG17271 - calcium ion binding  -2.55 
   
Transporters   
CG31103 - sugar transporter  -1.57 
CG14621 - glucose 6-phosphate:phosphate antiporter  SLC35E1 -1.65 
CG9706 - acetyl-CoA transporter activity SLC33A1 -1.68 
CG4484 - sucrose:hydrogen symporter activity SLC45A1 -1.69 
CG13795 - neurotransmitter transporter activity  -1.93 
CG15438 - sodium-dependent phosphate 
transmembrane transporter activity SLC17A9 -2.10 
CG8249 - glucose transmembrane transporter activity  -2.14 
CG3424 (path) - amino acid transmembrane 
transporter activity  -3.02 
CG2675 (Csat) - UDP-galactose transmembrane 
transporter activity SLC35A2 -3.53 
CG8100 - oxygen transporter activity  -6.53 
   
Cell death/apoptosis   
CG18593 (viaf) - regulation of caspase activity PDCL3 -1.54 
CG32491 (mod(mdg4)) - BTB domain, chromatin 
assembly, regulation of apoptosis  -1.56 
CG12297 (BG4) - death receptor binding  -1.79 
CG5123 (W) - anatomical structure development; 
programmed cell death  -2.00 
CG1274 (Jafrac2) - peroxidase activity, induction of 
apoptosis PRDX4 -2.47 
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Nucleic acid binding (DNA and RNA)   
CG11033 - similar to vertebrate jumonji, zinc ion 
binding  -1.51 
CG11494 (BtbVII) - BTB domain  -1.51 
CG10053 - nucleic acid binding CCDC75 -1.51 
CG8631 (msl-3) - chromatin/mRNA binding, 
transcriptional regulator MSL3 -1.85 
CG8205 (fus) - mRNA/nuclei acid binding, EGFR 
signaling ESRP1 -1.52 
CG5147 - DNA binding, RNA polymerase III POLR3D -1.56 
CG12863 - DNA binding, zinc-finger domain ZCCHC4 -1.58 
CG8730 (Drosha) - RNA polymerase III, miRNA 
processing RNASEN -1.60 
CG15552 (Sox100B) - DNA bending, transcription 
factor activity SOX8 -1.60 
CG8676 (Hr39) - hormone receptor, transcription 
factor  -1.61 
CG3019 (su(w[a])) - mRNA splicing, RNA processing SFRS8 -1.61 
CG12952 (sage) - transcription factor ATOH8 -1.96 
CG31365 - DNA binding, zinc finger domain  -1.63 
CG4360 - dna binding, zinc finger domain  -1.64 
CG2244 (MTA1-like) - DNA binding, Zinc finger, 
transcription factor MTA1 -1.64 
CG8920 - contains Tudor domain often found in RNA-
binding proteins TDRD7 -1.94 
CG6203 (Fmr1) - mRNA binding FXR2 and FXR1 -1.70 
CG6634 (mid) - transcription factor  -1.72 
CG5460 (H) - transcriptional co-repressor  -1.72 
CG1650 (unpg) - transcription factor activity GBX2 -1.74 
CG1070 (Alh) - transcription factor activity MLLT10 -1.80 
CG12245 (gcm) - DNA binding; transcription factor 
activity GCM1 -1.86 
CG3886 (Psc) - DNA binding  -1.86 
CG30291 (grau) - specific RNA polymerase II 
transcription factor activity  -1.87 
CG1856 (ttk) - specific RNA polymerase II 
transcription factor activity  -1.92 
CG7008 (Tudor-SN) - transcription coactivator 
activity SND1 -1.93 
CG11680 (mle) - ATP-dependent helicase activity DHX9 -2.05 
CG4717 (kni) - ligand-dependent nuclear receptor 
activity; transcription factor activity  -2.18 
CG8089 - zinc ion binding; nucleic acid binding  -2.20 
CG12296 (klu) - nucleic acid binding; zinc ion binding  -2.51 
CG1414 (bbx) - DNA binding; transcription factor 
activity BBX -2.54 
CG11205 (phr) - deoxyribodipyrimidine photo-lyase 
activity  -2.75 
CG10352 (Rat1) - 5'-3' exoribonuclease activity  -2.81 
CG17077 (pnt) - transcription factor activity ETS1 -4.50 
CG9989 - nucleic acid binding; metal ion binding  -5.21 





   
RNA processing   
CG8038 - RNA binding, rRNA/tRNA processing, mRNA 
cleavage POP4 -1.51 
CG9735 (Aats-trp) - tryptophan-tRNA ligase WARS -1.62 
CG32281 - tRNA methyltransferase activity TRMT5 -1.95 
CG5394 (Aats-glupro) - glutamate-tRNA ligase activity EPRS -1.78 
   
Unknown   
CG6559  -1.51 
CG8230 - contains Dymeclin domain  DYM (Dymeclin) -1.52 
CG13936  -1.52 
CG33052 (Rat) GORAB_RAT -1.53 
CG9669 C11orf10 -1.55 
CG11314 - mesoderm development, similar to 
Neimann Pick Type C protein  -1.55 
CG8997  -1.55 
CG8780 (tey) - involved in muscle development  -1.56 
CG7161 (Oseg1) - sensory cilium assembly IFT122 -1.58 
CG34331  -1.59 
CG42336  -1.60 
CG11395  -1.60 
CG42259  -1.61 
CG5174 TPD52L2 -2.11 
CG5850 TMEM184C -1.61 
CG14905 CCDC63 -1.62 
CG34276  -1.62 
CG6325 DCAF15 -1.62 
CG31606  -1.63 
CG14646 TMEM129 -1.64 
CG14629  -1.65 
CG5768  -2.38 
CG13857  -1.66 
CG13565  -1.66 
CG9257 MLEC (Malectin) -1.68 
CG7510 - contains Plekstrin domain, cell signaling GPR155 -1.68 
CG12063 - likely involved in carbohydrate binding  -1.68 
CG5021 FAM18A -1.68 
CG10616 C1orf27 -1.69 
CG33169  -1.84 
CG32243  -1.72 
CG3767 (Jhl-26)  -1.73 
CG6785  -1.74 
CG6983  -1.75 
CG13614  -1.79 
CG9196 (Spz6) - related to Spatzle  -1.81 
CG5862 DDRGK1 -1.81 
CG8613 - catalytic activity SPATA20 -1.81 
CG13082  -1.82 
CG1104  KIAA0776 -1.82 
CG11018  -1.83 
CG14454  -2.53 
CG8717 (slv) - likely transmembrane RAG1AP1 -1.83 
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CG8331 REEP5 -1.84 
CG10591  -1.84 
CG5484 YIF1B -1.86 
CG9945 WDR23 -1.87 
CG14265  -1.87 
CG7802  -1.89 
CG14400  -1.89 
CG33003  -1.89 
CG10157  -1.89 
CG2812  -1.90 
CG13394  -1.93 
CG14110  -1.93 
CG1077  -1.95 
CG15905  -1.99 
CG11905  -2.67 
CG33272 - is located in the glue gene cluster at 68C  -2.02 
CG12384   -2.09 
CG5039  -2.09 
CG4844  -2.12 
CG12011  -2.12 
CG14720  -2.13 
CG7300  -2.15 
CG9186 C2orf43 -2.17 
CG7011 ERGIC3 -2.18 
CG34224  -2.18 
CG4293 ERGIC2 -2.18 
CG13362  -2.20 
CG13822  -2.23 
CG15024  -2.32 
CG7137 RRP8 -2.32 
CG8145  -2.33 
CG34035  -2.36 
CG18661 C16orf13 -2.43 
CG30272  -2.50 
CG5476 (TwdlN)  -2.51 
CG6478 (TwdlB)  -2.77 
CG6447 (TwdlL)  -2.77 
CG7567  -2.99 
CG32039 SVIP -3.13 
CG14756   -3.23 
CG18343  -3.73 
CG10717 (ImpL1) - Ecdysone-inducible factor 1  -4.14 
CG32368  -5.46 
CG7936 (mex1) - midgut expression  -14.33 
   
Other   
CG9704 (Nrt) - axon guidance, axonogenesis  -1.76 
CG32282 (dro4) - defense response to fungus  -1.51 
   
Intracellular proteolysis   
CG6726 - metallopeptidase  -1.59 
CG10576 - aminopeptidase PA2G4 -1.65 
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CG7649 (Neu3) - metalloendopeptidase activity  -1.81 
CG42335 - aminopeptidase activity; metallopeptidase 
activity  -4.29 
CG6372 - aminopeptidase activity; 
metalloexopeptidase activity  -6.93 
   
Extracellular proteolysis   
CG3344 - serine type carboxypeptidase SCPEP1 -1.51 
CG10992 - cysteine endopeptidase CTSB -1.57 
CG13744 - serine endopeptidase   -1.60 
CG17633 - metallocarboxypeptidase activity  -1.68 
CG8539 - metallocarboxypeptidase activity; zinc ion 
binding  -1.83 
CG9460 - serine-type endopeptidase inhibitor  -1.88 
CG32483 - serine-type carboxypeptidase activity  -2.20 
CG8579 (Jon44E) - serine-type endopeptidase activity  -4.65 
   
Cell cycle   
CG8598 (eco) - N-acetyltransferase ESCO2 -1.51 
CG10800 (Rca1) - regulation of mitosis  -1.52 
CG1395 (Stg) - protein tyrosine phosphatase CDC25B/C -1.69 
CG8857 (RpS11) - ribosomal subunit RPS11P5 -1.71 
CG32417 (Myt1) - protein serine/threonine/tyrosine 
kinase activity PKMYT1 -1.77 
CG30291 - regulation of cyclin-dependent kinase 
activity CDK5RAP3 -1.87 
CG17064 (mars) - regulation of mitotic cell cycle  -1.90 
CG12740 (RpL28) - structural constituent of ribosome RPL28 -3.58 
   
Protein Binding   
CG3408 - containe leucine-rich repeat LRRC59 -1.56 
CG31274 - contains leucine-rich repeat  -1.59 
CG31447 (MESK4) - contains leucine-rich repeat  -1.59 
CG14351 - contains leucine-rich repeat  -1.58 
CG5692 (raps) - GTPase activator involved in cell 
division GPSM2 -1.65 
CG32356 (ImpE1) - contains LDLR domain  -2.14 
CG30023 (Sprt) - contains PDZ domain  -1.69 
CG4195 (l(3)73Ah) - zinc ion binding PCGF3 -1.71 
CG2198 (Ama) - cell adhesion, antigen binding LSAMP and NEGR1 -1.76 
CG13125 - protein phosphatase type 1 regulator 
activity LRRC48 -1.77 
CG10420 - contains Armadillo-helical domain SIL1 -1.87 
CG11714 - contains BTB domain  -1.95 
CG1418 - Rab GTPase binding RABAC1 -2.51 
CG1410 (waw) - GTPase activity GUF1 -2.54 
CG30483 (Prosap) - protein binding SHANK1 -2.90 
CG16757 (Spn) - protein phosphatase 1 binding PPP1R9B -3.01 
CG33983 (obst-H) - chitin binding  -4.93 
   
Cytoskeleton   
CG11242 - contains cytoskeleton associated CAP-Gly 
domain TBCB -1.52 
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CG8261 (Ggamma1) - actin organization GNG12 -1.52 
CG13913 (mwh) - actin binding  -1.73 
CG32149 (RhoGAP71E) - signal transduction  -2.16 
   
Ubiquitin/proteasome   
CG11887 (StIP) - proteasome assembly/activator ELP2 -1.52 
   
Mitochondria/Peroxisome   
CG10622 (Sucb) - succinate CoA ligase, tricarboxylic 
acid cycle SUCLG2 -1.53 
CG32174 - contains Coenzyme Q 4 domain  COQ4 -1.53 
CG6439 - isocitrate dehydrogenase (NAD+) activity IDH3B -1.65 
CG9961 - phosphoglycerate kinase activity, glycolysis  -1.78 
CG5904 (mRpS31) - mitochondrial ribosomal protein MRPS31 -1.84 
CG13827 - peroxisome fission PEX11G -1.84 
   
Receptors/Signal transduction   
CG18859 (Or19a) - olfactory receptor, odorant 
binding  -1.56 
CG32825 (Or19b) - olfactory receptor, odorant 
binding, G-protein signaling  -1.56 
CG4626 (Fz4) - frizzled 4 receptor  -1.58 
CG8967 (Otk) - cell adhesion molecule binding PTK7 -1.71 
CG17592 (LBR) - lamin B receptor USF2 -1.85 
CG5912 (arr) - Wnt receptor signaling pathway LRP6 -1.90 
CG6127 (Ser) - epidermal growth factor receptor 
binding JAG2 -2.03 
CG34449 - receptor activity ZDHHC8 -2.58 
CG6965 (mthl5) - G-protein coupled receptor activity  -2.15 
CG32475 (mthl8) - G-protein coupled receptor protein 
signaling pathway  -2.84 
CG6104 (m2) - Notch signaling pathway  -1.68 
CG8337 (malpha) - Notch signaling pathway  -1.91 
   
Metabolism   
CG11899 - O-phospho-L-serine:2-oxoglutarate 
aminotransferase  PSAT1 -1.59 
CG6673 - glutathione transferase activity  -1.60 
CG5171 - trehalose phosphatase activity  -1.60 
CG17560 - catalytic activity, male sterility  -1.61 
CG6870 - electron carrier, heme binding  -1.63 
CG18559 (Cyp309a2) - electron carrier, heme binding, 
monooxygenase activity  -1.63 
CG8036 - transketolase activity TKT -1.65 
CG7685 - alpha glucosidase activity, contains LDLR 
domain  -1.67 
CG7623 (sll) - UDP-galactose transmembrane 
transporter activity SLC35B2 -1.67 
CG3534 - xylulokinase activity/carbohydrate 
metabolism XYLB -1.51 
CG17026 - Inositol-monophosphate activity  -1.72 
CG17562 - catalytic activity, male sterility  -1.72 
CG6578 (Phm) - ecdysteroid 25-hydroxylase activity  -1.73 
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CG10621 - selenocysteine methyltransferase activity  -1.73 
CG1041 - carnitine O-acetyltransferase activity CRAT -1.73 
CG10361 - glycine C-acetyltransferase activity GCAT -1.74 
CG9523 - protein adenylyltransferase activity FICD -1.78 
CG14670 (Hcs) - biotin-[acetyl-CoA-carboxylase] 
ligase activity HLCS -1.81 
CG8652 (Ugt37c1) - glucuronosyltransferase activity  -1.86 
CG10924 - phosphoenolpyruvate carboxykinase (GTP) 
activity  -1.88 
CG11052 - acylphosphatase activity  -1.89 
CG1969 - glucosamine 6-phosphate N-
acetyltransferase activity GNPNAT1 -2.04 
CG33503 (Cyp12d1-d) - electron carrier activity  -1.95 
CG5946 - cytochrome-b5 reductase activity CYB5R3 -1.95 
CG6128 (Fuca) - alpha-L-fucosidase activity FUCA2 -1.96 
CG10512 - oxidoreductase activity  -1.97 
CG10467 - aldose 1-epimerase activity; carbohydrate 
binding GALM -2.00 
CG33093 - oxidoreductase activity  -2.00 
CG10391 (Cyp310a1) - electron carrier activity; heme 
binding  -2.12 
CG2062 (Cyp4e1) - electron carrier activity  -2.15 
CG5656 - alkaline phosphatase activity ALPL -2.17 
CG18585 - metallocarboxypeptidase activity CPA1 and CPA2 -2.27 
CG4899 (Pdh) - alcohol dehydrogenase (NAD) activity HPGD  
CG10116 - lipoprotein lipase activity, lipid metabolic 
process  -2.48 
CG9449 - acid phosphatase, phagocytosis, engulfment  -2.81 
CG16799 - lysozyme activity, defense response; 
antimicrobial humoral response  -2.65 
CG15362 - catalytic activity  -2.76 
CG31809 - steroid dehydrogenase activity  -2.95 
CG12242 (GstD5) - glutathione -S- transferase  -3.07 
CG15743 - 3'(2'),5'-bisphosphate nucleotidase activity IMPAD1 -3.14 
CG1749 - Mo-molybdopterin cofactor sulfurase 
activity UBA5 -3.44 
CG31313 - cysteine-type endopeptidase inhibitor 
activity  -4.00 
CG18088 - catalytic activity, metabolic process  -6.72 
CG2759 (w) - biogenic amine biosynthetic process  -3.80 
   
Secretory pathway   
ER-Golgi trafficking/transport   
CG8605 -  RINT1/TIP1 domain  RINT1 -1.51 
CG7966 - may function as selenium binding protein 
which is thought to function in the late stages of Golgi 
transport SELENBP1 -1.54 
CG32654 (Sec16) - protein exit from ER SEC16A -1.54 
CG12404 -  Yip1 domain YIPF5 -1.56 
CG4645 - Yip1 domain  YIPF1 -1.60 
CG4848 - Vps51/Vps67 domin  COG1 -1.60 
CG3652 - Yip1 domain  YIPF6 -1.64 
CG5183 (KdelR) - KDEL receptor  KDELR1 -1.68 
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CG31040 (Cog7) - conserved oligomeric Golgi complex COG7 -1.71 
CG1528 (gammaCop) - retrograde vesicle-mediated 
transport COPG -1.74 
CG6223 (betaCop) - retrograde vesicle-mediated 
transport COPB1 -1.89 
CG6699 (beta'Cop) - ER to Golgi vesicle-mediated 
transport COPB2 -1.90 
CG7961 (alphaCop) - retrograde vesicle-mediated 
transport COPA -2.11 
CG2023 -  Sec20 domain BNIP1 -2.31 
   
Endocytosis/membrane formation   
CG1049 (Cct) - choline phosphate cytidyltransferase 
activity PCYT1A -1.53 
   
Golgi modification enzymes/proteins   
CG3874 (frc) - sugar transmembrane transporter  SLC35D1 -1.53 
CG12030 - UDP-glucose-4 epimerase activity GALE -1.57 
CG32775 (GlcAT-I) - glucuronosyltransferase activity B3GAT3  
CG31002 - glucuronosyltransferase activity  -1.64 
CG9614 (pip) - heparan sulfate 2-O-sulfotransferase 
activity  -4.16 
CG12311 (tw) - dolichyl-phosphate-mannose-protein 
mannosyltransferase activity POMT2 -1.76 
CG10166 - dolichyl-phosphate beta-D-
mannosyltransferase activity, protein amino acid 
glycosylation DPM1 -1.77 
CG6822 (ergic53) - mannose binding  -2.46 
CG2103 (pgant6) - polypeptide N-
acetylgalactosaminyltransferase  GALNT10 -2.09 
   
Possible cargo   
CG8050 (Cys) - Cystatin, protease inhibitor   -1.53 
CG5634 (dsd) - contains EGF-like 3 domain found in 
proteins known to be secreted  -1.60 
CG13744 - serine endopeptidase - these enzymes are 
secreted  -1.60 
CG32400 (Lcp65Ab1) - structural constituent of 
chitin-based larval cuticle  -1.66 
CG32400 (Lcp65Ab2) - structural constituent of 
chitin-based larval cuticle  -1.66 
CG1567 (C901) - contains EGF-like 3 domain  DLK2 -1.67 
CG2560 (Cpr11A) - structural constituent of chitin-
based larval cuticle  -1.69 
CG14089 - contains collagen triple helix repeat   -1.71 
CG4914 - serine endopeptidase - these enzymes are 
secreted  -1.71 
CG5276 - member of Apyrase family of proteins  -1.76 
CG2044 (Lcp4) - structural constituent of chitin-based 
larval cuticle  -1.83 
CG9307 (Cht5) - chitinase activity  -1.85 
CG9355 (dy) - structural constituent of chitin-based 
cuticle  -2.01 
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CG17044 (yellow-e2) - member of Major Royal Jelly 
family.    -2.10 
CG2043 (Lcp3) - structural constituent of chitin-based 
larval cuticle  -2.37 
CG18348 (Cpr67Fb) - structural constituent of chitin-
based cuticle  -2.38 
CG9120 (LysX) - lysozyme activity  -2.65 
CG7941 (Cpr67Fa1) - structural constituent of chitin-
based larval cuticle  -2.98 
CG34270 (Cpr65Ax1) - structural constituent of 
chitin-based cuticle  -3.04 
CG18777 (Cpr65Ax2) - structural constituent of 
chitin-based cuticle  -3.04 
CG7663 (Cpr78Cb) - structural constituent of chitin-
based cuticle  -3.38 
CG33117 (Victoria) - member of Drosophila species 
specific Turandot humoral factor  -3.70 
CG9070 (Cpr47Eg) - structural constituent of chitin-
based cuticle  -4.43 
CG10533 (Lcp65Af) - structural constituent of chitin-
based larval cuticle  -4.44 
CG18349 (Cpr67Fa2) - structural constituent of chitin-
based cuticle  -1.82 
CG6912 - contains growth factor receptor domain, 
mucin like (runs of T)  -2.16 
CG14850 - mucin like (30.2% TS)  -2.20 
CG32453 - mucin-like (39.6% TS)  -2.53 
CG12546 - mucin (short 43.4% TS)  -2.58 
CG14452 - mucin (short 44.3% TS)  -2.58 
CG32073 - mucin (short 41.2% TS)  -3.19 
CG13738 - mucin (short 31.1% TS)  -4.28 
CG5402 - mucin (short 31.4% TS)  -4.37 
CG14453 - mucin (short 40.9% TS)  -4.58 
   
ER proteins   
CG9726 (PH4alphaMP) - procollagen proline-4 
dioxygenase activity  -1.54 
CG15818 - contains C-type lectin domain  -1.52 
CG31014 (PH4alphaSG1) - procollagen proline-4 
dioxygenase activity  -1.54 
CG16905 (eloF) - fatty acid elongase of the 
GNS1/SUR4 family  -1.58 
CG5417 (Srp14) - signal recognition particle SRP14 -1.59 
CG4758 (Trp1) - SRP-dependent cotranslational 
protein targeting SEC62 -1.63 
CG7748 (OstStt3) - oligosaccharyl transferase activity STT3B -1.72 
CG7556 - unfolded protein binding DNAJC1 -1.74 
CG9911 - protein disulfide isomerase activity ERP44 -1.75 
CG2469 - contains tetratricopeptide motif  CTR9 -1.76 
CG9539 (Sec61alpha) - protein transporter activity SEC61A2 -1.78 
CG5434 (Srp72) - SRP-dependent cotranslational 
protein targeting  SRP72 -1.81 




CG9459 - contains GNS1/Sur4 domain   -1.85 
CG5520 (Gp93) - unfolded protein binding HSP90B1 -1.87 
CG8860 - protein transporter activity SEC61G -1.88 
CG2522 (Gtp-bp) - signal recognition particle binding SRPR -1.88 
CG4457 (Srp19) - SRP-dependent cotranslational 
protein targeting  SRP19 -1.89 
CG5474 (SsRbeta) - protein retention in ER lumen SSR2 -1.97 
CG10130 (Sec61beta) - SRP-dependent 
cotranslational protein targeting  SEC61B -1.99 
CG8268 (Srp9) - SRP-dependent cotranslational 
protein targeting  SRP9 and SRP9L1 -1.99 
CG5885 - cotranslational protein targeting to 
membrane SSR3 -2.02 
CG8583 (sec63) - signal recognition particle binding SEC63 -2.03 
CG5064 (Srp68) - SRP-dependent cotranslational 
protein targeting  SRP68 -2.04 
CG8420 - contains ER targeting motif GRLF1 -2.05 
CG9342 (Mtp) - phosphatidylcholine transmembrane 
transporter  MTTP -2.06 
CG32276 - protein modification process SERP1 -2.07 
CG14214 (Sec61gamma) - SRP-dependent 
cotranslational protein targeting  -2.08 
CG9035 (Tapdelta) - protein retention in ER lumen SSR4 -2.12 
CG18431 - contains C-type lectin domain  -2.12 
CG1751 (Spase25) peptidase activity, signal peptide 
processing SPCS2 -2.19 
CG9302 - protein disulfide isomerase activity PDIA5 -2.24 
CG2358 (Spase18-21) - signal peptide processing SEC11B and SEC11C -2.30 
CG3810 (Edem1) - ER-associated protein catabolic 
process EDEM2 -2.42 
CG11840 (Spp) - membrane protein proteolysis HM13 -2.50 
CG11500 (Spase12) - signal peptide processing SPCS1 -2.55 
CG9698 - procollagen-proline 4-dioxygenase activity  -2.83 
CG12918 - contains ER targeting motif CNPY2 -2.87 
CG14105 - contains tetratricopeptide motif  TTC36 -3.25 
CG33162 (SrpRbeta) - SRP-dependent cotranslational 
protein targeting to membrane SRPRB -3.31 
CG11642 (TRAM) - SRP-dependent cotranslational 
protein targeting  TRAM1 -5.22 
CG7945 - unfolded protein binding BAG2 -7.05 
   
Vesicle/vesicle transport   
CG5359 - contains Tctex-1 domain  TCTEX1D2 -1.54 
CG13626 (Syx18) - SNAP receptor STX18 -1.55 
CG5341 (Sec6) - exocytosis EXOC3 -1.65 
CG33523 - structural molecule activity MOSPD2 -1.78 
CG8266 (Sec31) - component of COP II vesicle SEC31A -1.82 
CG33105 (p24-2) - vesicle transport  -1.90 
CG3948 (zetaCop) - intracellular protein transport COPZ1 -2.69 
CG3564 (CHOp24) - transport TMED2 -2.21 
CG11785 (bai) - vesicle-mediated transport TMED10 -2.24 
CG33104 (eca) - transport TMED4 -2.25 
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CG6773 (Sec13) - larval chitin-based cuticle 
development SEC13 -2.44 
CG10733 (loj) - transport, member of p24 family  -2.51 
   
Golgi morphology   
CG6838 - ARF GTPase activator ARFGAP3 -1.58 
CG4237 (Gap69C) - ARF GTPase activator activity ARFGAP1 -1.95 
CG7809 (Grasp65) - Golgi organization GORASP2 -2.38 
CG11061 (GM130) - Golgi organization GOLGA2 -2.40 
   





Supplemental Table 2:  Clustering analysis of gene ontology terms for CrebA target genes 
Gene Ontology term Fold Enrichment P-value 
Annotation Cluster 1 Enrichment Score: 15.12 
Cotranslational protein targeting to membrane 31 3.1E-19 
Protein targeting to membrane 28 3.0E-18 
Protein targeting to ER 30.5 9.6E-18 
SRP-dependent cotranslational protein targeting to 
membrane 
30.5 9.6E-18 
Protein targeting 3.9 3.1E-6 
Annotation Cluster 2 Enrichment Score: 10.63 
Endoplasmic reticulum membrane 11.5 1.6E-11 
Nuclear envelope – endoplasmic reticulum network 11.2 2.1E-11 
Endoplasmic reticulum part 9.7 4.0E-11 
Annotation Cluster 3 Enrichment Score: 8.17 
Secretory pathway 4.4 4.8E-9 
Secretion by cell 4.3 5.2E-9 
secretion 4.1 1.2E-8 
Annotation Cluster 4 Enrichment Score: 6.35 
Protein localization 3 3.5E-9 
Protein transport 3.1 3.6E-8 
Establishment of protein localization 3 4.7E-8 
Macromolecule localization 2.7 6.9E-8 
Intracellular protein transport 3.2 7.2E-8 
Cellular localization 2.1 2.0E-5 
Intracellular transport 2.2 3.9E-5 
Establishment of cellular localization 2.1 7.4E-5 
Annotation Cluster 5 Enrichment Score: 4.23 
Intracellular protein transport across a membrane 32.7 5.8E-6 
SRP-dependent cotranslational protein targeting to 
membrane, translocation 
32.7 5.8E-6 
translocation 10.7 5.9E-3 
Annotation Cluster 6 Enrichment Score: 3.78 
COPI coated vesicle membrane 25 1.4E-6 
COPI vesicle coat 25 1.4E-6 
COPI-coated vesicle 22.5 2.8E-6 
Vesicle coat 8.3 6.3E-4 
Coated vesicle membrane 8 7.5E-4 
Cytoplasmic vesicle membrane 8 7.5E-4 
Coated membrane 7.5 1.0E-3 
Membrane coat 7.5 1.0E-3 
Cytoplasmic vesicle part 6.4 2.1E-3 
Vesicle membrane 5.9 3.1E-3 
Annotation Cluster 7 Enrichment Score: 3.58 
Structural constituent of chitin-based cuticle 4.4 8.4E-5 
Structural constituent of cuticle 3.7 3.9E-4 
Insect cuticle protein 4.2 5.6E-4 
Annotation Cluster 8 Enrichment Score: 3.14 
Golgi-associated vesicle 10.9 9.9E-7 
Cytoplasmic membrane-bound vesicle 3.4 2.3E-3 
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Cytoplasmic vesicle 3.4 2.5E-3 
Coated vesicle 3.7 2.6E-3 
Membrane-bound vesicle 3.3 3.0E-3 






Supplemental Table 3.  List of genes upregulated by Creb3L1 T expression in HeLa cells. 
Table 









OE vs. Wild type) 
Linear FC (Creb3L1 




62   MX1  
 myxovirus (influenza virus) 




63   MX2  
 myxovirus (influenza virus) 








 cAMP responsive element 




35   OAS2  
 2'-5'-oligoadenylate synthetase 








30080   IFI27  
 interferon, alpha-inducible 




38   IFI6  
 interferon, alpha-inducible 








58   PARP9  
 poly (ADP-ribose) polymerase 







 sterile alpha motif domain 




87   OAS3  
 2'-5'-oligoadenylate synthetase 




16   OAS1  
 2',5'-oligoadenylate synthetase 




20   IFI44L  
 interferon-induced protein 44-












14   DDX58  
 DEAD (Asp-Glu-Ala-Asp) box 




68   IFIH1  
 interferon induced with helicase 








54   SAMD9  
 sterile alpha motif domain 




31683   IFIT3  
 interferon-induced protein with 




48   IFIT1  
 interferon-induced protein with 















 DEAD (Asp-Glu-Ala-Asp) box 




02   CTH  
 cystathionase (cystathionine 




31   DDX60  
 DEAD (Asp-Glu-Ala-Asp) box 








15   STAT1  
 signal transducer and activator 























 similar to Ig kappa chain V-I 







 KDEL (Lys-Asp-Glu-Leu) 
endoplasmic reticulum protein 








41   IFITM1  
 interferon induced 




54   PARP14  
 poly (ADP-ribose) polymerase 




83   WIPI1  
 WD repeat domain, 








47   IFIT2  
 interferon-induced protein with 




33   OASL  
 2'-5'-oligoadenylate synthetase-




35   UBA7  
 ubiquitin-like modifier activating 





















 eukaryotic translation initiation 












53   GBP1  
 guanylate binding protein 1, 




05   PLSCR1   phospholipid scramblase 1  0.0135583 3.04726 
79197




50   RCN3  
 reticulocalbin 3, EF-hand 








19   DHX58  
 DEXH (Asp-Glu-X-His) box 




70   PAPSS2  
 3'-phosphoadenosine 5'-








50   PARP12  
 poly (ADP-ribose) polymerase 





























 aldehyde dehydrogenase 1 












20   IFIT5  
 interferon-induced protein with 















72   SLC1A3  
 solute carrier family 1 (glial high 
















19   STAT2  
 signal transducer and activator 







 platelet-derived growth factor 








54   CYR61  
 cysteine-rich, angiogenic 



















 chromosome 1 open reading 








 chromosome 19 open reading 












 zinc finger CCCH-type, antiviral 








00   PSMB9  
 proteasome (prosome, 
macropain) subunit, beta type, 9 




00   PSMB9  
 proteasome (prosome, 
macropain) subunit, beta type, 9 




00   PSMB9  
 proteasome (prosome, 
macropain) subunit, beta type, 9 




31   IFI16  
 interferon, gamma-inducible 




35   ZNFX1  
 zinc finger, NFX1-type 














 chromosome 14 open reading 




42   PPM1K  
 protein phosphatase 1K (PP2C 
domain containing)  0.00916232 2.19234 
80346




87   IFT20  
 intraflagellar transport 20 








 POM121 membrane 
glycoprotein-like 8 (rat) 























 family with sequence similarity 
















65   EHD4   EH-domain containing 4  0.00249192 2.06938 
81016








 retinoic acid receptor responder 











 SEC24 family, member D (S. 




02   FABP3  
 fatty acid binding protein 3, 









 similar to Putative POM121-like 




08397   GPX8  
 glutathione peroxidase 8 







 butyrophilin, subfamily 3, 








35   BST2  
 bone marrow stromal cell 








 serpin peptidase inhibitor, clade 




11   ADAR  
 adenosine deaminase, RNA-








 solute carrier family 26 (sulfate 
























 phosphatidic acid phosphatase 












36493   MFSD2  
 major facilitator superfamily 














 chromosome 12 open reading 








 phosphodiesterase 4D 































 G protein-coupled receptor, 























 lectin, galactoside-binding, 











40443   PHF11   PHD finger protein 11  0.00268231 1.85963 
81803








 ribosomal protein S6 kinase, 




90   RAB43  
 RAB43, member RAS oncogene 








42   BAMBI  
 BMP and activin membrane-
bound inhibitor homolog 































 family with sequence similarity 




01   ISG20  
 interferon stimulated 








42576   RRBP1  
 ribosome binding protein 1 












 coronin, actin binding protein, 




78   IGFBP6  
 insulin-like growth factor binding 




09   PNPT1  
 polyribonucleotide 

























15   LBH  
 limb bud and heart development 












 killer cell immunoglobulin-like 







 ectonucleoside triphosphate 




72   GREM1  
 gremlin 1, cysteine knot 
superfamily, homolog (Xenopus 







 cellular retinoic acid binding 






















45   COG6  
 component of oligomeric golgi 







 meteorin, glial cell 




27   INA  
 internexin neuronal intermediate 






















 tumor necrosis factor, alpha-






27   PMAIP1  
 phorbol-12-myristate-13-










95   ACSL1  
 acyl-CoA synthetase long-chain 




29   COPZ2  
 coatomer protein complex, 




18   ULBP3   UL16 binding protein 3  0.0435273 1.74743 
78942








 solute carrier family 31 (copper 








 zinc finger, DHHC-type 












 TBC1 domain family, member 








 tubulointerstitial nephritis 
antigen-like 1  0.0156082 1.73451 
79989








00   LYPD3   LY6 0.000706136 1.72794 
78958




16   HLA-E  
 major histocompatibility 




16   HLA-E  
 major histocompatibility 
complex, class I, E  0.0214438 1.72538 
78951







 RAB27B, member RAS oncogene 











09   LIF  
 leukemia inhibitory factor 
















49   MLKL  
 mixed lineage kinase domain-




83   DDIT3  
 DNA-damage-inducible 




16   HLA-E  
 major histocompatibility 




15   UAP1  
 UDP-N-acteylglucosamine 




25579   NDEL1  
 nudE nuclear distribution gene E 
















 CCR4 carbon catabolite 






















 armadillo repeat containing, X-










43   GPT2  
 glutamic pyruvate transaminase 




02   NFKB2  
 nuclear factor of kappa light 




07   PYCR1  
 pyrroline-5-carboxylate 








 SH3-domain GRB2-like 








 UDP-Gal:betaGlcNAc beta 1,4- 




03   COG7  
 component of oligomeric golgi 








 ADP-ribosylation factor GTPase 








 cytochrome P450, family 27, 




59   PLAUR  
 plasminogen activator, 




27605   LIPA  
 lipase A, lysosomal acid, 







3   GRAM domain containing 3  0.0129393 1.67109 
80610








 chromosome 12 open reading 












 chromosome 10 open reading 




57   MORC4  
 MORC family CW-type zinc 


















52   ATP8B2  
 ATPase, class I, type 8B, 




57   NAP1L5  
 nucleosome assembly protein 1-
like 5  0.00626464 1.65123 
81480 NM_0025  NOV   nephroblastoma overexpressed 0.042079 1.65065 
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63   MOV10  
 Mov10, Moloney leukemia virus 











 carbohydrate (chondroitin 4) 




33   TCEAL8  
 transcription elongation factor A 







 family with sequence similarity 































 solute carrier family 35, member 




23   KCNK6  
 potassium channel, subfamily K, 








74   OAT  
 ornithine aminotransferase 












 cytochrome b-561 domain 
containing 2  0.00330491 1.63361 
79995
94 ---     0.0130072 1.62865 
79997
50 ---     0.0130072 1.62865 
79934
51 ---     0.0130072 1.62864 
79935








 chromosome 11 open reading 













 aspartate beta-hydroxylase 







 cyclin-dependent kinase 




87   DHDDS  
 dehydrodolichyl diphosphate 















 armadillo repeat containing, X-








 chromosome 6 open reading 







 DCN1, defective in cullin 







63   PCK2  
 phosphoenolpyruvate 




37   AMPD2  
 adenosine monophosphate 
deaminase 2 (isoform L)  8.86E-05 1.61189 
78948














79   GPR1   G protein-coupled receptor 1  0.0067493 1.60664 
80373







 butyrophilin, subfamily 3, 



























 chromosome 12 open reading 




44   TAP2  
 transporter 2, ATP-binding 




27   ABCG2  
 ATP-binding cassette, sub-family 


















 2-oxoglutarate and iron-
dependent oxygenase domain 




37   LPPR2  
 lipid phosphate phosphatase-




36   IFI27L2  
 interferon, alpha-inducible 



















5   solute carrier family 17 (anion 0.00666331 1.58646 
81497







 sema domain, immunoglobulin 




33   HMOX1   heme oxygenase (decycling) 1  0.0456024 1.58398 
78955






























 protein phosphatase 1, 














 solute carrier family 17, member 




33   TAP2  
 transporter 2, ATP-binding 




42   FKBP7   FK506 binding protein 7  0.00175355 1.57177 
78949








 pleckstrin homology domain 












24736   CD276   CD276 molecule  0.0016776 1.56766 
78929




55   HIAT1  
 hippocampus abundant 
transcript 1  0.0185598 1.56655 
79953








10   GFPT2  
 glutamine-fructose-6-phosphate 








 family with sequence similarity 




56   LEPRE1  
 leucine proline-enriched 


























 family with sequence similarity 








 solute carrier family 37 














 erythrocyte membrane protein 




26340   ORAI2  
 ORAI calcium release-activated 




























69   RAB6A  
 RAB6A, member RAS oncogene 




26   BET1L  
 blocked early in transport 1 




05   RDH14  
 retinol dehydrogenase 14 (all-















 Rho GTPase activating protein 








 MOB1, Mps One Binder kinase 
























15   CHPF2  
 chondroitin polymerizing factor 







 DnaJ (Hsp40) homolog, 




67   BCAR1  
 breast cancer anti-estrogen 




13   TGM2  
 transglutaminase 2 (C 
polypeptide, protein-glutamine-















56   GFPT1  
 glutamine-fructose-6-phosphate 












99   PIAS3  
 protein inhibitor of activated 






RNF19B   ring finger protein 19B  0.0206321 1.52974 
80702



















 Sec61 alpha 1 subunit (S. 







51   STS  
 steroid sulfatase (microsomal), 




44   TAP2  
 transporter 2, ATP-binding 




44   RAB6C  
 RAB6C, member RAS oncogene 







 TRIM6-TRIM34 readthrough 








 solute carrier family 12 




86   ULK4  
 unc-51-like kinase 4 (C. 















02   MOGS  
 mannosyl-oligosaccharide 
glucosidase  0.0119387 1.51031 
80225








22   TFAP2C  
 transcription factor AP-2 gamma 












 ADP-ribosylation factor GTPase 




77   CNTD2  
 cyclin N-terminal domain 














 dual specificity phosphatase 11 




24   HES1  
 hairy and enhancer of split 1, 







 DnaJ (Hsp40) homolog, 



















 chromosome 21 open reading 








88   TRAM2  
 translocation associated 


















SEC23A   Sec23 homolog A (S. cerevisiae)  0.0057885 1.49154 
78986 NM_0017  CDA   cytidine deaminase  0.025618 1.48875 
292 
 








 basic helix-loop-helix family, 












16   PATL1  
 protein associated with 
topoisomerase II homolog 1 











 adhesion molecule with Ig-like 








 solute carrier family 39 (zinc 








 solute carrier family 39 (zinc 








 solute carrier family 39 (zinc 










45   SERP1  
 stress-associated endoplasmic 
reticulum protein 1  0.000470728 1.48197 
78955



















21   RIPK2  
 receptor-interacting serine-




02   CDR2  
 cerebellar degeneration-related 




42393   NEDD9  
 neural precursor cell expressed, 








 family with sequence similarity 








 membrane-associated ring 




11   LANCL3  
 LanC lantibiotic synthetase 








49   TICAM2  
 toll-like receptor adaptor 




34   AOC3  
 amine oxidase, copper 
containing 3 (vascular adhesion 












 zinc finger protein 36, C3H type-




88   FAM3C  
 family with sequence similarity 
3, member C  0.00909144 1.46826 
79398 NM_0011   solute carrier family 39 (zinc 0.0116269 1.46723 
293 
 










24465   SOD2  
 superoxide dismutase 2, 




52   ABCC8  
 ATP-binding cassette, sub-family 




39   TGFB3  
 transforming growth factor, beta 







 MPV17 mitochondrial membrane 




87   GOSR2  
 golgi SNAP receptor complex 








 solute carrier family 31 (copper 






LRRC59   leucine rich repeat containing 59  0.000976533 1.46242 
79076










31677   RAB24  
 RAB24, member RAS oncogene 




98   AQP1  
 aquaporin 1 (Colton blood 








 pleckstrin homology domain 











 StAR-related lipid transfer 







 family with sequence similarity 






















04   BCAT1  
 branched chain 




59   HIP1R  
 huntingtin interacting protein 1 



















 basic helix-loop-helix family, 




88   FAM3C  
 family with sequence similarity 












 growth arrest and DNA-damage-







 TBC1 domain family, member 














 chromosome 3 open reading 












25   CKAP4  
 cytoskeleton-associated protein 


















 cysteine-serine-rich nuclear 




78   UBE2F  
 ubiquitin-conjugating enzyme 











26   ELOVL4  
 elongation of very long chain 




02   ARFIP2  
 ADP-ribosylation factor 








 protein kinase C, delta binding 




21   UBE2J1  
 ubiquitin-conjugating enzyme 








59   FLT3LG  
 fms-related tyrosine kinase 3 




66   BLZF1  
 basic leucine zipper nuclear 
factor 1  0.0191312 1.43549 
79044
80 ---     0.0335502 1.43546 
79049




60   ABHD4  
 abhydrolase domain containing 

















 coenzyme Q10 homolog B (S. 
cerevisiae)  0.0297971 1.43398 
80974








38   CASP7  
 caspase 7, apoptosis-related 







 sema domain, transmembrane 
domain (TM), and cytoplasmic d 0.00928872 1.43061 
78943
81 ---     0.0240954 1.42989 
78963



























 TBC1 domain family, member 
23  0.0380777 1.42389 
78932




94   TRAM1  
 translocation associated 







 Ras homolog enriched in brain 








 calcium binding and coiled-coil 







1   unc-93 homolog B1 (C. elegans)  0.0489471 1.4213 
78955
















 cerebral endothelial cell 
















31679   MSRB3  
 methionine sulfoxide reductase 







 SEC31 homolog A (S. 




36   PLD6  
 phospholipase D family, member 






ZNF398   zinc finger protein 398  0.0221567 1.41717 
80112










61   IL17RC   interleukin 17 receptor C  0.0388114 1.41546 
80585




55   KLF10   Kruppel-like factor 10  0.00306897 1.41476 
81803








 Rho guanine nucleotide 




62   VAMP4  
 vesicle-associated membrane 




19   TCIRG1  
 T-cell, immune regulator 1, 


















 family with sequence similarity 








 chromosome 10 open reading 















61616   RGL3  
 ral guanine nucleotide 








13   CRMP1  
 collapsin response mediator 




70   YIF1A  
 Yip1 interacting factor homolog 








44   GGA2  
 golgi associated, gamma adaptin 




1   ZRSR1  
 zinc finger (CCCH type), RNA-








68   CREB3  
 cAMP responsive element 








 family with sequence similarity 
114, member A1  0.00879035 1.39468 
78945












 solute carrier family 35 (UDP-








 solute carrier family 2 








45   DYRK4  
 dual-specificity tyrosine-(Y)-















 ankyrin repeat and sterile alpha 




86   PDP2  
 pyruvate dehyrogenase 




06938   TCEAL6  
 transcription elongation factor A 

















 CDC14 cell division cycle 14 

























 prostaglandin E receptor 4 








71   GOSR1  
 golgi SNAP receptor complex 








































01555   GRB10  
 growth factor receptor-bound 








32   DLK2  
 delta-like 2 homolog 
(Drosophila)  0.015154 1.37741 
78928




79   PSAT1  
 phosphoserine aminotransferase 








 TBC1 domain family, member 




52   UPRT  
 uracil phosphoribosyltransferase 








23   PHGDH  
 phosphoglycerate 



































88   FSCN1  
 fascin homolog 1, actin-bundling 




03   SRPRB  
 signal recognition particle 














98   PROSC  
 proline synthetase co-










85   TANC2  
 tetratricopeptide repeat, ankyrin 


























 SEC16 homolog A (S. 




28   COPG  
 coatomer protein complex, 











11   TBRG1  
 transforming growth factor beta 





























 solute carrier family 12 




68   MYD88  
 myeloid differentiation primary 




















04023   DYRK3  
 dual-specificity tyrosine-(Y)-

























 ankyrin repeat domain 27 (VPS9 
domain)  0.00806292 1.35353 
79329
60 ---     0.0401381 1.35347 
78928







 mitogen-activated protein 











































 sterile alpha motif domain 







 golgi phosphoprotein 3 (coat-











 zinc finger and BTB domain 




84   RSPO3  
 R-spondin 3 homolog (Xenopus 











 family with sequence similarity 
69, member A  0.0191944 1.34851 
81622








30   LPCAT1  
 lysophosphatidylcholine 




91   KCNJ2  
 potassium inwardly-rectifying 
















54   FRS2  
 fibroblast growth factor receptor 











 calcium channel, voltage-




26   NAPG  
 N-ethylmaleimide-sensitive 
factor attachment protein, 








48   DAPK3  
 death-associated protein kinase 




44   RAB6C  
 RAB6C, member RAS oncogene 















81 ---     0.0376108 1.33673 
81784











65   ELL3  
 elongation factor RNA 







 family with sequence similarity 




48   COG5  
 component of oligomeric golgi 




45   KCNK1  
 potassium channel, subfamily K, 








55   CBX4  
 chromobox homolog 4 (Pc class 
homolog, Drosophila)  0.0495441 1.33387 
78965




21   ELF4  
 E74-like factor 4 (ets domain 
















94   MFSD6  
 major facilitator superfamily 




10   PDIA5  
 protein disulfide isomerase 




17   HLA-C  
 major histocompatibility 




89   MFSD5  
 major facilitator superfamily 








 solute carrier family 35, member 








91   GCAT  
 glycine C-acetyltransferase (2-




42   ARAP1  
 ArfGAP with RhoGAP domain, 












10   SEZ6L2  
 seizure related 6 homolog 







 polymerase (RNA) III (DNA 
directed) polypeptide C (62kD) 0.0212257 1.32449 
81005










03   HIVEP3  
 human immunodeficiency virus 








 killer cell immunoglobulin-like 
receptor, two domains, l 0.0391197 1.32119 
81375






85   IFNAR2  
 interferon (alpha, beta and 




98   CREB5  
 cAMP responsive element 







 semaphorin 7A, GPI membrane 




32   BDNF  
 brain-derived neurotrophic 
















 transient receptor potential 







 ankyrin repeat and MYND 







 transmembrane BAX inhibitor 




46   NANS  
 N-acetylneuraminic acid 











 KDEL (Lys-Asp-Glu-Leu) 
endoplasmic reticulum protein 










GPR156   G protein-coupled receptor 156  0.00962717 1.31575 
78945












 killer cell immunoglobulin-like 




37   BTRC  
 beta-transducin repeat 
containing  0.0103385 1.31427 
79017



















 family with sequence similarity 




35   ACBD3  
 acyl-Coenzyme A binding 







 armadillo repeat containing, X-








92   NRBP1  
 nuclear receptor binding protein 











04   ANKIB1  
 ankyrin repeat and IBR domain 















 chromosome 9 open reading 











 DnaJ (Hsp40) homolog, 












53   GCC2  
 GRIP and coiled-coil domain 




24   ARID3A  
 AT rich interactive domain 3A 
(BRIGHT-like)  0.0330808 1.3092 
81109
















 SPT2, Suppressor of Ty, domain 














 ectonucleoside triphosphate 
















67   GGT3P  
 gamma-glutamyltransferase 3 








 pleckstrin homology domain 











17395   TMCC1  
 transmembrane and coiled-coil 




46   HDLBP  
 high density lipoprotein binding 








42   AOF1  
 amine oxidase (flavin 




93   ECM2  
 extracellular matrix protein 2, 




24947   YIPF5   Yip1 domain family, member 5  0.0416732 1.30131 
78931
36 ---     0.033156 1.30064 
79240








50   COPB2  
 coatomer protein complex, 














 eukaryotic translation initiation 






















39   FKBP10  
 FK506 binding protein 10, 65 




21   SNTB1  
 syntrophin, beta 1 (dystrophin-







 gamma-aminobutyric acid 




















03   ITGA2  
 integrin, alpha 2 (CD49B, alpha 








23   PI4K2B  
 phosphatidylinositol 4-kinase 


















 solute carrier family 25 




88   CLIP2  
 CAP-GLY domain containing 




57   MORC4  
 MORC family CW-type zinc 




45638   GPSM1  
 G-protein signaling modulator 1 








31617   COX19  
 COX19 cytochrome c oxidase 





























67   NAB2  
 NGFI-A binding protein 2 (EGR1 

















67   GGT3P  
 gamma-glutamyltransferase 3 






47   LZTFL1  
 leucine zipper transcription 











 SEC24 family, member A (S. 














44   RQCD1  
 RCD1 required for cell 
differentiation1 homolog (S. 








 RasGEF domain family, member 







 fibronectin type III domain 








51   STAT4  
 signal transducer and activator 













 golgi autoantigen, golgin 







 mitogen-activated protein 




46   RTKN   rhotekin  0.00453045 1.28249 
78927




38   FOXO4   forkhead box O4  0.0304929 1.28177 
80650




35   ACOX1  
 acyl-Coenzyme A oxidase 1, 























03   FBXL12  
 F-box and leucine-rich repeat 
protein 12  0.0166791 1.27606 
81803








 chromosome 20 open reading 








22   MIER3  
 mesoderm induction early 




79   MCFD2  
 multiple coagulation factor 







 pleckstrin homology-like 
domain, family B, member 3  0.00346149 1.27474 
78966
























 chromosome 9 open reading 








43989   NBPF4  
 neuroblastoma breakpoint 























68   PARS2  
 prolyl-tRNA synthetase 2, 







 carbohydrate (chondroitin 4) 








67   GGT3P  
 gamma-glutamyltransferase 3 












 thioredoxin domain containing 







 ATPase family, AAA domain 




06   ARL2BP  
 ADP-ribosylation factor-like 2 




02913   PTRH1  
 peptidyl-tRNA hydrolase 1 








 biogenesis of lysosomal 








02   EFHD1  
 EF-hand domain family, member 









phosphate 4-kinase, type II, 







 taste receptor, type 1, member 














93   F3  
 coagulation factor III 








 DnaJ (Hsp40) homolog, 




54   NAT9  
 N-acetyltransferase 9 (GCN5-




















 mitogen-activated protein 







 potassium channel 
tetramerisation domain 













 zinc finger, CCHC domain 







 chromosome 2 open reading 




01   APH1B  
 anterior pharynx defective 1 
homolog B (C. elegans)  0.0224002 1.26407 
78929




49   BAZ2A  
 bromodomain adjacent to zinc 












 family with sequence similarity 












 cytochrome P450, family 39, 







 secretory carrier membrane 













 mitogen-activated protein 







 chromosome 13 open reading 








 pleckstrin homology domain 







46   KIAA0746 protein  0.0445441 1.26135 
78955
62 ---     0.0244391 1.2613 
78941




18   POLK  
 polymerase (DNA directed) 


















 mitogen-activated protein 







 secretory carrier membrane 




18   NUB1  
 negative regulator of ubiquitin-




























18   KDM5B  
 lysine (K)-specific demethylase 







 olfactory receptor, family 2, 














 suppressor of Ty 5 homolog (S. 




60   MCL1  
 myeloid cell leukemia sequence 



































 low density lipoprotein receptor 




















30   RAB8B  
 RAB8B, member RAS oncogene 















 ATPase, H+ transporting, 







 family with sequence similarity 





Supplemental Table 4.  Clustering analysis of gene ontology terms for genes regulated by 
Creb3L1 T in HeLa cells. 
Gene Ontology term Fold Enrichment P-value 
Annotation Cluster 1 Enrichment Score: 9.25 
Golgi vesicle transport 6.9 2.9E-14 
Secretory pathway 3.7 3.0E-9 
Secretion by cell 3.3 1.4E-8 
secretion 2.8 8.1E-8 
Annotation Cluster 2 Enrichment Score: 5.2 
Intracellular transport 2.1 1.1E-6 
Cellular localization 1.8 1.1E-5 
Establishment of cellular localization 1.8 2.1E-5 
Annotation Cluster 3 Enrichment Score: 4.95 
Response to virus 5.3 3.7E-8 
Response to other organism 2.9 6.0E-5 
Multi-organism process 2.2 6.4E-4 
Annotation Cluster 4 Enrichment Score: 4.94 
Protein transport 2.1 2.9E-6 
Establishment of protein localization 2 3.6E-6 
Protein localization 1.9 1.8E-5 
Macromolecule localization 1.8 8.8E-5 
Annotation Cluster 5 Enrichment Score: 4.24 
PIRSF001733:rfp transforming protein 5.9 1.2E-5 
SPIa/RYanodine receptor SPRY 4.7 1.7E-5 
B302, (SPRY)-like 4.6 2.2E-5 
Butyrophylin-like 5.2 4.2E-5 
Domain:B30.2/SPRY 5.5 6.7E-5 
SPRY 4 9.7E-5 
SPRY-associated 5.6 1.7E-4 
PRY 4.7 5.7E-4 
Annotation Cluster 6 Enrichment Score: 4.2 
Localization 1.4 8.3E-6 
Establishment of localization 1.4 1.5E-4 
transport 1.4 1.9E-4 
Annotation Cluster 7 Enrichment Score: 3.29 
Positive regulation of cellular metabolic process 2.1 2.2E-4 
Positive regulation of metabolic process 2 3.1E-4 
Positive regulation of transcription 2.2 8.4E-4 
Positive regulation of nucleobase, nucleoside, nucleotide and 
nucleic acid metabolic process 
2.1 1.2E-3 
Annotation Cluster 8 Enrichment Score: 3.27 
Endoplasmic reticulum part 2 1.3E-4 
Nuclear envelope-endoplasmic reticulum network 1.9 9.1E-4 
Endoplasmic reticulum membrane 1.9 1.4E-3 
Annotation Cluster 9 Enrichment Score: 3.1 
Regulation of I-kappaB kinase/NF-kappaB cascade 3.7 2.0E-4 
Positive regulation of I-kappaB kinase/NF-kappaB cascade 3.7 3.8E-4 
I-kappaB kinase/NF-kappaB cascade 3 8.2E-4 
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Positive regulation of signal transduction 2.5 6.2E-3 
Annotation Cluster 10 Enrichment Score: 3.03 
Vesicle coat 5.3 9.2E-5 
Coated vesicle membrane 4.9 1.6E-4 
Golgi-associated vesicle 4.6 2.8E-4 
Membrane coat 4.3 5.0E-4 
Coated membrane 4.3 5.0E-4 
Cytoplasmic vesicle membrane 2.8 5.7E-3 
Cytoplasmic vesicle part 2.7 8.1E-3 
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